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In the ovary, following the preovulatory surge of gonadotrophins, but before
ovulation, follicular cells begin the changes associated with luteinization
which lead to the formation of the corpus luteum. Cells from the
preovulatory follicle differentiate into small and large luteal cells. The
corpus luteum is a transient endocrine organ which has a finite lifespan, and
is essential for the establishment and maintenance of early pregnancy in all
mammalian species, however, if no pregnancy occurs then it regresses. The
major secretory product of the corpus luteum is the steroid hormone
progesterone. Whilst the pattern of progesterone secretion during the
oestrous cycle is well established, the mechanism by which progesterone
leaves luteal cells in which it is synthesized and the regulation of this
synthesis is less well understood.
This project was designed to examine the intracellular location of
progesterone in bovine luteal cells. These experiments demonstrated the
existence of a particulate membrane fraction of luteal cells where much of
the endogenous progesterone was located. Results suggest an association
between this fraction and the plasma membrane. Moreover, it was shown
that these membranes were able to bind exogenous radiolabeled
progesterone in a highly specific manner. Other steroids, precursors etc.
were bound poorly. Thus, the experiments herein describe the
characterisation of this novel progesterone binding site, its distribution in the
cells of the bovine corpus luteum and preovulatory follicle, and attempts to
purify and identify the progesterone binding protein.
Results from these experiments indicated that the progesterone binding site
investigated was distinct from classical genomic progesterone receptors.
This non-classical progesterone binding protein (NCP4-BP) was found in
both large and small luteal cells of the corpus luteum, though levels were
greater in large cells. NCP4-BP was also found in the theca and granulosa
cells of the preovulatory follicle. Binding characteristics of the NCP4-BP
were determined, and partial purification achieved. Results demonstrated
that progesterone binding was not due to (i) steroid metabolizing enzymes,
(ii) non-specific intercalation of steroid into bi-layer membranes or (iii) the
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genomic progesterone receptor. Studies suggest that, given the pivotal role
of progesterone in the bovine oestrous cycle, and progesterone's potential
autocrine control over its own synthesis, that the membrane located
progesterone binding protein described herein is likely to be involved in the
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1.1 Endocrinology of the bovine oestrous cycle
The following is a summary of the secretory patterns of the hormones
controlling the oestrous cycle in cows. These hormonal secretion changes
and the effects they have are discussed further in following sections. Where
hormone secretory profiles are shown, it should be noted that the diagrams
are composite profiles from a number of studies to give an average,
representative secretory pattern, not absolute concentrations or times.
1.1.1 Luteinizing hormone (LH)
LH, secreted by the pituitary, follows the secretory pattern shown in Fig. 1.1.
From ovulation to day 5 basal LH secretion values remain constant. A small
increase in LH secretion has been observed between days 6 and 10; levels
then return to basal before a second increase which begins on day 17 and
culminates in the LH surge on day 20 (Schams et al, 1977). Basal LH
secretion values have been found to be in the range of 0.5 - 2.5 ng/ml and
LH surge values in the range of 20 - 40 ng/ml (Schams et al, 1977; Dobson,
1978). Following luteolysis, increases in LH secretion are thought to be due
to the increases in oestradiol secretion from developing follicles (Schams et
al, 1977). For simplicity, the diagram below does not show the pulsatility of
LH secretion. Experimental evidence indicates that pulsatility of LH
secretion is of more importance than basal circulating concentrations. LH
pulse frequency increases during the follicular phase of the oestrous cycle,
due to lack of progesterone suppression of its release (Wallace et al, 1988).
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Prior to the preovulatory LH surge, pulse frequency continues to increase,
doubling 24 hours after progesterone secretion has declined (due to
regression of the corpus luteum) (Baird & McNeilly, 1981). LH pulses are
closely followed by pulses of oestradiol and androstenedione from the
follicle (Bairdef al, 1976). Elevation of oestradiol levels at this time decrease
the pulse amplitude of pituitary secreted LH (Baird & McNeilly, 1981). It has
been suggested that follicular responsiveness to FSH may be modulated by
LH pulsatility; indicating a role of LH in conjunction with falling FSH
secretion in the induction of atresia in FSH deprived follicles (McNeilly et al,
1991). During the luteal phase in sheep, pulse frequency of LH is depressed
from ca. 1/hour to ca. 1/ 4-6 hours (Baird, 1978). From experiments
performed in cattle, it is suggested that progesterone exerts negative
feedback on the pulse frequency of LH secretion, thereby altering follicular
growth (Stock & Fortune, 1993). Control of oestradiol-17P secretion from the
dominant follicle is strongly associated with LH pulse frequency during the
follicular phase in cows. Small increases in pulse frequency are thought to
play a role in the maintenance of a dominant follicle; decreases in LH pulse
frequency are associated with a decline in follicular oestradiol production
and atresia of the dominant follicle (Stock & Fortune, 1993). Relationships




Figure 1.1 Peripheral plasma concentrations of LH during the bovine
oestrous cycle (data from Dobson & Kamonpatana, 1986; Dobson, 1978 and
Schams et al, 1977)
It has been reported that the LH surge occurs concomitantly with the peak of
oestradiol secretion (Schams et al, 1977), though measurements were of
urinary oestradiol and not plasma oestradiol. However, by assaying plasma
oestradiol it has been confirmed that both these hormones peak at
approximately the same time (Dobson, 1978). Oestrus occurs concomittantly
with the peak of oestradiol, and can be measured by decreases in the
electrical resistance of vaginal mucus, which reaches its lowest point at the
time of the LH peak (Schams et al, 1977). Administration of oestradiol to
ovariectomised cattle caused a small increase in the concentrations of acidic
LH isoforms, which have less bioactivity than basic LH isoforms. However,
differences in pituitary isoforms of LH do not differ from those found in
intact animals during the follicular phase, thus there would not appear to be
a significant effect of oestradiol on the ratios of LH isoforms found in the
bovine pituitary (Kojima et al, 1995).
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1.1.2 Follicle stimulating Hormone (FSH)
Secretion of FSH follows a pattern of small peaks leading to a main peak at
the same time as the LH surge (Schams et al, 1977) (Figure 1.2).
Days
Figure 1.2. Peripheral plasma concentrations of FSH throughout the bovine
oestrous cycle (Data from Schams et al, 1977; Dobson, 1978).
Studies have demonstrated that follicular growth correlates with increases in
FSH secretion (Schams et al, 1977). Apart from the preovulatory peaks, there
was little correlation between LH and FSH secretion in experiments where
measurements of both hormones have been performed (Schams et al, 1977;
Dobson, 1978). Thus there may be a separate mechanism of release, or, as
has been recently suggested, the secretion of FSH may be controlled by
inhibin in cows, which does not affect LH secretion (Turzillo & Fortune,
1990). A second peak of FSH has been reported (Dobson, 1978). This
secondary peak of FSH occurs approximately 24 hours after the preovulatory
surge, at the time of ovulation (Schams & Karg, 1969). The functional
significance of this second peak is uncertain, though it is suggested to have
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importance in the re-initiation of follicular growth after ovulation (Turzillo &
Fortune, 1990). The DNA sequence of the bovine FSH receptor has recently
been cloned, and the receptor shown to consist of 678 amino acids (Houde et
al, 1994). It was also demonstrated that in bovine granulosa cells, down-
regulation of the FSH receptor occurs at the mRNA level when exposed to
constant FSH levels (Houde et al, 1994). A number of isoforms of FSH exist
in the bovine pituitary. Studies have demonstrated that relative amounts of
these isoforms are not altered in response to oestradiol, and thus are unlikely
to be influenced during the follicular phase of the oestrous cycle (Kojima et
al, 1995).
1.1.3 Progesterone
On the two days preceding ovulation, and for a further three days post-
ovulation, progesterone levels are maintained at the lowest levels observed
throughout the oestrous cycle (approximately 0.2 - 0.6 ng/ml) (Schams et al,
1977). The low levels of progesterone secretion observed at this time are a
reflection of the cessation of progesterone secretory activity by the corpus
luteum following its regression. Progesterone secretion only increases from
day 4 onwards to approximately the tenth day after ovulation, with
circulating plasma levels of 6 - 8 ng/ml (Schams et al, 1977) (Figure 1.3).
Secretion of progesterone then decreases rapidly 5 days before the next
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Figure 1.3 Peripheral plasma secretory pattern of progesterone over the
bovine oestrous cycle. (Data from Dobson & Kamonpatana, 1986; Schams et
al, 1977)
There is some apparent disagreement over whether or not there is a
preovulatory rise in progesterone synthesis and secretion just prior to
ovulation. In some studies no preovulatory rise in progesterone secretion
was observed (Schams et al, 1977). However, in vitro experiments designed
to study the progesterone secreting ability of the bovine preovulatory
follicle, in which follicles were removed at various stages before and after the
preovulatory LH surge, have indicated that after the LH surge, but before
ovulation occurs, there is an increase in the progesterone synthesising ability
of follicular cells (Dieleman & Blankenstein, 1985). Up until the LH surge,
follicular steroidogenesis is mainly concerned with oestrogen production,
but after the LH surge, moderate levels of progesterone are produced by
follicular cells cultured in vitro (Dieleman & Blankenstein, 1985). 20 hours
after the LH surge, and continuing through to ovulation, there is a sharp 4-
fold increase in the amount of pregnenolone converted to progesterone in
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follicular cell cultures (Dieleman & Blankenstein, 1985), in agreement with
measurements of progesterone concentrations in follicular fluid of
preovulatory follicles removed 20 hours post-LH surge (Dieleman et al 1983).
It was suggested that this sharp increase in progesterone synthesis and
secretion, and its correlation with the morphological luteinization of
granulosa cell layer reflects granulosa-derived progesterone, and that the
smaller amounts of progesterone secreted prior to this time (20 hours post-
LH surge) are theca-cell derived (Dieleman et al, 1983b). However, though
thecal progesterone secretion in vitro increases after the LH surge, the
granulosa cells continue to contribute a major amount of total follicular
progesterone (Fortune & Hansel, 1979). Progesterone secretion during the
luteal phase is discussed in more detail in following sections.
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1.1.4 Oestradiol 17(3
The pattern of oestradiol-17(3 secretion is shown in Figure 1.4. This pattern
was determined in many studies by direct radioimmunoassay on bovine
plasma (Dobson & Dean, 1974). Other studies using measurement of urinary
oestradiol with correction of results for creatinine clearance have shown a
similar pattern (Schams et al, 1977).
Days
Figure 1.4. Plasma oestradiol secretory pattern over the bovine oestrous
cycle. (Data from Dobson & Kamonpatana, 1986; Dobson & Dean, 1974)
Increases in oestradiol-17(3 over the oestrous cycle are considered to be
reflections of follicular growth (Dobson & Dean, 1974). Some studies have
demonstrated that of the total oestrogens secreted, oestradiol 17a is present
in the largest proportion, in significantly greater quantities than oestradiol
17(3 (Dobson & Dean, 1974), though the significance of the proportions of
each epimer of oestradiol secreted is unclear. Concentrations of oestradiol
were observed to increase 4-5 days before oestrus, peaking at the time of
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oestrus (Dobson, 1978), with base values of approximately 1-6 pg/ml and
elevated peak values of approximately 10 pg/ml (Dobson & Dean, 1974).
1.2 Oestrus
The behavioural characteristics associated with the oestrous cycle, termed
oestrus behaviour, lasts between 12.5 - 27.5 hours in cows (Dobson &
Kamponpatana, 1986). For the effective use of artificial insemination in
cows, it is important to be able to recognise the symptoms of oestrus so that
the insemination can be timed correctly. This behaviour is characterised by
cows standing to be mounted, indeed, this is used by many dairy herd
owners to gauge the reproductive cycle stage that animals are at (Williamson
et al, 1972). Other signs include reddening and swelling of the vulva, and the
secretion of mucus from the vulva during oestrus.
The day of oestrus behaviour is termed day 0 of the bovine oestrous cycle.
In cows, this cycle lasts approximately 21 days. It has been reported that 85%
of cows display oestrus behaviour between days 18-22 (Asdell, 1964), with
ovulation occurring approximately 10 hours after the end of the display of
oestrous behaviour (Asdell, 1964). Though daylength has been shown to
influence reproductive timing (Bullman & Lamming, 1978) as has
environmental temperature and rainfall (Rahka & Igboeli, 1971), these
factors only appear to affect animals whose environment may show
extremes, such as domestic buffaloes found in Egypt and India (El-Fouly et
al, 1976), and have not been of major importance in temperate countries such
as Britain, in which dairy and beef cow production does not fall under full
control of these factors.
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1.3 Temporal endocrine relationships during the bovine oestrous cycle
It has been demonstrated that the increased secretion of oestradiol prior to
the preovulatory surge of LH (Schams et al, 1977) is made up of high
frequency, high amplitude pulses of oestradiol (Walters & Schallenberger,
1984). In ewes, it has been observed that such pulses of oestradiol are a
direct consequence of LH pulses stimulating the follicle (McNeilly et al,
1982). Experimental data from studies in cows have also demonstrated a
close similarity between LH pulse freqency and oestradiol pulse frequency
(Walters & Schallenberger, 1984). Whereas pulse frequency remained
similar for the two hormones, indicating a link between oestradiol and LH
secretion, pulse amplitude of oestradiol increased prior to the LH surge
(Walters & Schallenberger, 1984), indicating that the ovarian responsiveness
to LH may have increased (Staigmiller et al, 1982).
Prior to the LH surge, high oestradiol concentrations, secreted from the
follicle, appear to exert two types of feedback, positive and negative (Walters
& Schallenberger, 1984). Positive feedback occurs at the pituitary, by
sensitising the pituitary to pulses of GnRH from the hypothalamus (Kesner
et al, 1981), resulting in increased LH secretion in response to GnRH. Using
oestradiol treated ovariectomised cows and castrated steers as models (since
an oestradiol-induced LH surge occurs in oestradiol treated ovariectomised
cows but not in castrate steers), it has been observed that oestradiol
increased pituitary responsiveness to GnRH (Kesner et al, 1981). In both
animal models, treatment with exogenous GnRH after oestradiol treatment
induced an LH surge, though GnRH alone was incapable of this action
(Kesner et al, 1981). Moreover, results from these studies indicated that
maximal pituitary responsiveness to GnRH occurs some time before the
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oestradiol-induced LH surge occurs, suggesting that oestradiol suppresses
GnRH secretion at this time; it appears that this suppression is lifted some
time after oestradiol exposure (c. 12 hours), eliciting an LH surge (Kesner et
al, 1981). Though secretion of LH has been shown to increase in response to
high oestradiol concentrations (Walters & Schallenberger, 1984), pulse
amplitude of LH does not increase (Schallenberger et al, 1984). In rats it has
been demonstrated that oestradiol can reduce GnRH pulse amplitude but
not pulse frequency (Sarkar & Fink, 1980), and in ewes it has been observed
that LH pulse amplitude is closely related to GnRH pulse amplitude (Clarke
& Cummins, 1982), thus it has been suggested that in cows high oestradiol
concentrations, whilst increasing pituitary responsiveness to GnRH, decrease
the pulse amplitude of GnRH by negative feedback on the hypothalamus,
thereby decreasing the pulse amplitude of LH pulses from the pituitary
(Walters & Schallenberger, 1984). Ovariectomy in cows has demonstrated
enhanced pituitary levels of mRNA encoding for LHP, FSHP and the
common gonadotrophin a subunit (Cupp et al, 1995). Addition of exogenous
oestradiol at levels found during the bovine follicular phase to these
ovariectomised animals depressed levels of all gonadotrophin subunits
However, secretion of LH was enhanced (Cupp et al, 1995). Thus, though
secretion of LH during the bovine follicular phase is enhanced, the
expression of subunits for gonadotropins is not. Though overall secretion
of FSH was unchanged by this treatment, secretion frequency of FSH was
enhanced, suggesting that oestradiol regulates FSH and LH secretion at the
levels of the gonadotroph (Cupp et al, 1995). However, the change observed
in pulsatility of FSH secretion with oestradiol treatment does not take into
account the action of ovarian factors such as inhibin (Cupp et al, 1995) which
is known to suppress FSH secretion in ewes (Ying, 1988). However, these
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studies indicated that oestradiol plays a role in modulation of bovine FSH(3
expression which does not appear to be dependent on any other factors
(Cupp et al, 1995).
The trigger for the LH surge remains enigmatic. It does not appear that
increased pituitary sensitivity to GnRH is the sole cause of the surge (Kesner
et al, 1981). In both sheep (Baird & McNeilly, 1981) and cows (Walters &
Schallenberger, 1984), oestradiol secretion decreases immediately prior to the
LH surge, then increases as the surge commences. It has been postulated
that this decrease in oestradiol immediately prior to the preovulatory surge
of LH may be the trigger for the surge, since a decrease of circulating
oestradiol at this time could free the hypothalamus from the negative
feedback imposed on it by elevated oestradiol levels (Walters &
Schallenberger, 1984). Thus the amplitude of GnRH pulses could increase,
stimulating the pituitary, which, after oestradiol priming is maximally
responsive to GnRH at this time (Kesner et al, 1981), resulting in a maximal
pituitary response of high amplitude, high frequency pulses of LH,
characteristic of the preovulatory LH surge (Walters & Schallenberger, 1984).
Thus it appears that both increased pituitary responsiveness to GnRH and
increased secretion of GnRH are necessary to elicit the oestradiol-induced
preovulatory surge of LH (Kesner et al, 1981).
Concomitant with the preovulatory surge of LH, a surge of FSH occurs
(Walters & Schallenberger, 1984), though, whereas the LH surge may be up
to 20-fold greater than basal secretion, the surge of FSH has been observed to
be only 2-3 fold greater than basal secretion (Walters & Schallenberger,
1984). Pulses of these two gonadotrophins have been observed to occur
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simultaneously, indicating that the releasing hormone GnRH appears likely
to effect the release of both LH and FSH from the pituitary (Walters &
Schallenberger, 1984). However, as mentioned above, a second FSH peak
occurs some 4-12 hours post-preovulatory surge in cows (Dobson, 1978).
The mechanism controlling the secondary FSH surge is unclear. In sheep it
has been suggested that a secondary FSH surge is the result of decreased
inhibition of FSH release because of low oestradiol concentrations, whereas
in humans low oestradiol concentrations have been implicated with
inhibition of gonadotropin release (Johnson & Everitt, 1988). Experiments
in rats have demonstrated that exogenous administration of oestradiol has
little effect on the secondary FSH surge (Chappel & Barraclough, 1977).
Thus it has been postulated that in rats the secondary FSH surge is a result of
lowered inhibin concentrations allowing FSH secretion to increase above
basal values (Elias et al, 1982; Depaulo et al, 1979). However, in cows, the
secondary FSH surge has been demonstrated to be made up of high
amplitude, high frequency pulses of FSH, suggesting the involvement of
GnRH, as in the preovulatory surge of FSH (Walters & Schallenberger, 1984).
This has led to the suggestion that post-preovulatory surge alterations in
pituitary responsiveness to GnRH occur, allowing a selective response to low
GnRH concentrations and resulting in the secondary, post LH/FSH
preovulatory surge, surge of FSH (Walters & Schallenberger, 1984). In
ovariectomised ewes it has been observed that treatment with oestradiol to
levels comparable to late follicular levels in intact, cycling animals induces
an LH surge accompanied by a GnRH surge that lasts longer than the LH
surge (Moenter et al, 1990). This extended duration of the GnRH surge has
also been observed in cattle (Kesner et al, 1981). It has been suggested that
this may be the mechanism by which the LH surge is terminated ie. by
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down- regulation of GnRH receptors due to continuous exposure to elevated
GnRH levels (Moenter et al, 1990), since it has been demonstrated that
continuous exposure of ewes to exogenous GnRH decreases the number of
pituitary receptors for GnRH (Nett et al, 1981).
Progesterone secretion has also been demonstrated to increase at
approximately the same time as oestradiol secretion increases (Walters &
Schallenberger, 1984). This may be a result of functional luteinization
occurring in follicular cells before ovulation (Dieleman et al, 1983). Oxytocin
secretion has been observed to be low in the absence of a functional corpus
luteum (Walters & Schallenberger, 1984), even though high concentrations of
oxytocin have been found in the follicular fluid of bovine follicles prior to
ovulation (Schams et al, 1983).
1.4 Bovine follicular dynamics
Follicle development can be viewed as two main processes, follicle
recruitment and follicle selection. Follicle recruitment involves the
development of a number of follicles, recruited in waves. Follicle selection is
the subsequent development of a dominant follicle from the pool of follicles
which have undergone the initial stages of development. Initially, these
processes were examined by morphologic and histological examination of
ovaries removed post-mortem from cows at various stages of the oestrous
cycle. The development of techniques such as ultrasound imaging of cattle
ovaries have contributed much information in recent years, since this
technique allows the ovaries of a normally cycling animal to be examined
intact, via an intrarectal ultrasound probe.
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Follicle growth rates and developmental stages have been elucidated in cows
by a number of studies. These studies have demonstrated that early
follicular growth is due to proliferation of granulosa cells (Lussier et al, 1987).
Antrum formation is first detectable in follicles with a diameter of 0.14 - 0.28
mm (Lussier et al, 1987). Growth of follicles additional to the growth
observed due to granulosa cell proliferation appears to be a result of antrum
development (Lussier et al, 1987). It is postulated that two complete oestrous
cycles are required for a follicle to grow from antral size to preovulatory size
(Lussier et al, 1987). Antral follicles display slower growth than follicles in
the size range 0.68 - 3.67 mm; the increase in growth rate is thought to be a
reflection of an increase in mitotic index and a decrease in the duration of
mitosis (Lussier et al, 1987). Treatment of heifers with bovine somatotrophin
(BST) has been shown to increase the numbers of 2-5 mm antral follicles
(Gong et al, 1991). This suggests that growth hormone (GH) may be
implicated in folliculogenesis (Gong et al, 1991). Subsequent studies have
indicated that increased numbers of small antral follicles in response to BST
treatment may be via increased levels of IGF-1 or insulin (Gong et al, 1993
a;b). Moreover, increased small antral follicle numbers by BST treatment did
not affect the inhibitory influence of the dominant follicle on subordinate
follicle growth (Gong et al, 1993 a).
In individual cattle, the number of waves of follicles that are recruited in the
oestrous cycle has been shown to vary. Waves of follicle development were
first reported by Rajakoski (1960), who observed two waves in each oestrous
cycle, the first occurring between days 3-12 and the second between day 12
and the onset of oestrus. More recently it has been shown that each wave
consists of the development of 3-6 follicles > 5 mm (Fortune et al, 1988), one
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of which will develop to become the dominant follicle, whilst the others
regress. From studies in heifers, it has been observed that the oestrous cycle
has 2-3 waves of follicle development, three waves being the most common
(Savio et al, 1988; Gong et al, 1993a). Other studies have indicated that two
waves of follicle development may be more common than three (Ginther et
al, 1989a). Breed and parity are unlikely to be factors influencing the number
of waves an animal displays over the course of the oestrous cycle. Genetic
and/or environmental factors controlling the number of follicular waves are
unknown (Ginther et al, 1989a). The dominant follicle of the first wave
reaches its maximum size by day 6 (Savio et al, 1988). Follicles of the second
and third waves may grow either on the ovary that possessed the first wave,
or on the contralateral ovary (Savio et al, 1988). However, the
morphologically dominant follicle, (that is, the largest follicle observable by
ultrasound), may not be the functionally dominant follicle (Lavoir &
Fortune, 1990). Evidence for this comes from studies in which the ability of
follicles to ovulate in response to administration of a luteolytic dose of PGF2a
was examined. These results suggested that morphological dominance and
functional dominance were congruent during the development of the
dominant follicle, but when growth slowed and the development of the
dominant follicle had plateaued, the morphologically dominant follicle may
have lost functional dominance, since ovulation could occur in a follicle from
the second wave of follicular recruitment (Lavoir & Fortune, 1990). Thus the
use of follicle size alone as a criterion for assessment of dominance is
unsuitable in cattle (Fortune et al, 1991). In cycles where there are three
waves of follicle development, the morphologically dominant follicle of each
wave has been shown to be present on days 6 (first wave), 16 (second wave)
and 21 (third wave) (Savio et al, 1988). The period of detection (from follicle
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detection to atresia) was longer in dominant follicles from the first wave than
in subsequent waves. It has been suggested that the first dominant follicle
may be able to inhibit growth of other follicles, though the mechanism by
which it exerts this suppression of the second wave is unknown (Savio et al,
1988; Lazar & Maracek, 1994). Conversely, it has been observed that the
presence of a large oestrogenic dominant follicle actually promoted the
appearance of 5 - 10 mm diameter follicles at all stages of the oestrous cycle
(Lazar & Maracek, 1994). Ginther et al (1989a) noted that dominant follicles
did not begin to regress until after the next successive wave of follicles
appeared. Moreover, it was observed that the time interval (approximately 3
days) between the emergence of the next follicular wave and the
commencement of regression of the existing dominant follicle was similar to
the interval observed between the time at which a follicle displayed
morphological dominance and the point at which inhibition of the
subordinate follicles of the same wave occurred (Ginther et al, 1989a). In
cycles with only two waves of follicular development, growth of secondary
follicles was similar to the growth of secondary follicles in three wave cycles
(Savio et al, 1988). Whereas the secondary follicle in two wave cycles
continues to grow and then ovulate, in 3 wave cycles the secondary
dominant follicle regresses (Savio et al, 1988). A third dominant follicle,
presumably inhibited by the secondary dominant follicle, then develops and
grows at a comparable rate to that of the final phase of growth of a
secondary dominant follicle from a two wave cycle (Savio et al, 1988).
Growth rates of dominant follicles from the first and third waves are fastest
in the latter stages of follicle growth, suggesting that growth of the
secondary dominant follicle is slowed by the high levels of progesterone
secreted from the corpus luteum during the luteal phase, presumably by
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inhibition of gonadotrophs secretion from the pituitary (Savio et al, 1988).
Thus, depending on the time of luteal regression, the secondary dominant
follicle may either ovulate, or (if the luteal phase continues), become atretic,
in which case the third dominant follicle will ovulate (Savio et al, 1988).
Ovulatory follicles of three wave cycles tend to be smaller in diameter than
the ovulatory follicles of two wave cycles since the time between emergence
and ovulation may be up to 4 days shorter in cycles in which the tertiary
dominant follicle is the ovulatory follicle (Ginther et al, 1989). Three wave
cycles were also observed to be longer than two wave cycles by up to two
days (Ginther et al, 1989).
It has been suggested that a follicular wave in cattle is produced
approximately every seven days in response to basal gonadotrophin
concentrations (Fortune et al, 1991). Evidence to support this hypothesis
comes from the observation that animals which only exhibit two waves of
follicular development (ie. in which the second dominant follicle is destined
to become the ovulatory follicle) have both shorter cycles overall and shorter
luteal phases. Thus at the time of luteal regression, the second dominant
follicle remains the morphological and functionally dominant follicle and
ovulates (Fortune & Sirois, 1989). Moreover, in two wave animals, it was
observed that the first dominant follicle grew larger than that in three wave
animals; this existence of the larger first dominant follicle appears to delay
the onset of the second follicular wave (Fortune & Sirois, 1989).
The effect of cycle length on the number of follicular waves has been studied
in detail by prolonging the oestrous cycle to 30 days by administration of
exogenous progesterone at levels found during the luteal phase. Though
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some animals showed 4-5 waves of follicular development in this extended
cycle, others showed only the normal three waves (Sirois & Fortune, 1990).
Animals which were treated with lower doses of progesterone (1.5 ng/ml),
that is, sub-luteal phase concentrations, also displayed only three follicular
waves, and in some cases only two follicular waves, during the extended
cycle (Sirois & Fortune, 1990). These animals displayed prolonged final
waves associated with complete suppression of growth of other follicles,
indicating that subtle changes in progesterone levels, either directly or
indirectly, may have the ability to alter the timing of follicular waves and the
length of dominance displayed by dominant follicles (Sirios & Fortune,
1990). The regularity of follicular waves in cattle ovaries subjected to basal
concentrations of gonadotropins is further illustrated by the observation
that follicular waves continue during pregnancy in the cow (Ginther et al,
1989b). The preovulatory surge of gonadotrophins disturbs this balance of
repeated waves of follicular development by causing ovulation of the follicle
that is functionally dominant at the time of the surge (Fortune et al, 1991).
After the ovulatory surge of LFI and FSH, there is a secondary surge of FSH
approximately one day later (Dobson, 1978; Schams & Karg, 1969).
Inhibition of this secondary surge of FSH (by treating heifers with bovine
follicular fluid (bFF) containing inhibin which inhibits the secretion of FSH,
but not that of LH or progesterone) delays the onset of the first wave of
follicular development after ovulation by approximately two days (Turzillo
& Fortune, 1990). The early luteal phase increase in circulating oestradiol
was delayed for a similar time, as was the appearance of the second follicular
wave, leading to ovulation of the second dominant follicle in most of the bFF
treated animals (Turzillo & Fortune, 1990). These results suggest that the
secondary peak of FSH may be important in the initiation of follicular
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growth after ovulation, though a direct effect of the bFF on the ovary could
not be ruled out (Turzillo & Fortune, 1990).
1.5 Ovulation
Ovulation occurs in cows approximately 10 hours after the end of oestrus
(Asdell, 1964). The exact mechanism by which the ovulatory follicle
ruptures is unclear, but would not appear to be simply due to increased
intrafollicular hydrostatic pressure (Johnson & Everitt, 1988). As in other
species such as sheep (Murdoch & Dunn, 1983), prostaglandins are
implicated in the ovulatory process of cows (De Silva & Reeves, 1985).
Indomethacin, a substance known to block prostaglandin synthesis, has been
shown to prevent ovulation in cows when infused into the ovary below the
preovulatory follicle, but not when administered by intramuscular or
intrauterine injection, suggesting that local prostaglandin synthesis in the
ovary may play an important role in ovulation (De Silva & Reeves, 1985).
Additional support for the involvement of ovarian produced prostaglandin
in ovulation comes from in vitro studies in which synthesis of prostaglandins
by bovine follicular tissue has been demonstrated; moreover, this
prostaglandin synthesis was shown to be enhanced by LH (Shemesh &
Hansel, 1975a).
1.6 Luteinization
After the preovulatory gonadotrophin surge, but before ovulation, the
follicular cells of the ovulated follicle begin the changes associated with
luteinization (Niswender & Nett, 1988). These changes eventually lead to
the formation of the corpus luteum. Formation of this transient organ is a
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complex process, likened to that of wound healing and tumour formation
(Smith et al, 1994). Cells from the preovulatory follicle differentiate into
small and large luteal cells. Implicated in this process is an increase in the
diameter of the steroidogenic cell types (Farin et al, 1986). The morphology,
origins, functions and biochemical properties of luteal cells are discussed in
detail in following sections.
1.7 Morphology of luteal cells
In the bovine corpus luteum, at least five different cell types have been
described. The early descriptions were based on physical properties of the
cells examined such as size, morphology and staining (Foley & Greenstein
1958). It is now accepted that the corpus luteum of domestic ruminants
contains two steroidogenically active cell types; theca lutein cells (TLC)
derived from the theca cells of the preovulatory follicle, and granulosa lutein
cells (GLC) , derived from the granulosa layer of the preovulatory follicle
(Sinha et al, 1971; Mossman & Duke, 1973). These cell types are often termed
small (TLCs) and large (GLCs) because of their distinct size differences,
though recent developments in the study of the luteal cell types has
indicated that these terms may be somewhat misleading because of the
heterogeneity in size of each cell type and the controversy over the origins of
each cell type (Donaldson & Hansel, 1965; Alila & Hansel, 1984). Indeed, it
has recently been suggested that there may be sub-types of small luteal cells
from ovine corpora lutea, though no functional differences were noted
(Brannian et al, 1993). Nonetheless, in general TLCs are approximately 10-22
|im in diameter, and GLCs are considered to be >25 |im in diameter in cows
(Alila & Dowd, 1991). Approximately 40% of total luteal tissue is made up
of GLCs and 30% is TLC derived in the ovine corpus luteum (Rodgers et al,
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1984). Endothelial cells, fibroblasts and other vascular system associated
cells in conjunction with connective tissue make up the remainder of the CL.
What were previously described as Type 5 cells and thought to be
microvascular endothelial cells are now thought to be similar to immature
granulosa cells, and are suggested to play a role in the renewal of luteal cells,
though the origin of these cells and their importance in the lifespan of the
corpus luteum is at present unknown (Spanelborowski et al, 1994). Though
GLCs account for a larger percentage of the total cellular volume of the
bovine CL they are present in much lower numbers than small (TLC) cells.
A number of different studies have observed that there are 10-20 times more
small cells than large cells (O'Shea et al, 1986, 1989; Hansel et al, 1987).
However, tissue dispersion methods vary; separate studies have indicated
that bovine GLCs are more sensitive than TLCs to tissue dispersion (O'Shea
et al, 1989; Broadley et al, 1994) and thus may be numerically underestimated
in cell counts of dispersed luteal tissue.
Morphological features found in other steroidogenic cells are present in both
luteal cell types (Christensen & Gillim, 1969; Enders, 1973). Both cell types
contain numerous lipid droplets (presumably containing esterified
cholesterol stores for utilisation by steroidogenic enzymes), numerous
mitochondria (fewer in small luteal cells) and well-developed smooth
endoplasmic reticulum and Golgi. The nuclei of the two cell types are
morphologically distinct; large luteal cells possess spherical nuclei whereas
the nuclei of small luteal cells are irregular in shape (Koos & Hansel, 1981).
Large luteal cells display an ultrastructure consistent with not only
steroidogenic cells but also that normally found in cells whose function is the
secretion of protein (Fawcett et al, 1969), namely well developed Golgi and
rough endoplasmic reticulum. Large luteal cells also possess a more
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prominent surrounding basal lamina than small cells and have numerous
cell surface microvillous foldings (Enders, 1973). It has been observed that
large luteal cells contain many electron dense granules in their cytoplasm, of
approximately 0.2-0.4 |im in diameter. These granules have been
demonstrated to be distinct from lysosomes and microperoxisomes due to
their lack of acid phosphatase and catalase activity (Gemmell et al ,1974;
Gemmell & Stacy, 1979). Indeed, initial experiments suggested that these
granules were the 'missing link' in progesterone secretion, that is, they were
initially thought to contain progesterone in a protein-bound form and were
believed to transport progesterone for active secretion by luteal cells
(Gemmell et al, 1974; Stacy et al, 1976; Sawyer et al , 1979). At times of
elevated progesterone secretion numbers of these granules increased and
exocytosis of these granules could be observed. However, if this was the
mechanism of secretion of progesterone from luteal cells then it raises a
number of questions, not least that since small luteal cells contain no
secretory granules, then the mechanism of progesterone secretion must be
functionally different in the two cell types. Also, binding of exogenous
progesterone by these granules could not be demonstrated (Sernia et al, 1982;
Rice et al, 1986). Indeed, later studies in both sheep (Rice et al, 1986) and
cows (Guldenaar et al, 1984) demonstrated that these secretory granules
contained oxytocin and neurophysin, not progesterone. Subsequent studies
have demonstrated that the secretion of progesterone and oxytocin are
independent of each other in bovine luteal cells cultured in vitro (Luck, 1988).
The accepted theory of the mechanism whereby progesterone is secreted by
the luteal cell is that progesterone simply diffuses out of its cell of origin
down the concentration gradient set up between the progesterone producing
cell and the circulation (Enders, 1973; Carlson et al, 1983a). In the latter study,
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it was shown that progesterone intercalates into phospholipid bi-layers
which contain cholesterol, suggesting a simple diffusion mechanism for
progesterone release from the luteal cell across the plasma membrane
(Carlson et al, 1983a). Though this theory is still widely accepted, it has not
gone unchallenged, and the actual mechanism of progesterone secretion, if
indeed different to that proposed by Carlson, remains enigmatic.
1.8 Origin of luteal cells
Early studies in the porcine and guinea pig CL indicated that the cell types of
the corpus luteum were derived from both the thecal and granulosa cells of
the preovulatory follicle (Loeb, 1906; Corner, 1919). This theory of the
origins of luteal cells is still accepted today, and has been described in a
number of species including the cow (Donaldson & Hansel, 1965; Priedkalns
et al, 1968), the sheep (McClellan et al, 1975; O'Shea et al, 1980), the pig
(Corner, 1919) and human (Guraya, 1971), though more recent studies have
indicated that the divisions between the two cell types may not be as clear as
was previously thought. Since the initial suggestion in 1965 that small luteal
cells can transform to become large luteal cells (Donaldson & Hansel, 1965),
a wealth of studies have been performed to investigate the origins of luteal
cells in newly-formed and fully developed corpora lutea. Direct evidence to
support this theory of small to large cell conversion arose from studies in
which monoclonal antibodies specific to cell surface antigens for each
follicular cell type were used to probe luteal tissue from various stages of the
bovine luteal phase (Alila & Hansel, 1984). These studies found that in luteal
tissue from the early luteal phase, 70-80% of large luteal cells bound an
antibody raised to antigens on the granulosa cell surface whereas
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approximately 70% of small cells bound only the anti-theca cell surface
antigen antibody. However, in later luteal phase corpora lutea,
approximately 50% of the large luteal cells bound only the antibody directed
against the theca cell surface antigens (Alila & Hansel, 1984). The conclusion
reached from this was that two sub-populations of large luteal cells exist -
those derived initially from the granulosa cells of the preovulatory follicle
and others which develop from the small, theca cell-derived luteal cells as
the corpus luteum matures (Alila & Hansel, 1984). However, as mentioned
previously, tissue dispersion by enzymes does appear to preferentially
damage large luteal cells. Thus antigenicity of large luteal cells may be lost
during tissue disruption, and large luteal cells may be numerically
underrepresented in disrupted tissue cell subpopulations (Farin et al, 1986;
Braden et al, 1988; O'Shea et al, 1989). The possibility of the large luteal cells
which bind the antibody directed against small luteal cells actually being
"larger" small luteal cells cannot yet be completely discounted. Earlier
evidence for a small to large cell conversion was derived from studies in
which alkaline phosphatase (a commonly used plasma membrane marker)
was found, in early luteal tissue, to be confined to the plasma membrane of
the theca lutein (small) cells. In the preovulatory follicle it has been observed
that this enzyme is only found in theca interna cells, and is absent in the
granulosa cells of sheep, pigs and cows (Corner, 1948). Up to day 9 of the
luteal phase in cattle (Lobel & Levy, 1968) and day 8 in sheep (O'Shea et al,
1980) alkaline phosphatase activity was found only in small luteal cells, as
defined morphologically. After this time, alkaline phosphatase activity was
found in both small and large luteal cells, supporting the small to large cell
conversion theory. Indeed, more recent studies have indicated that, in
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sheep, LH has the ability to stimulate the conversion of small to large luteal
cells (Niswender et al, 1985a; Farin et al 1988).
One other theory of the origins of luteal cells exists. Whilst not in complete
agreement with those discussed, it does highlight the uncertainty involved
in pinning down exact cellular origins of luteal cells throughout the luteal
phase. From detailed morphometric analyses using cell ultrastructure rather
than cell size as the criterion to identify cell types of the ovine corpus
luteum, it has been demonstrated that the volume of the corpus luteum
occupied by each cell type remains relatively constant, though the ratio of
the numbers of small : large cells increases throughout the luteal phase,
(Farin et al, 1986). It was observed that whilst small luteal cells expanded in
numbers, their size remained constant; large luteal cells appeared to expand
in size whilst the numbers of large luteal cells did not appear to increase
significantly. Since it is difficult to differentiate between small and large
luteal cells by their respective sizes because of an apparent size similarity at
that time in the early sheep corpus luteum (Farin et al, 1986), it has been
suggested that the "small" luteal cells that appear to grow to become large
luteal cells were indeed always true "large" cells, but, in the early luteal
phase appeared small in size (Farin et al, 1986). Though compelling, this
data has not achieved the same acceptance as data derived from studies
using cell-type-specific antibodies. Figure 1.5 is a diagrammatic
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Figure 1.5 Diagrammatic representation of the origin of the two cell types of
the ruminant corpus luteum from the preovulatory follicle.
1.9 Functional differences between small and large luteal cells
The observation that the corpus luteum is made up of two morphologically
distinct luteal cell types raises the question of whether or not the two
steroidogenic cell types are also functionally distinct. With the advent of cell
separation techniques such as flow cytometry and centrifugal elutriation,
studies on isolated large and small luteal cell populations have begun to
clarify the differences in the functions of the two cell types.
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1.9.1 Large and small cell responses to luteinizing hormone (LH)
A very striking difference between the two cell types is found in the receptor
populations expressed by each type. Numbers of LH receptors found on
small cells are much higher than numbers localized to large cells,
highlighting an important functional difference (Fitz et al, 1982). The control
of luteal steroidogenesis is exerted by both intra-ovarian paracrine factors
and endocrine factors produced elsewhere in the body. Probably the most
important endocrine factor is LH, synthesised and secreted by the pituitary.
LH is considered to be the single most important factor involved in the
support and function of the corpus luteum in cattle. Classic experiments
that demonstrated LH to be the major luteotrophin were performed some
years ago. It was shown that exogenous LH can prolong the lifespan of the
bovine corpus luteum (Hansel, 1967; Hansel et al, 1973), that LH stimulates
progesterone production in vivo (Schomberg et al, 1967; Niswender et al,
1976) and in vitro (Armstrong & Black, 1966; Hansel, 1971) and that blockade
of the action of LH by a specific antibody to LH reduces progesterone
secretion and luteal mass in heifers (Snook et al, 1969). Radioligand binding
allowed the presence of the LH receptor to be demonstrated in specific
tissues and cell types. From studies in the rat corpus luteum, the LH
receptor was localized to the plasma membrane of luteal cells. In the rat
luteal cell, the LH receptors were found predominantly in regions
characterised by microvillous folds. In contrast, very few receptors were
found on the basolateral surfaces of the cells (Anderson et al, 1979). This has
since been demonstrated in a number of species. Indeed, LH receptor
binding of radiolabeled LH/hCG is widely utilised as a marker for the
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plasma membrane of luteal cells (Bramley & Menzies, 1988a; 1988b; 1993;
1994; Menzies & Bramley, 1994). The mechanism of action of LH (and hence
the mechanism of signal transduction from receptor to effector) has been the
subject of intensive experimental investigation. The LH receptor is a
member of the large family of seven-transmembrane guanosine nucleotide-
binding proteins (G-proteins) linked receptors, and displays sequence
similarity to other receptors involved in G-protein activation (Niswender &
Nett, 1994). The LH receptor structure comprises a 26 or 27 amino acid
signal peptide with a large N-terminal extracellular domain (333 to 341
amino acids) containing the hormone binding site(s) and six putative
glycosylation points (Loosfelt et al, 1989), seven transmembrane domains
and a seventy amino acid cytoplasmic C-terminus tail, which is involved in
G-protein activation (Niswender & Nett, 1994). The COOH terminal
intracellular tail has been shown to possess putative protein kinase C
phosphorylation sites, but is not thought to possess the sites required for
phosphorylation by protein kinase A (Loosfelt et al, 1989; Koo et al, 1991).
1.9.2 Action of LH receptor
The LH receptor is coupled to adenylate cyclase; binding of ligand (LH/CG)
to the receptor results in activation of this enzyme in the corpus luteum
(Marsh, 1975) by interaction with G-proteins . The G-protein complex which
activates (stimulates) adenylate cyclase is termed Gs (Abramowitz &
Birnbaumer, 1982; Gillman, 1984). G-protein complexes are heteromeric
proteins composed of three subunits designated a, (3 and y (Johnson &
Dhanasekaran, 1989). It is the a-subunit that possesses the ability to bind
guanine nucleotides; in the inactivated state (ie. no ligand bound to the
receptor) this binding site is occupied by GDP. Receptor activation of the G-
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protein complex occurs by catalysis of the exchange of bound GDP for GTP.
The binding of GTP to the a-subunit, which is a magnesium-dependent
process, brings about the dissociation of the trimeric complex subunits
(which in the inactivated state, form an a-fJ-y complex) to give free a-GTP
and p-y complex. It is the dissociated a-GTP complex that regulates the
activation of adenylate cyclase (Johnson & Dhanasekaran, 1989). The
activated a-GTP complex stimulates the catalytic subunit of adenylate
cyclase (Savard, 1973; Marsh, 1975), which in turn stimulates the conversion
of Mg-ATP to cAMP. The cAMP produced then binds to the regulatory
subunit of protein kinase A, which causes the dissociation of the catalytic
subunit of the protein kinase A. The catalytic subunit of protein kinase A
phosphorylates a number of luteal proteins, including some of the enzymes
involved in steroidogenesis and other related processes such as cholesterol
synthesis and LDL uptake. This response can be deactivated by the action of
phosphoprotein phosphatases which dephosphorylate the enzymes
phosphorylated by the catalytic subunit of the protein kinase A (Krebs &
Beavo, 1979). The intrinsic GTPase activity of the a-subunit ensures
hydrolysis of the GTP to GDP after a period of approximately 3-5 minutes.
Thus the a-P^y-complex is reformed until restimulation of the coupled
receptor occurs (Johnson & Dhanasekaran, 1989). Although there is some
uncertainty about the precise proteins phosphorylated by protein kinase A, it
has been suggested that in the luteal cell protein kinase A effects include
cholesterol esterase activation (Caffrey et al, 1979b), stimulation of the
cytochrome P450 cholesterol side chain cleavage complex (Caron et al, 1975)
and stimulation of the transport of cholesterol across the mitochondrial wall
(Hall, 1985) to the inner mitochondrial membrane where the side chain
cleavage system is localised.
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It is now apparent that activation of the LH receptor may activate other
second messenger systems in luteal cells. LH has been shown to stimulate
the Ca2+ polyphosphatidylinositol-protein kinase C pathway. Receptor
binding of LH activates phospholipase C. This in turn catalyses the
hydrolysis of phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-
triphosphate (InsP3) and diacylglycerol (DAG). InsP3 acts on specific
intracellular receptors in the endoplasmic reticulum, resulting in the
mobilization of Ca2+ from intracellular stores and a rise in intracellular Ca2+
concentration. DAG binds to protein kinase C (Nishizuka, 1984; Berridge,
1984), which then phosphorylates a number of different luteal proteins. Both
the rise in intracellular Ca2+ and protein kinase C (PKC) activation are
required to elicit a full biological response (Alila & Dowd, 1991). The bovine
corpus luteum has been shown to contain only the alpha and epsilon
isoforms of PKC, associated with the cytosol and plasma membrane
respectively (Orwig et al, 1994).
Further studies to elucidate the Ca2+-polyphosphatidylinositol-protein
kinase C pathway have demonstrated that calcium is required for the full LH
response of luteal cells in culture. When calcium was removed, the LH-
stimulated increase in progesterone secretion from small luteal cells was
reduced (Alila et al, 1990), in agreement with earlier studies which
demonstrated the ability of LH to mobilise intracellular stores of calcium in
these cells (Alila et al, 1989; Davis et al, 1987). This reduction of progesterone
secretion in the absence of calcium was only observed in small luteal cells in
response to LH stimulation; calcium removal had no effect on small cell
basal progesterone production (Alila et al, 1990). Moreover, in small cells,
the effect of calcium removal could not be negated by addition of 8-bromo-
cyclic 3',5' adenosine monophosphate (8-bromo-cAMP) suggesting that the
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effects of calcium on progesterone production stimulated by LH in small
cells were mediated after cAMP generation. Indeed, it was shown that
lowered calcium had no effect on cAMP production in response to LH or
PGE2 (Alila et al, 1990). Calcium was also demonstrated to be involved in
the basal secretion of progesterone from large luteal cells. Basal, LH- and
forskolin- stimulated progesterone secretion was reduced in the presence of
lowered calcium concentrations in the culture media. However, since
lowered calcium had little effect on large cell progesterone secretion in the
presence of 8-bromo-cAMP, the effect of calcium on large cell luteal
progesterone secretion was concluded to be exerted prior to the generation
of cAMP in these cells (Alila et al, 1990). It has been suggested from
experimental studies performed on sheep luteal cells that each luteal cell
type has distinct calcium influx regulatory mechanisms, and that calcium
regulation of progesterone secretion plays a more critical role in large cells
than in small luteal cells (Martinezzaguilan et al, 1994).
Recent studies have also demonstrated the likelihood of the involvement of
protein kinase C in transmembrane signalling in the bovine corpus luteum
(Davis, 1992). These studies have shown that although basal progesterone
secretion in mixed luteal cell populations was enhanced by protein kinase C
activators such as the tumour promoting phorbol ester, 12-0-
tetradecanolphorbol 13-acetate (TPA) (Brunswig et al, 1986; Hansel et al,
1987), synthetic diacylglycerol analogues (Brunswig et al, 1986) and
exogenous phospholipase C (Alila et al, 1988a; Benhaim et al, 1990), LH-
stimulated calcium mobilisation was inhibited, as was accumulation of
inositol mono-, bis- and tri-phosphates (Davis, 1992). No effects on
progesterone secretion were observed in control or LH-stimulated cells.
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Thus it was concluded that this mechanism of signal transduction from the
LH receptor was not required for acute LH-stimulated steroidogenesis
(Davis, 1992). It has been reported that concentrations of the phorbol ester
phorbol 12-myristate-13-acetate (PMA) in the region of 10 nM are
stimulatory to progesterone production, but that higher concentrations
inhibit steroidogenesis (Brunswick et al, 1986). Other studies involving
longer culture times of up to 4 hours have demonstrated that though cAMP
levels remain elevated, progesterone production is reduced in response to
chronic exposure to phorbol esters such as TPA, suggesting that for a
maximal steroidogenic response to gonadotrophin stimulation the
phospholipase C second messenger pathway may be of importance
(Brunswick et al, 1986; Budnick & Muckhopadhyay, 1987; Benhaim, 1990). It
was suggested that phorbol esters act on the coupling between the LH
receptor and the inositol-phospholipid-phospholipase C (Davis, 1992). In
small bovine luteal cells, activation of protein kinase C with the phorbol ester
PMA potentiated LH-induced increases in cAMP at a range of doses of LH,
though progesterone production was increased by PKC activation only at
low doses of LH. At higher doses of LH PKC activation was inhibitory to
progesterone production (Benhaim et al, 1987). It has been suggested that a
control system may operate to control the stimulatory response of small
luteal cells to LH. Thus, high doses of LH, in addition to stimulating
adenylate cyclase, may also activate PKC to control the stimulatory effects of
high LH concentrations (Benhaim et al, 1987).
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1.10 Ovarian steroidogenesis
The following is a brief review of ovarian steroidogenesis (see review by
Strauss and Miller, 1991). There is a great deal of interspecies variation in
not only the control of the enzymes involved in steroidogenesis, but also in
the actual steroidogenic enzymes present in the corpus luteum. Figure 1.6
shows ovarian steroidogenesis from cholesterol through to the production of
oestrogen (cholesterol acquisition and its control by LH is discussed in
Section 1.12 - LH mediated effects on steroidogenesis). However, as stated in
Section 1.12, in the bovine corpus luteum, the major product of the
steroidogenic process is progesterone since the aromatase enzyme and P450
C17a hydroxylase/c!7,20 lyase enzyme are absent.
Cytochrome P450S are so called because of the Soret absorbance band shift
from 420nm to 450nm when reduced in the presence of carbon monoxide
(Hall, 1986). All cytochrome P450S contain ca. 500 amino acids and possess a
haem binding region close to the carboxy (C) terminus (Strauss & Miller,
1991). The main requirements of these enzymes are reducing factors and
oxygen. Reducing agents are donated from NADPH, whose electrons are
transferred to the cytochrome P450 by a microsomal or a mitochondrial
electron transport chain which utilises a flavoprotein constituent (Strauss &
Miller, 1991).
Cholesterol side chain cleavage (Cytochrome P450SCC)
This is the enzyme that catalyses the first committed step of steroidogenesis,
the cleavage of the side chain of cholesterol, the net result being the removal
of 6 carbon atoms from the side chain (Strauss & Miller, 1991). This reaction
occurs in the inner mitochondrial membrane and yields pregnenolone; this is
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Figure 1.6 Possible routes of ovarian steroidogenesis (reproduced from
Turner, 1992)
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also the major rate limiting step of steroidogenesis (Strauss & Miller, 1991).
The overall equation for the reaction is:
Cholesterol + 3NADPH + 3H+ + 3O2 > Pregnenolone + isocapraldehyde +
4H20 + 3NADP+
The associated electron transport system consists of adrenodoxin reductase
and the iron-sulphur shuttle protein adrenodoxin (Miller, 1988). The slowest
event, and thus rate limiting step, of steroidogenesis is the binding of
cholesterol to the haem pocket of P450SCC (Strauss & Miller, 1991). The
reaction that proceeds entails 2 hydroxylations at C20 and C22, followed by
cleavage of the bonds between these carbons. Hence 3 pairs of electrons are
required, and 3 cycles of reduction/oxidation of adrenodoxin occur (Strauss
& Miller, 1991). Reducing agents are donated to the P450SCC by adrenodoxin
by cycles of reduction and oxidation. A 1:1 adrenodoxin : adrenodoxin
reductase complex is formed, resulting in catalytic reduction of
adrenodoxin+ to adrenodoxin-. The reduced adrenodoxin then disassociates
from the adrenodoxin reductase and forms a new 1:1 complex with P450SCC.
Adrenodoxin becomes oxidised, donates the electron from this oxidation to
the P450SCC, then recomplexes with the adrenodoxin reductase and is once
more reduced (Strauss & Miller, 1991). It appears that LH and cAMP are
responsible for the upregulation of P450SCC and adrenodoxin which occurs as
luteal development proceeds (Rodgers et al, 1986a). In cows it has been
shown that increasing levels of LDL can increase the synthesis of P450SCC in
cultured granulosa cells (Funkenstein et al, 1984). P450SCC is detectable in
both granulosa and theca cells in the bovine ovary, and, after formation of
the corpus luteum, both luteal cells types express this enzyme in increasing
amounts as the luteal phase proceeds (Rodgers et al, 1986a; b; c).
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Cytochrome P450 C17 (17a hydroxylase/C17,20 lyase)
As suggested by its names, this enzyme has two functions - (i) hydroxylation
of progesterone and pregnenolone at CI7, to yield 17a hydroxyprogesterone
and 17a hydroxypregnenolone, and (ii) conversion of the 17a hydroxylated
C21 steroids into the C19 androgens, androstenedione and
dehydroepiandrosterone (DHA). In bovine preovulatory follicles the major
androgen produced is androstenedione (Lacroix et al, 1974). However, the
major products of enzyme catalysis are dependent on various factors, eg. in
the presence of low substrate concentrations the CI 7 hydroxylation reaction
predominates (Zuber et al, 1986). A similar electron donor system to that
which operates with the side chain cleavage system is utilised by cytochrome
P450 C17 (Strauss & Miller, 1991). The main difference is that P450 reductase
is the flavoprotein utilised, rather than adrenodoxin reductase (Strauss &
Miller, 1991). Two electrons from NADPH are required. The first is
transferred from P450 reductase, the second from cytochrome bs (Miller,
1988).
In the ovary, Cytochrome P450 C17 is found only in the endoplasmic
reticulum of thecal cells, as demonstrated by immunocytochemistry
(Rodgers et al, 1986 a). This is integral to the two cell - two gonadotropin
hypothesis of steroid synthesis. Prior to ovulation in cows, follicular content
of this enzyme increases with follicular growth (Rodgers et al, 1986a).
However, after ovulation levels of Cytochrome P450 CI 7 are dramatically
reduced. Indeed, no detection of this enzyme in the early bovine corpus
luteum was evident (Rodgers et al, 1986c).
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The hydroxysteroid dehydrogenase family
These enzymes are located in the cytosol or microsomes, and require
NADP(H) and NAD(H) as cofactors (Strauss & Miller, 1991).
(i) 3fi-Hydroxysteroid dehydrogenase (313-HSD)
NAD+ is the cofactor used by this enzyme (Miller, 1988). 3fi-HSD catalyses
the conversion of pregnenolone to progesterone, 17a hydroxypregnenolone
to 17a hydroxyprogesterone, and DHA to androstenedione. There may be a
number of isoforms of this enzyme with individual specificities for different
substrates; however, identification of these isoforms in the ovary is as yet
incomplete (Strauss & Miller, 1991). This enzyme is not thought to be rate
limiting for steroidogenesis, and indeed its activity is in excess in the bovine
corpus luteum (Caffrey et al, 1979a). However, it has recently been
demonstrated that levels of 3C-HSD do come under control of non-ovarian
hormones, since it has been demonstrated that PGF2a causes a rapid, large
decrease in levels of 3fiHSD mRNA in the ovine corpus luteum (Hawkins et
al, 1993), which was suggested to be due to decreased synthesis and
increased degradation of the 3PHSD (Hawkins et al, 1993). Other studies
have demonstrated upregulation of 3pHSD transcription in response to hCG
stimulation in luteinised porcine granulosa cells (Chedrese et al, 1990).
Ovine 3PHSD is reported to be found in greater amounts in large luteal cells
than in small luteal cells. This is reflected in the progesterone output of these
two cell types (Hawkins et al, 1993). Thus, though perhaps not rate-limiting
in the classical sense, regulation of this enzyme by luteotrophic/luteolytic
factors does impose a form of regulation of progesterone secretion.
(ii) 17fi-Hydroxysteroid dehydrogenase (17fi-HSD)
This enzyme, located in the endoplasmic reticulum, is the catalyst for the
reversible conversion of oestrone to oestradiol-17fi, androstenedione to
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testosterone, and DHA to androstenediol. NADH and NADPH are utilized
as cofactors (Strauss & Miller, 1991).
(iii) 20a-Hydroxysteroid dehydrogenase (20aHSD)
This NADP(H) dependent enzyme appears to act catabolically in the ovary,
converting progesterone to the biologically inactive derivative 20a-
progesterone (Strauss & Miller, 1991).
Aromatase (Cytochrome P450aromatase)
This enzyme has been demonstrated to be specific to the granulosa layer of
the preovulatory follicle (endoplasmic reticulum), and, as in the case of C17,
is absent from the bovine corpus luteum (Savard, 1973). It is the aromatase
enzyme which catalyses the conversion (aromatization) of theca-derived
androgen to oestrogen (Miller, 1988). This process involves the loss of the
CI 9 methyl group via 2 hydroxylations, and a further hydroxylation of the
2f3-hydroxyl group (Miller, 1988). In the same manner that Cytochrome P450
CI7 utilises a P450 reductase electron transport, aromatase receives 3 pairs of
electrons from 3NADPH and 3 molecules of oxygen (Thompson & Siiteri,
1974a; b).
5 a reductase
NADPH is utilised as the cofactor for this enzyme. In the ovary, 5a
reductase acts on CI9 steroids to produce the 5a reduced androgens, and on
C21 steroids to produce steroids whose function is currently unknown
(Strauss & Miller, 1991).
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1.11 The two-cell-two-gonadotrophin hypothesis
The two-cell theory of follicular oestrogen secretion was proposed by Short
in 1962. Since then, the theory has been expanded and reworked to give the
two-cell-two-gonadotrophin hypothesis, which has now gained almost
universal acceptance. The theory proposes that the granulosa cells
synthesise oestrogen from androgen supplied by the thecal cells. Indeed,
immunocytochemical studies have demonstrated that the enzyme
responsible for the production of androgen (17a hydroxylase/C17,20 lyase)
is found exclusively in the theca cells of bovine preovulatory follicles
(Rodgers et al, 1986a). Synthesis of androgen in the theca is under the control
of LH at all follicular stages, principally through cAMP production
(Henderson et al, 1984). The preferred route in cows for the conversion of
cholesterol to androgens is the 5-ene-3f) hydroxysteroid pathway (Lacroix et
al, 1974). DHEA produced by this pathway is then converted to
androstenedione (Gore-Langton & Armstrong, 1988). It has been
demonstrated that the theca cells of cows can contribute to the overall
ovarian production of oestrogens (LacroLx et al, 1974), however, the extent to
which this occurs is minor as compared to oestrogen production by the
granulosa. Androgens derived from theca cells diffuse accross the basement
membrane to the granulosa cells where they act as substrate for the
aromatase enzyme. Control of aromatization in the granulosa cell is exerted
by FSH (Dorrington et al, 1975). It is now accepted that during granulosa cell
maturation LH receptors develop through a priming effect of FSH (Gore-
Langton & Armstrong, 1988). Thus LH also exerts some control over
oestrogen synthesis, but only in the preovulatory follicle. The other main
product of granulosa cell steroidogenesis is progesterone and its C21
metabolites, which are produced under the control of LH (Gore-Langton &
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Armstrong, 1988). In vitro, increased synthesis of androgen by cultured
theca cells is associated with increased expression and activity of cl7,20
lyase. Both cell types express side chain cleavage and synthesise
progesterone and pregnenolone in cows (Lacroix et al, 1974).
1.12 LH mediated effects on steroidogenesis
There is much interspecies variation in almost all aspects of the function and
regulation of corpora lutea, and the steroidogenic capacity of corpora lutea
varies dramatically from species to species. For example, the bovine corpus
luteum secretes no oestrogens, unlike that of the human, secreting only the
simplest steroidal products (in terms of the number of enzymatic reactions
involved), progesterone, pregnenolone and 20(3-hydroxy-4-pregnen-3-one,
with progesterone being by far the major secretory product (Mason et al,
1962). The bovine corpus luteum appears to lack the 17a-hydroxylase/C17,
20 lyase enzyme responsible for the formation of C19 androgens, and thus
secretion of these steroids is absent (Savard, 1973). Indeed, gene expression
of this enzyme is absent in the bovine corpus luteum (Lauber et al, 1991).
The bovine corpus luteum also lacks the ability to synthesise and secrete
oestrogenic steroids due to the absence of the aromatase enzyme (Savard &
Telegdy, 1965). The luteal cell can be influenced by LH through the scheme
of the events triggered by LH binding to its receptor as detailed above. The
increase of cAMP dependent protein kinase is thought to have a number of
effects on steroidogenesis, though many of the proposed effects remain
putative. One of the major effects of cAMP dependent protein kinase
increases is the increase in protein synthesis by luteal cells (Niswender &
Nett, 1994). This is suggested to be due to an increase in the requirement of
carrier proteins to shuttle the various intermediates of steroidogenesis to the
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particular sites of the steroidogenic enzymes in the cell (Niswender & Nett,
1994), since sterols and steroids alone are insoluble in aqueous media. In
vitro, SCP2 (sterol carrier protein 2), a protein whose function is thought to
be the intracellular transport of cholesterol to the inner mitochondrial
membrane where it undergoes side chain cleavage to form pregnenolone
(Steinschneider et al, 1989) is a substrate for protein kinase C. Thus the
secondary Ca2+/ InsP3/DAG signalling pathway from the LH receptor may
exert some of its action via phosphorylation of SCP2. In the rat corpus
luteum, oestradiol has been shown to increase levels of SCP2 (McLean et al,
1989). Cholesterol utilised in the steroidogenic process has three main
origins, (i) de novo synthesis, (ii) LDL/HDL mediated uptake and (iii)
utilisation from intracellular pools of cholesterol ester. Cholesterol ester
hydrolase, (the enzyme which hydrolyses cholesterol esters to free
cholesterol for utilisation in steroidogenesis) has been demonstrated to be
activated through phosphorylation by cAMP dependent protein kinase
(Caffrey et al, 1979b), and thus is likely to be under regulation of LH
(Niswender & Nett, 1994). LDL receptor expression has been shown to be
increased by gonadotrophin stimulation in ovarian tissue (Strauss & Miller,
1991), presumably through increased transcription of the LDL receptor
mRNA (Golos & Strauss, 1987).
HMG-CoA reductase, the enzyme that catalyses the rate limiting step of de
novo cholesterol biosynthesis, is increased in cells stimulated by LH, at least
in part through increased transcription of the mRNA encoding for this
enzyme (Golos & Strauss, 1988). HMG-CoA reductase is also regulated by
negative feedback exerted by local factors. Hydroxysteroids (eg. 25-hydroxy
cholesterol) inhibit cholesterol and LDL receptor synthesis. In the rat ovary,
25 and 26-hydroxycholesterol are both potent inhibitors of the de novo
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cholesterol synthesis pathway. 26-cholesterol hydroxylase is inhibited by
progesterone and pregnenolone. This in turn reduces production of 26-
hydroxycholesterol allowing de novo cholesterol synthesis and LDL receptor
expression to be maintained (Strauss & Miller, 1991). It appears that the
regulation of expression of LDL receptor mRNA and HMG-CoA reductase
mRNA in response to negative feedback of sterols is through two different
routes, though as yet these have not been elucidated (Strauss & Miller, 1991).
The next point of LH regulation of steroidogenesis is the cholesterol side
chain cleavage enzyme, located in the inner mitochondrial membrane.
Levels of P450 see and its associated electron transport system consisting of
adrenodoxin and adrenodoxin reductase are increased in response to
gonadotrophin stimulation. It has been observed that cAMP analogues act
via cAMP dependent protein kinase to increase levels of synthesis and
accumulation of the respective mRNAs for the components of the cholesterol
side chain cleavage system (Goldring et al, 1987). In addition to the levels of
these enzymes, their actual enzymatic activities may also be modulated by
activation of the LH receptor. Cytochrome P450 see can be phosphorylated
by calcium dependent protein kinase C, and adrenodoxin by cAMP
dependent protein kinase, though the significance of these processes in intact
cells remains unknown (Strauss & Miller, 1991). Gonadotrophin stimulation
of large luteal cells is not essential for the continued expression of the
constituent parts of the cholesterol side chain cleavage system, unlike small
luteal cells where a large decrease in the activity of this enzyme is observed
when cAMP stimulation is removed (Aflalo & Meidan, 1993). However,
these experiments used bovine preovulatory follicle cells luteinized in
culture (Aflalo & Meidan, 1993). Whether the same regulatory mechanisms
exist in cells which luteinize in vitro or in vivo remains unknown. Finally,
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availability of cholesterol to the side chain cleavage system located in the
inner mitochondrial membrane also appears to be under some control of LH.
The intracellular transport of cholesterol is mediated, at least in part, by the
cytoskeleton. Substances which inhibit microfilament (but not microtubule)
formation have been shown to cause a decrease in steroidogenesis in
cultured bovine luteal tissue (Gwynne & Condon, 1982), and microtubules
are implicated in regulation of steroidogenesis by rat granulosa cells
(Carnegie et al, 1987). However, the exact processes by which components of
the cytoskeleton facilitate cholesterol movement remain to be elucidated
(Strauss & Miller, 1991). Carrier proteins such as SCP2 (see above) and fatty
acid binding protein may also play a part in the regulation of the
bioavailability of cholesterol to the inner mitochondrial membrane, though
again, these processes are poorly understood (Strauss & Miller, 1991).
The enzyme which catalyses the final conversion in bovine luteal
steroidogenesis of pregnenolone to progesterone is the 3[3-hydroxysteroid
dehydrogenase/A5-A4 isomerase (3S-HSD) enzyme. Present in excess in
ovarian cells, it has been suggested that this enzyme does not respond to LH
stimulation in the acute fashion of previously discussed responses, but
instead, 3p-HSD synthesis may reflect part of a longer term regulation of
steroidogenesis by LH in the corpus luteum (Niswender & Nett, 1994). End
product inhibition occurs with all of the enzymes discussed above
(Niswender & Nett, 1994). The affinity of 3|3-HSD for progesterone, its
product, is approximately six times greater than that of its substrate,
pregnenolone (Caffrey et al, 1979a). Oestradiol and testosterone have similar
high affinities for this enzyme (Caffrey et al, 1979a). Thus the question of
how progesterone synthesis can proceed without the products formed
inhibiting synthesis is raised. It is suggested that binding proteins sequester
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progesterone and thus prevent negative feedback effects on its own
production (Caffrey et al, 1979a; Rothchild, 1981). Secondarily, the high
blood flow to the corpus luteum may also help to keep levels of steroid
down (Caffrey et al, 1979a) by efficient removal into the blood.
1.13 Progesterone secretion
In general, the cAMP pathway of second messenger generation from the LH
receptor is considered to be the primary pathway in luteal cells, with the
Ca2+-InsP3/DAG pathway of secondary importance (Alila & Dowd, 1991).
The mechanisms of LH stimulated progesterone secretion are still not fully
understood. In large luteal cells from the bovine corpus luteum, basal
progesterone secretion is 5-10 fold greater than the basal secretion of
progesterone from small luteal cells (Koos & Hansel, 1981). Bovine large
cells cultured in vitro show little or no response to LH concentrations that
maximally stimulate progesterone production in small luteal cells (1-5
ng/ml) however, and concentrations of up to 100 ng/ml LH are required to
elicit an increase in progesterone production (Alila et al, 1988a). Thus it
appears likely that in vivo, large cells do not respond to LH stimulation,
since the levels of LH found in the circulation of ruminants are only of the
order of 5-10 ng/ml (Alila & Dowd, 1991). In sheep large luteal cells, which
possess LH receptors, little or no response to LH is observed (Harrison et al,
1987). Since other trophic substances such as PGE2 and PGI2 can mediate an
increase in progesterone secretion through the cAMP second messenger
system in bovine large cells (Alila et al, 1988b), as indeed do exogenous
cAMP analogues (Fitz et al, 1984; Silvia et al, 1984; Alila et al, 1988a), it
appears that the LH receptors of large luteal cells are uncoupled from the
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cAMP second messenger system (Hoyer et al, 1984; Hoyer & Niswender,
1986; Harrison et al, 1987; Davis et al, 1989). The mechanism of this apparent
uncoupling is as yet unknown (Alila & Dowd, 1991). It is also possible that
an apparent uncoupling may be simply an artifact produced by the process
of tissue disruption.
Intercellular communication between large and small luteal cells is also
implicated in the control of progesterone secretion. In sequential perifusion
systems of separated bovine luteal cell types, small luteal cell secretions were
observed to inhibit large luteal cell progesterone production, whilst large
luteal cell to large luteal cell perfusions produced the most progesterone
(Del Vecchio et al, 1994). Arachidonic acid was implicated in these effects
since the inhibitory effects of small luteal cells on large luteal cell
progesterone production could be negated by it, suggesting that exogenous
arachidonic acid increases the production of a small cell-derived luteotrophic
eicosanoid or inhibits production of a small cell-derived luteolytic eicosanoid
(Del Vecchio et al, 1994). Arachidonic acid added to a large to small luteal
cells perfusion arrangement inhibited progesterone secretion in small luteal
cells, perhaps through stimulation of oxytocin release (Del Vecchio et al,
1994). Contact dependant communication (via gap junctions) between
bovine luteal cells has recently been reported (Redmer et al, 1991). Small cell
to small cell and small cell to large cell contact dependent communication
was evident, however, this type of communication was not observed
between large luteal cells (Redmer et al, 1991). Other studies have shown
stimulatory effects of oxytocin on luteal cell progesterone production which
appear to be dependent on cell contact-mediated communication (Miyamoto
& Schams, 1991). Recent reports indicated that oxytocin had little effect on
progesterone production in bovine luteal cells in contact with each other (Del
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Vecchio et al, 1995). However, these studies excluded non-luteal cells from
the culture systems and thus the effects of oxytocin may be dependent on
luteal cell contact with non-luteal cells of the corpus luteum Contact
dependent communication between bovine large and small luteal cells
occurs at all stages of the luteal phase (Del Vecchio et al, 1995). Large and
small luteal cells in contact with each other secrete significantly more
progesterone in response to stimulation with LH than do separated large
and small cells, (Del Vecchio et al, 1995), underlining the importance of
intercellular contact between bovine luteal cells in luteal cell responses to
LH.
Basal bovine luteal progesterone secretion has been shown to be pulsatile
(Rossmanith et al, 1991). Pulse frequency was unaffected by hCG stimulation
of tissue slices of bovine corpora lutea perfused in vitro. However, the
amplitude and release rates of progesterone were increased (Rossmanith et
al, 1991; 1992). This pulsatile progesterone release was suggested to be due
to large luteal cells since it appeared to be independent of LH stimulation.
Furthermore, the antiprogesterone ZK 96.734 increased the amplitude and
frequency of the progesterone pulses, suggesting that progesterone exerted
inhibitory effects on its own release by short, local inhibitory progesterone
feedback in the bovine corpus luteum (Rossmanith et al, 1991). In sheep, it
has been demonstrated that secretion of progesterone from the corpus
luteum in vivo is episodic during the early and late luteal phase (McNeilly et
al, 1992). Suppression of LH release had no effect on pulsatile progesterone
secretion, indicating that pulsatile progesterone secretion was not LH
dependent (McNeilly et al, 1992). It has been suggested that the intrinsic
pulsatile release of progesterone is maintained, and progesterone secretion
optimised by hCG stimulation of the bovine corpus luteum in vitro
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(Rossmanith et al, 1992). LH support of the corpus luteum is required during
its formation and development in cows (Peters et al, 1994), and insufficient
LH support during the early stages of luteal development reduced large
luteal cell populations in the corpus luteum, suggesting that LH induced
differentiation of small luteal cells to large luteal cells (Peters et al, 1994).
Recently, steroids have been implicated in the control of the cells from which
they are produced. The regulation of steroidogenic cells by steroids was
proposed by Rothchild in 1981, who suggested that progesterone may have
the ability to stimulate its own synthesis and secretion. Evidence for this
arose from observations that (i) a direct relationship existed between
intraluteal progesterone concentrations and the rate of progesterone
secretion, and, as discussed above, (ii) a lack of correlation between
progesterone secretion and the luteotrophin (LH) thought to drive
progesterone secretion (Rothchild, 1981). Also, progesterone is known to
activate cholesterol esterases (Caffrey et al, 1979b), thereby increasing
substrate availability for its continued synthesis. Recently, steroid receptors
have been described in the corpus luteum of a number of species, principally
the primate corpus luteum. Primate luteal tissue has been shown to possess
classical receptors for androgens (Hild-Petito et al, 1991; Zelinski-Wooten et
al, 1994) and progesterone receptors (Aladin Chandrasekher et al, 1994), but
not oestrogen receptors (Aladin Chandrasekher et al, 1994). It has been
suggested that androgens may be inhibitory to progesterone production in
the primate corpus luteum (Hild-Petito et al, 1991). There is disagreement
over the numbers of progesterone receptors present in the corpus luteum
throughout the luteal phase. Some workers report changes in levels
throughout the luteal phase of primates (Hild-Petito et al, 1988;) and humans
(Horie et al, 1992), with peak numbers present at mid-luteal phase which
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gradually decline towards the end of the luteal phase, and, low levels of
progesterone receptor mRNA in early primate luteal tissue which increase
by the mid-luteal phase and are then maintained throughout the luteal phase
(Duffy & Stouffer, 1995). In contrast, others report no changes in luteal
progesterone receptor content throughout the human menstrual cycle
(Duncan et al, 1994). Studies have indicated that LH, in addition to
promoting progesterone secretion during luteinization, also promotes
progesterone receptor expression (Hild-Petito et al, 1988; Aladin
Chandrasekher et al, 1994). The intracrine/paracrine actions of steroids on
the corpus luteum are as yet poorly understood, though this work is at
present still in a period of relative infancy, and current investigations may
throw light on the mechanism whereby progesterone controls its own
synthesis and secretion from luteal cells.
Though large luteal cells are thought to have a much higher basal output of
progesterone, small luteal cells (by virtue of their greater numerical
representation in the corpus luteum and their responsiveness to LH) are
thought to make a significant contribution to the total progesterone output of
the bovine corpus luteum (Koos & Hansel, 1981). In this study (Koos &
Hansel, 1981), contamination of large luteal cell populations with clumps of
small luteal cells was taken into account and results of progesterone output
measurements corrected accordingly, enabling effects of LH and PGF2a on
large and small luteal cell populations to be studied. In the absence of LH,
the progesterone output of large luteal cells was approximately twenty fold
greater than that of small luteal cells, however in response to LH stimulation
the output of progesterone from large luteal cells increased only slightly,
whereas that of the small luteal cells increased eleven-fold in the first hour of
LH stimulation, and continued to increase over the three hour culture period
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(Koos & Hansel, 1981). At low concentrations of LH, small cells continued to
respond, but no increased progesterone secretion was observed from the
large luteal cell culture. Neither cell type responded to PGF2a, either alone
or in conjunction with LH. Moreover, neither cell type appeared to have the
ability to convert exogenously added testosterone to oestradiol (Koos &
Hansel, 1981), agreeing with the generally accepted theory that the bovine
corpus luteum contains no aromatase enzyme and hence is incapable of
oestradiol synthesis. (Savard, 1973). However, other studies have shown
that both large and small cells from bovine corpora lutea respond to PGF2a
stimulation by increasing progesterone production (Alila et al, 1988a). These
experiments demonstrated that basal progesterone secretion from small
luteal cells was stimulated by PGF2a (via PKC activation), but whereas
PGF2a potentiated LH-stimulated progesterone secretion in small cells, this
effect was reversed in large luteal cells (Alila et al, 1988a; b). No effect of
PGF2a on large luteal cell basal progesterone secretion was observed (Alila et
al, 1988a). Given the low response to LH observed in large luteal cells, it
would appear that small luteal cells are the luteal cell type which respond to
the stimulatory effects of PGF2a (Alila et al, 1988a). PGI2 and PGE2 have
both been demonstrated to stimulate progesterone production in small and
to a lesser extent, large luteal cells, and thus may play an important
paracrine regulatory role, however, in large luteal cells these stimulatory
effects can be abolished by PGF2a, suggesting that large luteal cells are the
target for the luteolytic action of PGF2a (Alila et al, 1988b).
The number of LH receptors present in the corpus luteum is in a state of
dynamic flux, and varies with the stage of the luteal phase. Numbers of
luteal LH receptors correlate with the weight of the corpus luteum and its
levels of progesterone secretion (Diekman et al, 1978a). The percentage of
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occupied LH receptors at the time of maximal progesterone secretion in the
ewe corpus luteum is approximately 0.6% (Diekman et al, 1978a). Similarly,
during the mid-luteal phase of the cow maximum progesterone secretion
occurs and maximum numbers of LH receptors are found (Rao et al, 1976).
However, the luteal expression of LH receptor was more highly correlated
with progesterone secretion than with circulating levels of LH (Niswender et
al, 1985a). Indeed, in in vitro studies of early bovine corpora lutea,
exogenous progesterone increased numbers of LH receptors, as did forskolin
treatment, perhaps via increased progesterone production (Jones et al, 1992).
Presumably, increases in receptor numbers in the presence of low
circulating levels of LH may enable the corpus luteum to maximise its
response to LH by ensuring a large supply of unoccupied receptors
(Niswender & Nett, 1994). LH also controls the numbers of LH receptors
found in the corpus luteum. Indeed, increased concentrations of LH initially
'up-regulate' the number of LH receptors, followed by a reduction in the
numbers of LH receptors, which appears to indicate a correlation between
the numbers of occupied receptors and the numbers of receptors lost
(Niswender et al, 1985a). Though the mechanism for up-regulation of LH
receptors is unclear, down-regulation (receptor loss) occurs through the
process of receptor-ligand internalisation (Niswender et al, 1985a). It is
thought that the LH receptor : LH complex is internalised by the cell, and
subsequently degraded by lysosomal enzymes, leaving the free receptor
which can then be recycled back to the luteal cell surface (Niswender & Nett,
1994).
1.14 Oxytocin
Though progesterone is considered to be the single most important product
of the bovine corpus luteum, other hormones are also synthesised and
secreted in significant amounts. In the preovulatory follicle of cows,
oxytocin is synthesised and secreted predominantly by the granulosa cells
(Voss & Fortune, 1991). The ability to secrete oxytocin is greatly enhanced in
the late follicular phase, after the LH surge (Voss & Fortune, 1991). Oxytocin
was demonstrated to increase progesterone production by granulosa cells,
suggesting a possible autocrine role of oxytocin in the control of granulosa
cell steroidogenesis (Aladin Chandrasekher & Fortune, 1990). The corpus
luteum of the cow contains considerable amounts (0.4 - 1.8 pg/g) of oxytocin
(Alila & Dowd, 1991). Bovine large luteal cells synthesise and secrete
oxytocin (Ivell & Richter, 1984). Oxytocin is packaged in secretory granules
(Rice & Thorburn, 1985), and is released from the corpus luteum
concomitantly with its carrier protein, neurophysin (Sawyer et al, 1986).
Levels of mRNA encoding oxytocin are minimal before ovulation, however,
the mRNA coding for oxytocin is detectable in luteal tissue from the early
luteal phase (Fehr et al, 1987), and the proportion of mRNA to total mRNA
increases dramatically at the time of ovulation (Ivell et al, 1985). Secretion of
oxytocin is maximal during the mid-luteal phase, and decreases back to
preovulatory levels as the corpus luteum regresses (Alila & Dowd, 1991).
The factors regulating the synthesis and secretion of oxytocin are poorly
understood. In cows, injection of exogenous PGF2a stimulates increased
secretion of oxytocin (Schallenberger et al, 1984). This effect was not seen in
in vitro experiments (Hirst et al, 1986). Stimulation of oxytocin secretion in
vitro was observed when ovine luteal cells were stimulated with PGF2a;
however, this effect was limited to tissue collected on day 6 of the ovine
oestrous cycle, and tissue from day 12 showed no response (Cooke &
Ahmad, 1994a). It was suggested that the effects of PGF2a on the secretion of
oxytocin in vivo may be due to the changes observed in the blood supply to
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the corpus luteum observed at the onset of luteal regression which are
attributable to PGF2a (Hirst et al, 1986). In vitro, a number of different factors
have been shown to stimulate oxytocin secretion, including the
secretagogues CuATP and MgATP (Rice et al, 1986), arachidonic acid and its
metabolites (Hirst et al, 1988), IGF-1 and insulin (McArdle & Holtorf, 1989;
Sauerwein et al, 1992). Conversely, administration of exogenous oxytocin
has been shown to cause a release of PGF2a into the uterine vein of
progesterone primed cattle (Milvae & Hansel, 1980b). However, injection of
oxytocin does not induce luteolysis, except on days 2 - 6 of the oestrous cycle
(Hansel & Wagner, 1960; Ivel et al, 1985). It has been suggested that this
impairment of normal luteal function is due to interference with the normal
processes of oxytocin synthesis and secretion (Hansel & Dowd, 1986).
Administration of oxytocin at this time has been shown to impair the ability
of the corpus luteum to synthesise the luteotrophin PGI-2, (see next section)
but not the luteolysin PGF2a; though progesterone production was not
impared significantly, the luteal cell's ability to respond to LH was
diminished (Hansel & Dowd, 1986). The effects of oxytocin are discussed
further in Section 1.17, Luteal regression.
1.15 Arachidonic acid and arachidonic acid metabolites
The corpus luteum of the cow has been demonstrated to contain large
quantities of arachidonic acid (ca. 3 mg/g) which is mostly esterified in
membrane phospholipids (Lukaszewska & Hansel, 1980). The origins of
luteal arachidonic acid are unclear; some may be uterine derived (Shemesh
& Hansel, 1975b), whereas some may be derived from the action of
phospholipases on membrane phospholipids (Alila & Dowd, 1991). Infusion
of arachidonic acid directly into the bovine corpus luteum causes a decrease
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in the levels of plasma progesterone in vivo (Hansel & Fortune, 1978).
However, in vitro studies have observed increased secretion of oxytocin from
large cells and increased progesterone secretion from both luteal cells types
when arachidonic acid is added to culture media (Lafrance & Hansel, 1992).
In vitro, the bovine corpus luteum has the ability to bind significant
quantities of arachidonic acid (Shemesh & Hansel, 1975b). However, since
the metabolites of arachidonic acid also have known effects on luteal tissue,
attributing effects directly to arachidonic acid is difficult (Alila & Dowd,
1991). Important metabolites of arachidonic acid found in the bovine corpus
luteum are prostacyclin (PGI-2) (Nothnick & Pate, 1989) and 5-
hydroxyeicosatetraenoic acid (5-HETE). PGI-2, a product of the
cyclooxygenase pathway of arachidonic acid metabolism, is a potent
luteotrophin, causing increased progesterone synthesis and secretion both in
vivo and in vitro (Milvae & Hansel, 1980a). The corpus luteum of the cow
has higher levels of PGI-2 synthesis than any other tissue studied (Sun et al,
1977). It has been suggested that PGI-2 is required for normal development
of the early corpus luteum (Hansel & Dowd, 1986). Infusion of
indomethacin, an inhibitor of the cycloxygenase pathway, into the uterus in
the early luteal phase, inhibits normal CL formation (Milvae & Hansel, 1985).
In the late luteal phase, intrauterine infusion of indomethacin prolongs CL
lifespan, due to inhibition of PGF2a synthesis (Lewis & Warren, 1977). 5-
HETE, a product of the lipoxygenase pathway of arachidonic acid
metabolism, is luteolytic in the bovine corpus luteum (Hansel & Dowd,
1986). It is not known whether or not the bovine corpus luteum can
synthesise 5-HETE, but experiments have shown that this compound is
present in luteal tissue (Hansel & Dowd, 1986). In vitro, products of the 5-
and 15-lipoxygenase pathways have the ability to reduce progesterone
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secretion and levels of PGI-2, but do not affect PGF2a levels (Milvae et al,
1986). It is suggested that 5-HETE may be an important uterine derived
luteolysin (Hansel & Dowd, 1986), and 5-lipoxygenase products of
arachidonic acid metabolism may play a role in the control of luteal oxytocin
release (Cooke & Ahmad, 1994b).
1.16 Other substances implicated in bovine corpus luteum function
In addition to the products of the corpus luteum described above, other
substances are known to affect the function of the bovine corpus luteum.
Growth factors such as epidermal growth factor (EGF) have been implicated
in luteal function in the ewe, and the EGF receptor has been found in ovine
luteal tissue (Niswender et al, 1985b). However, no effects of EGF on the
production of progesterone in vitro have been observed (Battista et al, 1989a).
Transforming growth factor-alpha (TGFa) is expressed in the corpus luteum,
and has been immunolocalised predominately to large luteal cells; in the
preovulatory follicle it is known to have mitogenic and steroidogenic actions,
though its function in the corpus luteum remains under investigation (Lobb
& Dorrington, 1993). Insulin-like growth factor-I (IGF-1) immunoreactivity
has been localised to bovine large and small luteal cells, and insulin-like
growth factor-II (IGF-II) is localised to non-steroidogenic luteal cells, in
particular to the pericytes of capillaries and the perivascular fibroblasts of
luteal arterioles and venules, where it is suggested to play a role as an
autocrine growth factor (Amselgruber et al, 1994). In the rabbit corpus
luteum IGF-1 has been shown to be capable of maintaining progesterone
secretion to the same extent as LH during culture, suggesting a possible role
in the regulation of luteal steroidogenesis (Constantino et al, 1991). The
ruminant corpus luteum also contains amines such as adrenaline,
noradrenaline, seretonin and dopamine which stimulate progesterone
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production in vivo (Battista et al, 1987) and in vitro (Battista et al, 1989b).
However the mechanism of stimulation, the physiological roles and the
origins of these amines remains unclear (Alila & Dowd, 1991). In sheep,
conceptus proteins had no effects on PGF2a binding to large luteal cells,
however, they blocked events downstream of PGF2a receptor binding and
protein kinase C activation, since antisteroidogenic effects of phorbol ester
and calcium ionophores were abolished in the presence of conceptus
proteins (Wiltbank et al, 1992). Alpha interferon (INFa) has been observed to
stimulate progesterone production from the bovine corpus luteum in vitro
when given in low doses, and a role for conceptus proteins in the
maintenance of the bovine corpus luteum during pregnancy has been clearly
established (Luck et al, 1992). Recombinant bovine INFa I which has a 70%
sequence homology with bovine trophoblast protein-1 delays luteolysis
(Gaverick et al, 1992), and INFa I may act as an anti-luteolysin in sheep
(Parkinson et al, 1992). INFa may also lengthen the lifespan of the bovine
corpus luteum through suppression of luteal oxytocin secretion and
consequent interference with oxytocin-stimulated uterine release of PGF2a
(Plante et al, 1991). However, inseminated heifers given exogenous bovine
INFal at approximately the time when luteal maintenance by the conceptus
begins showed that INFa I had no enhancing effects on pregnancy rates
(Barros et al, 1992a). Rather, treated animals showed a slight reduction in
pregnancy rate as compared to controls (Barros et al, 1992a). Furthermore,
progesterone concentrations in plasma from cows treated with INFa were
reduced (Barros et al, 1992b). Since INFa suppressed pituitary LH secretion,
and since the decrease in circulating progesterone levels was not due to
enhanced rates of clearance of steroid, it was suggested that reductions in
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progesterone secretion were due to interference with pituitary LH driven
luteal synthesis of progesterone (Barros et al, 1992b).
Tissue inhibitor of metalloproteinases (TIMP-1) is a major peptide secretory
product of the ovine corpus luteum (Smith & Moor, 1991). The presence of
mRNA encoding TIMP-1 protein has been demonstrated in large and small
ovine luteal cells (Smith et al, 1994b). In addition to the inhibitory effects of
this protein on metalloproteinase action, TTMP-1 is also known to possess
growth factor activity (Hayakawa et al, 1992), though its role in luteal
function has not yet been elucidated. Beta-carotene, the lipid soluble
antioxidant which imparts the orange colour to the bovine corpus luteum,
appears to be necessary for normal luteal function in cows, since dietary
deficiencies lead to follicular atresia and disrupted luteal regression
(Lutwack-Mann, 1962). Moreover, lack of anti-oxidant activity has been
implicated in the crosslinking of P450scc to its electron donor adrenodoxin
(Young et al, 1995).
1.17 Luteal regression
The corpus luteum is a transient organ; if pregnancy does not occur luteal
regression takes place. The mechanism of luteal regression (luteolysis) has
been the subject of intensive investigation over a number of years. Whilst
the mechanism of luteolysis in domestic ruminants is not fully clear, more is
understood of the process of luteolysis in these species than in the primate
and human.
It has been recognised for some time that luteal regression in cows involves
the uterus. Hysterectomy prolongs the luteal phase (Wiltbank & Casida,
1956). Moreover, the uterus exerts its luteolytic effect(s) locally (Ginther et al,
1967). Removal of the uterine horn (unilateral hysterectomy) adjacent to the
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ovary that posseses the corpus luteum extended the lifespan of that corpus
luteum; removal of the uterine horn on the opposite side to the ovary with a
functional corpus luteum had no effect and luteolysis proceeded as normal
(Ginther et al, 1967). Thus, the uterine luteolytic factor does not reach the
ovary through the circulatory system of the body, but directly affects the
adjacent ovary (Niswender & Nett, 1994). Removal of vascular connections
between ovary and uterus prolongs luteal function and lifespan in cows.
Although there are no direct connections between the uterine vein and
ovarian artery, the two blood vessels are in intimate contact. The ovarian
artery is coiled round the uterine vein from the junction between ovary and
uterus all the way to the connections with the aorta and vena cava (Del
Campo & Ginther, 1973a,b). Where contact between the two blood vessels
occurs, thinner walls are found (Del Campo & Ginther, 1974). Although
removal of the uterine horn opposite to the functional corpus luteum does
not induce luteal regression, in both sheep (Ginther et al, 1973; Mapletoft &
Ginther, 1975) and cows (Mapletoft et al, 1976) surgical joining of the uterine
vein with the ovarian artery does induce luteal regression, but only in the
ovary adjacent to the uterine horn which was removed. Luteal regression in
unilaterally hysterectomised sheep and cows can also be demonstrated if the
ovarian artery from the side adjacent to the remaining uterine horn is
connected to the uterine vein from the hysterectomised side (Mapletoft et al,
1976). Thus it appears that uterine luteolytic factor(s) are transported
directly to the ovary by the close contact between ovarian artery and uterine
vein. In species where this contact is not present, (eg. horses; Ginther et al,
1972), local uterine effects of luteal regression do not occur (Niswender &
Nett, 1994).
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It was a number of years after the identification of the uterus as the site of
production of luteolytic effects that PGF2a was identified as the uterine
derived luteolytic factor. Luteolytic effects of PGF2a were initially described
in pseudopregnant rats (Pharriss & Wyngarden, 1969) but have been
demonstrated in a number of other species, including cows (Lauderdale,
1972; Liehr et al, 1972; Rowson et al, 1972). Treatment of cattle with
indomethacin (see above), which blocks PGF2a synthesis by inhibiting the
cyclooxygenase pathway of arachidonic acid metabolism, prevents normal
luteal regression (Lewis & Warren, 1977). Moreover, passive immunisation
of cattle (Fairclough et al, 1981) and sheep (Scaramuzzi & Baird, 1976;
Faiclough et al, 1976) to PGF2a prevents spontaneous luteal regression.
Endometrial concentrations of PGF2a in cows are highest during the time of
luteal regression (Shemesh & Hansel, 1975b). Thus, the major luteolysin of
the bovine corpus luteum is uterine-produced PGF2a. However, inhibitors
of the lipoxygenase pathway have also been shown to prolong the oestrous
cycle (Milvae et al, 1986). It has been suggested that arachidonic acid itself,
derived from the uterus, may also play a role in luteolysis (Alila & Dowd,
1991).
The mechanism by which PGF2a affects luteal cells appears to be exerted in a
number of ways. An early suggestion for the action of PGF2a on luteal cells
was that it decreased blood flow, leading to luteal tissue hypoxia and luteal
regression. However, although luteal blood flow during luteolysis is
reduced, it is still much greater than blood flow to the rest of the ovary
(Niswender et al, 1976). Indeed, the blood supply to the corpus luteum is
extremely high. Luteal blood vessels are primarily sinusoidal vessels rather
than capillary beds with arteriole supply (Koering & Thor, 1978). The
control of luteal blood flow is complex; trophic hormones such as LH
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increase ovarian blood flow but do not affect luteal blood supply
(Norjaavara et al, 1987; Wiltbarik et al, 1989a). It has been suggested that the
lack of vascular smooth muscle in early luteal tissue may be due to
formation of sinusoidal vessels from endothelial cells; with insufficient time
for growth and differentiation of smooth muscle in these vessels (Wiltbank et
al, 1990). It is at present unclear whether or not fully developed corpora
lutea posses greater development of these structures that permit active
regulation of luteal blood flow (Wiltbank et al, 1990). PGF2a causes a
decrease in luteal blood flow, with a concomitant rapid decrease in
progesterone secretion in sheep (Niswender et al, 1976) and cows (Heath et
al, 1983). The decrease in progesterone secretion is a reflection of a decrease
of 3|3HSD mRNA which occurs very rapidly in large ovine luteal cells in
response to PGF2a (Hawkins et al, 1993). These events are attributed to
increases in intracellular calcium levels and PKC activation in ovine luteal
cells. However, as previously discussed, PKC may be stimulatory to
progesterone production in the bovine corpus luteum, and the mechanism of
action of PGF2a may differ in these two species. Indeed, a number of
important differences between the ovine and bovine corpus luteum exist.
For example, in sheep PGI2, PGE2 and PGF2a have no affect on progesterone
synthesis in small luteal cells (Fitz et al, 1984a), however, all of these
substances increase small luteal cell progesterone production in the bovine
corpus luteum (Alila et al, 1988b). In addition, PGF2tt does not effect basal
progesterone synthesis in large bovine luteal cells (Alila et al, 1988a; b),
however, it is directly cytotoxic to large luteal cells from the ovine corpus
luteum (Fitz et al, 1984b). Nonetheless, PGF2a would appear to be the
luteolytic hormone in cows, though its exact mechanism of action has yet to
be elucidated in the bovine corpus luteum. It is unclear how the corpus
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luteum regresses in response to uterine PGF2a, whilst also synthesising
significants amounts of this substance (Alila & Dowd, 1991). It has been
suggested that the relative numbers of theca-derived and granulosa-derived
luteal cells, and thus the numbers of LH receptor-expressing large luteal cells
(small luteal cells which have developed into large luteal cells) may vary
between sheep and cows at particular stages of the luteal phase, giving rise
to some of the differences between the two species luteal cell responses to
prostaglandins. Luteal derived PGF2a may play a regulatory role over
bovine luteal progesterone production (Alila et al 1988a), and the effects of
prostaglandins are dependent on their concentrations, the proportion of each
luteal cell type present and the receptor content of the corpus luteum (Alila
et al, 1988b).
Concomitant with decreased progesterone secretion at the onset of
luteolysis, release of secretory granules takes place in large bovine luteal
cells (Heath et al, 1983). It has been suggested that this degranulation may
represent PGF2a-driven luteal secretion of oxytocin which may act on the
uterus to promote increased secretion of PGF2a (Heath et al, 1983). Following
the decrease in serum progesterone levels, the numbers of LH receptors in
the corpus luteum falls (Diekman et al, 1978b). In vitro, LH induced increases
of cAMP and progesterone secretion were blocked by PGF2a (Fletcher &
Niswender, 1982). Since it is the small luteal cells which possess LH
receptors, whilst large luteal cells possess receptors to PGF2a, a form of
cellular communication has been suggested between the two cell types
(Niswender & Nett, 1994; Pate, 1994). Communication between luteal and
non-luteal cells in the corpus luteum may also play a role in the transmission
of the luteolytic signal, in particular, communication with cells of the
immune system, which appear to be actively involved in luteolysis (Pate,
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1994). Indicative of this communication between ovine small and large
luteal cells is the observation that a luteolytic dose of PGF2a decreases the
number of large luteal cells within 12 hours of administration, whereas small
cell numbers do not decrease until around 24 hours after PGF2a
administration (Braden & Niswender, 1985). Moreover, Redmer et al (1991)
have demonstrated the formation of gap junctions between luteal cells in
culture. They suggest that contact-dependent communication may allow the
transmission of signals from cell to cell without the requirement that all cells
possess specific receptors for the hormone originally transmitting the signal.
Whereas large to small and small to small luteal cell contact-dependent-
communication was observed, (Redmer et al, 1991), contact-dependent-
communication was not observed between large luteal cells (Redmer et al,
1991). If luteolytic signals are transmitted by this form of communication,
large to large cell communication would not be required since large luteal
cells can already respond to PGF2a through specific PGF2a receptors.
However, large to small cell and small to small cell communication could
then allow the transmission of the luteolytic signal to all cell types of the
corpus luteum. Recently however, studies have indicated the binding of LH
and PGF2a to both large and small bovine luteal cells (Chegini et al, 1991).
Indeed, earlier studies have indicated the ability of both bovine luteal cell
types to respond to PGF2a and LH (Alila et al, 1988a; b) However, PGF2a
binding increased in large luteal cells to a much greater extent than in small
luteal cells from early to late luteal phase (Chegini et al, 1991), suggesting
that, functionally, large cells are more sensitive to the luteolytic signal of
PGF2a than are small luteal cells. Interestingly, specific binding of LH/hCG
to luteal blood vessels was also shown (Chegini et al, 1991). Thus the model
of luteal cell function in which small cells respond to luteotrophic (LH)
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stimuli, whilst large cells respond to PGF2a may require some revision, not
least from the observations that small bovine luteal cells appear to be
sensitive to PGF2a, responding with increased progesterone production
(Alila et al, 1988,a; b). Coupled with the apparent response of non-luteal
cells to trophic stimuli, the regulation of luteal function appears to be much
more complex than was previously thought.
The direct involvement of oxytocin in the process of luteal regression has
been suggested. The trigger for the release of PGF2a from the uterus is
thought to be the secretion of oxytocin from the corpus luteum (Flint et al,
1989) and the acquisition of oxytocin receptors by the endometrium. Early
studies demonstrated that treatment of heifers with high doses of oxytocin in
the first 7 days of the oestrous cycle impairs the development of the corpus
luteum (Armstrong & Hansel, 1959), though no effects were observed if
oxytocin was administered at the end of the cycle, before the onset of
luteolysis. Active immunization of sheep against oxytocin prolongs the
oestrous cycle (Sheldrick et al, 1980; Schams et al, 1983). In cows,
hysterectomy negates the effects of oxytocin on early luteal regression
(Armstrong & Hansel, 1959; Ginther et al, 1967), thus suggesting involvement
between oxytocin and the uterus. Oxytocin may also act directly on luteal
cells. Bovine large luteal cells synthesise oxytocin and neurophysin (Ivell &
Richter, 1984). It was suggested that oxytocin may mediate large - small cell
communication (Schwall et al, 1986), since its presence in large luteal cells of
the ovine corpus luteum has been demonstrated (Rodgers et al, 1983) and the
PGF2a analogue cloprostenol has been shown to increase oxytocin secretion
(Flint & Sheldrick, 1982). Moreover, hCG stimulation of progesterone
secretion by the bovine corpus luteum was inhibited by oxytocin (Tan et al,
1982), suggesting that small luteal cells may possess receptors for oxytocin.
63
Studies in which luteal oxytocin receptors have been demonstrated (Sernia et
al, 1989) are not without controversy, since luteal cell preparations from
pregnant ewes also contained vascular smooth muscle cells, which are
known to contain oxytocin receptors (Alila & Dowd, 1991). Other
investigators have suggested that the communication mediator may be
neurophysin-1 (Schams et al, 1985), which is co-secreted with oxytocin.
Studies have shown that low levels of oxytocin are stimulatory to basal and
hCG-stimulated progesterone production; at higher levels oxytocin is
inhibitory to these processes (Tan et al, 1982). Luteal cells from fully
developed corpora lutea appear to be unresponsive to oxytocin (Hansel &
Dowd, 1986), though inhibition by oxytocin of progesterone production from
bovine luteal cells was shown in luteal cells recovered between days 4 - 5 of
the oestrous cycle (Schams et al, 1987). However, studies in the ewe have
shown that though hysterectomy caused luteal depletion of oxytocin,
progesterone levels were unaltered (Sheldrick & Flint, 1983a). Also,
mediation of the effects of PGF2a on luteal cells does not appear to involve
oxytocin directly, since the response of hysterectomised ewes to cloprostenol
remains the same as that of the intact animal (Sheldrick & Hint, 1983b). It
appears that the response of the corpus luteum to oxytocin is dependent on
the time of exposure. Thus it has been suggested that the premature loss of
luteal function observed in cows when the early corpus luteum is exposed to
oxytocin is because the CL is the main tissue responding to oxytocin at that
time; later in the luteal phase the uterus is thought to be the main responding
tissue to oxytocin (Alila & Dowd, 1991). Indeed, this critical period (days 2 -
6) is the time when expression of the oxytocin gene rises sharply in the
bovine ovary (Iveil et al, 1985) and the time that administration of exogenous
oxytocin in large amounts causes impairment of normal luteal function. It
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has been suggested that this impairment is due to interference with the
normal processes of oxytocin synthesis and secretion (Hansel & Dowd,
1986). Administration of oxytocin at this time has been shown to impair the
ability of the corpus luteum to synthesise the luteotrophin PGI-2, but not
PGF2a; though progesterone production was not impaired significantly,
luteal cell ability to respond to LH was diminished (Hansel & Dowd, 1986).
The major uterine release of PGF2a follows the start of luteolytic changes
(Thorburn et al, 1973; Flint & Sheldrick, 1983) in the sheep corpus luteum.
Thus, it is postulated that initially, the uterus releases a small amount of
PGF2a. This initial release triggers a release of oxytocin from large luteal
cells with a concomitant decrease in progesterone production in these cells.
Decreased progesterone secretion increases the numbers of uterine oxytocin
receptors, which respond to the increased levels of oxytocin, causing further
uterine release of luteolytic amounts of PGF2a (Auletta & Flint, 1988).
However, recent reports of experiments in microdialysed bovine corpora
lutea in vitro indicate that oxytocin was stimulatory to progesterone
production; this effect being dependent on cell-to cell contact (Miyamoto &
Schams, 1991).
The cloning of PGF2a receptors from ovine large luteal cells has shown that
the ovine luteal PGF2a receptor consists of 362 amino acids (Graves et al,
1995). In sheep, PGF2a binds to specific receptors on large luteal cells, and
activates protein kinase C (McGuire et al, 1994). This in turn reduces
secretion of progesterone, and increases intracellular free calcium which
appears to be involved in apoptosis (Sawyer et al, 1990), and causes a
decrease in mRNA encoding for 3-pHSD, but not cholesterol side chain
cleavage mRNA (Hawkins et al, 1993; McGuire et al, 1994) (however, PKC
activation with the phorbol ester PMA did reduce cholesterol side chain
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cleavage mRNA levels) (McGuire et al, 1994). However, protein kinase C has
been demonstrated to increase progesterone secretion in bovine luteal cells
(Brunswig et al, 1986; Hansel et al, 1987; Alila et al, 1988a; Miyamoto et al,
1993). Thus further experimental work is required to resolve the apparent
difference between sheep and cows in their response to PGF2a (Niswender &
Nett, 1994). Indeed, PGF2a increases progesterone synthesis by dispersed
bovine luteal cells (Hansel et al, 1973; Hixon & Hansel, 1979; Weston &
Hixon, 1980). Perfusion of bovine corpora lutea in vitro demonstrated that
PGF2a actually stimulated progesterone and oxytoxcin secretion from
corpora lutea removed from early and mid-luteal phase animals over a thirty
minute perfusion time, though this effect was less evident in late luteal phase
corpora lutea (Miyamoto et al, 1993). The stimulation of progesterone
secretion is greater in small rather than large luteal cells, and PGF2a also
potentiates small luteal cell responses to LH (Alila et al, 1988a).
PGF2a has been used for synchronizing oestrus in a large number of studies,
however, it is ineffective during the early luteal phase in cows, suggesting
that the early bovine corpus luteum is unresponsive to PGF2a, and only
induces regression of the bovine corpus luteum between day 5 and day 16
after oestrus (Rowson et al, 1972; Lauderdale, 1972; Hafs et al, 1972). The lack
of responsiveness to PGF2a was not due to a lack of luteal PGF2a receptors
since these have been demonstrated in the early bovine corpus luteum
(Wiltbank et al, 1995). It is suggested that the lack of development of the
degenerative and blood flow mechanisms in the developing corpus luteum
may account for this lack of responsiveness (Wiltbank et al, 1995). However,
the mechanism involved remains unclear. The action of PGF2a in reducing
progesterone secretion may be due in part to interference with the ability of
LH receptor activation to promote increased intracellular levels of cAMP. In
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cows, the reduction of progesterone secretion occurs prior to interference
with LH action on luteal cells (Weston & Hixon, 1980). Membrane related
events such as ligand binding to plasma membrane located receptors are
affected by the structure of the membrane. PGF2a has been shown to affect
plasma membrane structure (Carlson et al, 1983b). Both PGF2a-induced and
spontaneous luteal regression in rats were associated with increased
membrane fluidity in luteal cells and with a reduction in progesterone
secretion (Carlson et al, 1983b). These changes occurred within one hour of
PGF2a treatment, indicating that an early effect of PGF2a may be to cause
changes in the plasma membranes of luteal cells (Carlson et al, 1983b),
modifying plasma membrane receptor functions, such as the integrity of the
LH receptor and intracellular signalling.
Scope of this thesis
The work detailed in this thesis was undertaken to examine the subcellular
location of progesterone in luteal cells, in an attempt to elucidate the
mechanism and regulation of progesterone secretion, leading to a deeper
understanding of the regulation of the bovine corpus luteum.
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Chapter 2
Intracellular location of endogenous
bovine luteal progesterone
2.1 Introduction
The regulation of progesterone secretion (see Niswender & Nett, 1994 for
review) and its levels throughout the bovine oestrous cycle (Dobson &
Kamonpatana, 1986; Dieleman & Blankenstein, 1985; Schams et al, 1977) have
been well documented. However, less well understood is the actual
mechanism whereby progesterone leaves the luteal cell in which it is
synthesised. Suggestions have included packaging into secretory granules
(Gemmell et al, 1974; Stacy et al, 1976; Sawyer et al 1979) in a protein-bound
form. Indeed, the existence of cytosolic binding proteins with high affinities
for progesterone has been described, but the significance of these to
progesterone secretion remains unknown (Willcox & Thorburn, 1981;
Willcox & Alison, 1982; Willcox, 1983). Later studies demonstrated that the
secretory granules contained oxytocin and neurophysin, but not
progesterone (Rice et al, 1986 - sheep CL; Guldenaar et al, 1984 - bovine CL).
Subsequent studies have demonstrated that the secretion of progesterone
and oxytocin are independent of each other in cultured bovine luteal cells
(Luck, 1988).
The accepted theory of the mechanism whereby progesterone is secreted by
the luteal cell remains that proposed by Enders (1973), in which
progesterone simply diffuses out of its cell of origin down the concentration
gradient set up between the progesterone producing cell and the blood. In a
later study, it was shown that progesterone intercalates into phospholipid bi-
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layers which contain cholesterol, suggesting a simple diffusion mechanism
for progesterone release from the luteal cell across the plasma membrane
(Carlson et al, 1983a). This theory is still widely accepted, but it has not gone
unchallenged, though the actual mechanism of progesterone secretion, if
indeed different to that proposed by Enders, remains enigmatic.
To study the intracellular location of progesterone, homogenates of bovine
luteal tissue were subjected to fractionation on continuous sucrose density
gradients. The locations of the major intracellular organelles in sucrose
gradient fractions were determined by utilising the activities of enzymes
used as markers of each organelle. To this end, assays which have been
developed in other species/tissues were characterised and optimised for use
on bovine luteal tissue fractions.
Levels of progesterone in sucrose gradient fractions from corpora lutea
fractionated at different stages of the luteal phase of the bovine oestrous
cycle were determined by radioimmunoassay. To further establish any
association between progesterone and intracellular organelles, in some
experiments luteal homogenates were incubated with the saponin, digitonin,
prior to fractionation. Digitonin complexes with sterols, such as cholesterol,
which possess the 313, A5 configuration, (Severs & Robeneck, 1983).
Commonly used in freeze fracture studies and as a cell membrane
perturbant, digitonin has been demonstrated to form unimolecular 1:1
complexes with unesterified cholesterol. Previous studies have
demonstrated the ability of digitonin to increase the buoyant density of
cellular membranes containing unesterified cholesterol (see Bramley & Ryan,
1979), this increase in buoyant density being proportional to the levels of
unesterified cholesterol in the membrane. Since progesterone does not
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possess the 313, A5 configuration, it does not complex with digitonin (Severs
& Robeneck, 1983). Hence, any increase in the buoyant density of
progesterone would indicate association of progesterone with a cellular
membrane whose cholesterol has been complexed to digitonin, since
although interactions may occur between digitonin and other steroids
containing the 313, A5 configuration, cholesterol is the major cellular steroid
affected by digitonin that is integral to cellular membranes.
Attempts were also made to examine the subcellular locations of
steroidogenic enzymes. This was accomplished by fractionation of sucrose
density gradient fractions on SDS-PAGE gels, followed by Western blotting
with polyclonal antisera to cytochrome P450 313 hydroxysteroid
dehydrogenase, cytochrome P450 CI7a-hydroxylase/C17, 20 lyase and
cytochrome P450 cholesterol side chain cleavage. The intracellular locations
of these enzymes are well established, but it has not gone completely
unchallenged (see Lieberman & Prasad, 1990 for review). Thus in this study
the aim was to assay sucrose density gradient fractions for the presence of
these enzymes and to correlate this with the distribution of marker enzymes
for the major intracellular organelles.
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2.2 Materials & Methods
2.2.1 General materials
All substrates, fine chemicals, inhibitors, reagents and unlabelled steroids
were purchased from Sigma Chemical Co., Poole, Dorset, U.K., or from
BDH, Poole, Dorset, U.K. Polyclonal antisera, raised in rabbits against ovine
P450 side chain cleavage, human P450 3{3-hydroxysteroid dehydrogenase/A4-
A5 isomerase (3^-HSD) and bovine P450 17a hydroxylase/cl7,20 lyase were
the generous gift of Professor I. Mason, Department of Clinical Chemistry,
The University of Edinburgh.
2.2.2 Radiolabeled tracers
Radiolabelled steroid used was: [l,2,6,7-3H]-labelled progesterone (100
Ci/mmol), from New England Nuclear Research Products, Du Pont (U.K.)
Ltd., Stevenage, Herts, U.K.
2.2.3 Ovarian Tissue
Ovaries were recovered from presumed non-pregnant cows slaughtered at a
local abattoir and transported to the laboratory in ice-cold phosphate-
buffered saline (PBS; sodium chloride (0.15 mol/1) in sodium phosphate
(10mmol/l; pH 7.4) within 1 hour of death. The stage of the luteal phase was
assessed by gross morphology (Figure 2.2.1), and mid-luteal phase corpora
lutea were dissected free from connective tissue and stroma, minced with
scissors and homogenized in ice-cold sucrose (0.3mol/l)/ EDTA
(lmmol/l)/Tris-HCl (10 mmol/1), pH 7.4 (SET medium; 200 mg tissue/ml)
using a Polytron homogenizer (Kinematica, Lucerne, Switzerland) with two
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10-s bursts at full speed, interspersed with a 1-min cooling period on ice.
Homogenates were then filtered through two layers of cheesecloth.
2.2.4 Sucrose density gradient fractionation
Continuous sucrose density gradients (30 ml; 10-50 % w/w) were prepared
by the method of Stone (1974). 15 ml of 10% w/v sucrose (EDTA, Tris pH
7.4) was layered gently onto 15 ml 50% sucrose w/v (EDTA, Tris, pH 7.4) in
ultracentrifuge polyallomer tubes. Tubes were capped, then tilted to
horizontal and allowed to diffuse for 16 hours at 4°C. Diffused gradients
were then returned to vertical, uncapped and stored at 4°C for up to 4 hours
before use. Aliquots of mid-luteal phase corpus luteum homogenate (2.5
ml) were mixed with either 0.5 ml SET medium (controls) or 0.5 ml SET
medium containing digitonin (BDH) (10 mg/ml). After a 30 min incubation
on ice, 2.5 ml aliquots were gently layered over the sucrose density gradients
and centrifuged at 30,000 gav for 2h in a Sorvall VTR 50 vertical tube rotor
(4°C). Each gradient was then fractionated using a Buchler-Searle
Autodensiflo gradient fractionator equipped with a meniscus-sensitive
probe, and fractions (1ml) frozen at -20°C until assay. Sucrose gradient
fractions were then assayed for endogenous progesterone content and a
range of enzyme activities to serve as intracellular organelle markers.
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Figure 2.2.1 Bovine corpora lutea staged by gross morphology. From left to
right, each plate shows the appearance of a CL from each stage on the whole
ovary, the appearance of the CL when dissected free of the ovary, and the
appearance of the interior of the CL.
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2.2.5 Sucrose content and protein content estimations
Measurement of the sucrose content of density gradient fractions was
performed using an Abbe refractometer (Atago, Japan). Buoyant densities of
enzymatic activities from the sucrose concentration equivalent to the peak of
enzyme activity were calculated using tables of standard data. Protein was
measured by the method of Lowry et al, (1951), using bovine serum albumin
(BSA) as a standard.
Conditions were optimised for marker activities specific for the major
subcellular organelles and luteal plasma membrane in the bovine corpus
luteum based on previously described assays in other species (Bramley &
Menzies, 1988a; c). For each enzyme, except where indicated, optimum pH,
temperature and duration of incubation, enzyme concentration, co-factor
and metal ion concentrations were established. In each case, during
optimization of conditions and final measurement of activity levels in
sucrose gradient fractions, enzyme assays were performed in duplicate.
2.2.6 Determination of the amount of homogenate required for enzyme
assay characterisation
Enzyme activities were optimised using filtered luteal homogenate in SET
medium, pH 7.4. To determine the concentration of homogenate required to
show measurable activities of enzymes, a range of homogenate
concentrations were assayed under conditions optimised in other species
(Bramley & Menzies, 1988a; c). Homogenate concentrations which were on
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the linear portion of the activity curve were then used for the optimisation of
other incubation conditions.
2.2.7 Optimum pH determinations
Buffers with pH range from 4 - 10.5 were prepared (0.2M sodium
acetate/acetic acid, pH 4-6; 0.2M Tris/HCl pH 6.5 - 8; 0.2M Piperazine/HCl
pH 8.5 - 10.5). Using the homogenate concentrations determined for each
enzyme, enzyme activities were assayed over the pH range 4 - 10.5, at
divisions of 0.5 pH units. The pH at which maximal activity of each enzyme
were recorded was deemed optimal.
2.2.8 Optimum metal ion concentrations
A range of metal ions were tested for their ability to stimulate marker
enzyme activities. The ions tested were manganese (manganous chloride),
calcium (calcium chloride), EDTA, sodium (sodium chloride), magnesium
(magnesium acetate), zinc (zinc sulphate) and potassium (potassium
chloride). In the assay of 5'-nucleotidase, the effects of cobalt ions was
studied. To avoid any optical interference between these coloured salts and
the interpretation of assay results determined spectrophotometrically,
enzyme blank tubes (all reagents apart from homogenate) containing the
highest concentration of each salt were routinely included.
2.2.9 Intracellular organelle marker enzyme assays
The marker enzyme assays characterised for optimal activity in bovine luteal
tissue were cytochrome oxidase (mitochondrial marker) (Gospodarowicz,
1973; Rao et al, 1981; Bramley & Menzies, 1986), NADH cytochrome C
reductase (endoplasmic reticulum marker) (Bramley & Menzies, 1988a; c;
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Greenhalgh, 1990), NADPH cytochrome C reductase (endoplasmic reticulum
marker) (Bramley & Menzies, 1988a; c), fluoride-sensitive acid phosphatase
(GERL marker) (Bramley & Ryan, 1978a; 1978b; 1979), N-acetyl fi-
glucosaminidase (lysosomal marker) (Bramley & Menzies, 1988a), DNA
(nuclear marker) (Bramley & Ryan, 1978a) and three plasma membrane
markers, alkaline phosphatase (Bramley & Ryan, 1978a; 1979), 5'-
nucleotidase (Gospodarowicz, 1973; Menon & Kiburz, 1974; Rao et al, 1981;
Bramley & Menzies, 1978a; 1986), and the LH/hCG receptor
(Gospodarowicz, 1973; Menon & Kiburz, 1974; Rao et al, 1981; Bramley &
Menzies, 1978a; 1986). Details of the establishment of optimised assays used
to determine distribution of marker enzymes in sucrose density gradients of
bovine luteal homogenates are given in the following descriptions.
2.2.9 (i) Mitochondrial marker : Cytochrome oxidase
This assay utilises the change in optical density (550 nm) that occurs when
dithionite-reduced horse heart cytochrome c is oxidised. Control tubes
containing no enzyme (all other reagents present) were routinely monitored
for oxidation not due to cytochrome oxidase. Little or no such oxidation was
observed to occur. Reaction rates were calculated from the linear slopes
recorded using a Phillips flat-bed chart recorder set at 1 cm/min.
Cytochrome oxidase assay
Enzyme (10 pi sucrose gradient fraction) and 100 jil dithionite-reduced horse
heart cytochrome C (Sigma) (10 mg/ml in H2O) were added in quick
succession to a 1.3 ml reaction system (500 pi 0.2 M Tris-acetic acid buffer,
pH 6.8, 800 pi H2O). After rapid mixing, this mixture was loaded
immediately into a flow-through cuvette system fitted to a Pye Unicam UV
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spectrophotometer, and the decrease in optical density at room temperature
(20°C), measured for 2 minutes at 550 nm, and recorded on a chart recorder
linked to the spectrophotometer. Reaction rates were then calculated from
the linear slopes recorded.
2.2.9 (ii) Fluoride-sensitive acid phosphatase (GERL marker)
Acid phosphatase has been shown to catalyse the hydrolysis of p-
nitrophenylphosphate, yielding free p-nitrophenol (yellow colour) (Bramley
& Ryan, 1978a). Free p-nitrophenol was estimated by absorbance
measurements (Pye Unicam UV spectrophotometer) at 420 nm. Each
sample was assayed in both the presence and absence of 10 mM sodium
fluoride (in duplicate). Subtraction of absorbance values obtained in the
presence of sodium fluoride from values measured in the absence of sodium
fluoride gave a final estimate of fluoride-sensitive acid phosphatase.
Acid phosphataseIfluoride sensitive acid phosphatase assay
A 1.0 ml phosphatase reaction system (0.1 M sodium acetate-acetic acid
buffer, pH 4.7; + 10 mM sodium fluoride, 3 mM p-nitrophenylphosphate
(pNPP), 0.2% (v/v) Triton-X-100, 25 jil sucrose gradient fraction) was
incubated at 37°C for 2 hours. The reaction was stopped by addition of 3 ml
0.5 M NaOH, 0.5 % (w/v) Na2EDTA (Bramley & Ryan, 1978a), and optical
density measured at 420 nm. Fluoride-containing and fluoride-free blanks
were used to zero the spectrophotometer.
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2.2.9 (iii) Plasma membrane marker I: Alkaline phosphatase
Measurement of liberated p-nitrophenol from the hydrolysis of p-
nitrophenylphosphate as described for acid phosphatase formed the basis of
this assay.
Alkaline phosphatase assay
A 1ml phosphatase system (0.1 M Piperazine-HCl buffer, pH 10.8, 0.2%
Triton-X-100, 5 mM magnesium acetate, 3 mM pNPP, 10 jil sucrose gradient
fraction) was incubated at 37°C for 2 hours or until sufficient colour had
developed. The reaction was stopped and the reaction rate estimated from
the optical density of the sample in the same way as described for acid
phosphatase.
2.2.9 (iv) Plasma membrane marker II: LH/hCG receptor
Measurement of levels of binding of 125I-labelled human LH (Chelsea
Reagent, specific activity 100 Ci/g) in the presence and absence of excess
unlabelled hormone (50 IU/tube hCG - Chorulon, Intervet U.K Ltd,
Cambridge) were performed. Each sucrose gradient fraction was assayed in
triplicate, with a duplicate set of tubes containing excess Chorulon included
for each sample to measure non-specific binding. Specific binding was
calculated by subtraction of non-specific binding levels from binding
recorded in tubes with no added unlabelled hormone. Positive control tubes
containing homogenate of known high specific binding (sheep corpus
luteum homogenate) were routinely included to allow comparison of
individual assay binding efficiencies.
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LH receptor assay
A 1 ml binding system (40 mM Tris-HCl buffer, pH 6.5, 0.5% w/v BSA, 125I-
hLH (100,000 cpm) +. 50 IU hCG, 100 jil sucrose gradient fraction) was
incubated overnight at 20°C. To separate bound hormone from free, 0.5 ml
ice-cold IgG (0.5% w/v, 40 mM Tris-HCl, pH 7.4) and 1 ml 25% w/v
polyethyleneglycol (8000 m.w in 40 mM Tris-HCl, pH 7.4) were added to
each tube, vortexed, then centrifuged (2500 rpm, 30 min, 4°C). Supernatants
were aspirated, and pellets containing bound LH-receptor complex counted
using a Hewlett-Packard 'Crystal' gamma-counter, with a counting efficiency
of 75%.
2.2.9 (v) Plasma membrane marker III: 5'- nucleotidase
5'-nucleotidase has been demonstrated to be a marker of the plasma
membrane in the rat ovary (Bramley & Ryan, 1978a) and the corpus luteum
of sheep and pigs (Bramley & Menzies, 1986; 1988a; c). It catalyses the
release of Pi (inorganic phosphate) from adenosine 5'-monophosphate
(AMP). Na+/K+Tartrate was included in the assay system to prevent
interference caused by acid phosphatase activity (Bramley & Menzies, 1986).
Activity was estimated from the amount of Pi released.
5'-nucleotidase assay
A 1 ml assay system (40 mM Tris-HCl, pH 6.4, 3 mM cobaltous chloride, 50
mM Na+/K+Tartrate, 5 mM AMP, 30 pi sucrose gradient fraction) was
incubated for 3 hours at 37°C. The reaction was then terminated by the
addition of 1 ml of ice-cold 10% trichloroacetic acid. Tubes were then
centrifuged (2500 rpm, 10 min, 4°C). 1 ml aliquots of each de-proteinised
sample were then removed, and Pi present in each determined by the
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method of Fiske and Subbarow (1925), measured in a Pye Unicam
spectrophotometer at OD 660 nm.
2.2.9 (vi) Lysosomal marker: N-acetyl-fi-glucosaminidase
Activity of N-acetyl-fi-glucosaminidase was estimated by measuring the
release of free p-nitrophenol from p-nitrophenyl-N-acetyl-fi-D-
glucosaminide (Bramley & Menzies, 1986).
N-acetyl-fl-glucosaminidase assay
A 1 ml assay system (0.1 M sodium acetate-acetic acid buffer, pH 5.8,1 mM
magnesium acetate, 2 mM p-nitrophenyl-N-acetyl-fi-D-glucosaminide
(Sigma), 20 jil sucrose gradient fraction) was incubated for 2 hours at 37°C.
The reaction was stopped by addition of 3 ml 0.5 M NaOH, 0.5% (w/v)
Na2EDTA (Bramley & Ryan, 1978a). Optical density (420 nm) was measured
for each sample and the enzyme activity calculated.
2.2.9 (vii) Endoplasmic reticulum markers: NADPH cytochrome C
reductase and NADH cytochrome c reductase
The activities of these enzymes were measured in the presence of freshly
prepared co-factor (NADPH or NADH). Activity was calculated from the
rate of reduction of horse heart cytochrome C at 550 nm recorded on a chart
recorder. Potassium cyanide was included in all tubes to prevent
cytochrome oxidase re-oxidising the cytochrome C and thus interfering with
rates of reduction measured. Reduction rates with no added enzyme or
added co-factor were routinely recorded to serve as controls.
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NADPH cytochrome C reductase assay
The 1 ml system contained piperazine-HCl buffer over a range of pH values,
Triton-X-100 at a range of concentrations, 500 pg cytochrome C, 150 pM
NADPH, KCN (0-5 mM) and sucrose gradient fractions or whole cow
luteal homogenate (5-100 pi). Despite varying all reagents and conditions,
including testing for stimulation by metal ions, little activity above baseline
values was recorded, thus this assay could not be utilised.
NADH cytochrome C reductase assay
A 1.5 ml assay system (0.5 ml Tris acetate-buffer, pH 7.0, 2 jimol KCN, 0.15
pmol NADH) was prepared. To this system, 100 pi (10 mg/ml in H2O) horse
heart cytochrome C and 30 pi sucrose gradient fraction were added in quick
succession, immediately prior to measuring the rate of reduction. After
rapid mixing, each sample was loaded immediately into a flow-through
cuvette system fitted to a Pye Unicam UV spectrophotometer, and the
increase in optical density at room temperature, measured for 2 minutes at
550 nm, recorded on a chart recorder linked to the spectrophotometer.
Reaction rates were then calculated from the linear slopes recorded.
2.2.10 Progesterone radioimmunoassay
Progesterone content of density gradient fractions was measured by direct
radioimmunoassay by a modification of the method developed by McNeilly
& Fraser, (1987), or following petroleum ether extraction of fractions. The
details of the extraction method were: 100 pi of each sucrose density gradient
fraction was extracted with 2 ml petroleum ether (BDH). Also, 20 pi [3H]-
progesterone (ca. 1200 c.p.m) was added to each tube for recovery
estimation. This mixture was vortexed vigorously for 5 minutes at room
temperature, after which the tubes were placed in a freezing bath of dry
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ice/ethanol. The ether phase was removed and the aqueous phase (frozen)
discarded. The ether residue was then dried down under a stream of
nitrogen at 50°C. After reaching total dryness, the residue was reconstituted
in 200 fil phosphate-citrate buffer, 1 mg/ml gelatin (progesterone
radioimmunoassay buffer). After leaving overnight at room temperature to
ensure complete reconstitution and mixing had occurred, a 50 |il aliquot of
each sample was removed and mixed with 4 ml scintillant (Ecoscint A,
National Diagnostics, Atlanta, Georgia) in scintillation vials, then counted
for tritium using an LKB Rackbeta II scintillation counter. Recovery
efficiency was calculated by multiplying the counts in each sample by 4 to
give an estimation of counts in the total 200 jil of the sample, then dividing
this value by the total counts added; the value of this division was
multiplied by 100 to give a % recovery. Recoveries were calculated for each
sample individually to correct the results of the progesterone concentrations
in each sample so that the assay could be compared to the progesterone
concentrations obtained by radioimmunoassay of non-extracted samples.
Briefly, the details of the immunoassay were : tubes received either 100 jil
progesterone standard (covering the range 5 - 1000 pg) or 50 |il sample at a
suitable dilution (1:200). Standards were freshly prepared and assayed for
comparison with established in-house standards. Primary antibody (S-361
in-house polyclonal antibody raised in sheep against a progesterone-BSA
conjugate) (100 fil) at a concentration of 1:9500 was added. Finally, a 100 fil
aliquot of 125I-progesterone in assay buffer (no gelatin added) containing 1
mg/ml 8-anilino-l naphthalene sulphonic acid (ANS - to block binding to
steroid binding globulins) corresponding to 15,000 c.p.m was added, and
tubes vortexed. After 3 hours incubation at room temperature 200 jil of
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second antibody solution, containing normal sheep serum (1:3200) (SAPU)
and donkey-anti-goat IgG (1:64) (SAPU) was added. Tubes were vortexed
then incubated overnight at 4°C. Finally, 1 ml of 4% polyethylene glycol,
0.2% Triton-X-100 in 0.9% saline was added to each tube. After mixing,
tubes were centrifuged (lOOOgav., 4°C, 30 min) to separate free steroid from
steroid-antibody complex. Supernatants were decanted, tubes dried and
pellets counted using a Hewlett-Packard 'Crystal' gamma-counter with a
counting efficiency of 75%. B/Bo was calculated using a commercial assay
calculation software package ('Assayzap', Biosoft Ltd.). Routinely included
controls in the assay were non-specific binding tubes (no primary antibody)
and quality controls at the beginning and end of each assay. Within assay
variation was calculated to be 10.84 % and the lower detection limit of
progesterone immunoassays was 12 pg/100 jil.
2.2.11 DNA content of sucrose gradient fractions
DNA content of bovine corpus luteum sucrose gradient fractions was
determined by the method of Burton, (1956), using salmon sperm DNA
(Sigma) as a standard.
2.2.12 SDS-PAGE electrophoresis of sucrose gradient fractions
SDS-PAGE was performed by the method of Laemmli, (1970), using a
commercially available gel electrophoresis tank (Protean II xi , Bio-Rad). Gel
reagents are shown below.
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(All volumes are in ml)
Briefly, resolving gels of approximately 11 cm X 16 cm were formed by
pouring between two glass plates on a purpose built casting stand (Bio-Rad).
Once poured, resolving gels (7.5%) were overlaid immediately with 1:1
butan-l-ol : H2O. After polymerization had occurred (ca. 1 hour), the
overlay was rinsed off (dH20) and a 3.6% stacking gel poured onto the
resolving gel. A fifteen-well comb (Bio-Rad) was placed in each stacking gel.
After polymerisation of the stacking gel, combs were removed and wells
rinsed thoroughly with H2O. Gels were then clipped to a central water-
cooled core. Samples of each fraction (ca. 30 Jig protein) from sucrose
gradients were denatured by mixing with an equal volume of reducing
sample buffer (10% w/v sucrose, 0.2% v/v 2-mercaptoethanol, 0.02%
bromophenol blue w/v, 0.2% SDS w/v in 0.375 M Tris-HCl, pH 6.8) in 1.5 ml
microcentrifuge tubes. After heating to 100°C for 10 minutes, samples were
cooled and applied to the wells of the stacking gel. Low and high molecular
weight markers were also applied to each gel (Rainbow markers™,
Amersham International pic). Electrophoresis was carried out at 40 mA/gel
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during stacking (ca. 1 hour) and 30 mA/gel during separation (ca. 3 hours).
After electrophoresis was complete, gels were removed and separated
proteins electroblotted on to nitrocellulose membranes (Hybond-C,
Amersham International pic) using Bio-Rad electroblotting equipment, in
electroblot buffer (0.25 M Tris, 0.6 M glycine, 20% (v/v) methanol) for 15
hours, at 15 V. After blotting was completed, nitrocellulose blots were
immediately probed with antiserum against the protein of interest.
2.2.13 Western Blotting
Nitrocellulose blots were initially incubated in 5% (w/v) defatted milk
protein (Marvel™, Cadbury Ltd), Tris-buffered saline (TBS) (50 mM
Tris/HCl, pH 8.0, 0.85% sodium chloride) for 1 hour to block non-specific
binding sites. Blots were then rocked gently in primary antibody at an
appropriate (1:200 to 1:1000) dilution in TBS, 0.1 % (v/v) TWEEN 20, 5%
(w/v) milk protein for 2 hours. After excess antibody was washed away
(TBS, 0.1% v/v TWEEN 20) (1 x 15 min wash, 3x5 min washes), blots were
incubated with secondary antibody (donkey anti-rabbit, horseradish
peroxidase linked IgG) (Amersham International pic) for 1 hour, at 1:4000
dilution in TBS, 0.1% (v/v) TWEEN 20,5% (w/v) milk protein. After excess
secondary antibody was removed by repeated washes (TBS, 0.1 % (v/v)
TWEEN 20) (1 x 15 min wash, 3x5 min washes), blots were incubated in
ECL™ solution (Enhanced chemiluminescence detection kit, Amersham
International pic) (10 ml ECL A + 10 ml ECL B) for 60 seconds, wrapped in
clingfilm and exposed to autoradiograph (ECL Hyperfilm™, Amersham
International pic) film for 15 - 60 seconds, depending on signal intensity.
Autoradiography were then developed by placing in developer (Kodak) for
60 seconds, rinsed with water and placed in fixative (Kodak) for a further 60
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2.3.1 Cytochrome oxidase (mitochondrial marker)
Optimum pH determination
Cytochrome oxidase activity was minimal below pH 3 (Figure 2.3.1). Above
pH 7, cytochrome oxidase activity was reduced, compared to levels observed
between pH 6.4 - pH 6.8. Activity of cytochrome oxidase was maximal at pH
6.8, thus this was the pH (of incubation) used in further cytochrome oxidase
assays.
. Metal ion concentration
Of the range of metal ions tested, none apart from calcium showed any
stimulatory effect on cytochrome oxidase activity (Figure 2.3.2). Zinc ions at
concentrations greater than 0.03 mM inhibited enzyme activity. Stimulation
by calcium ions was only observed at very high concentrations (30 mM).
Since activity was observed to be high in the absence of metal ions it was
decided to omit calcium from further assays because of the high
concentrations required, and because stimulation of cytochrome oxidase to
these levels made measurement of the initial rate of oxidation (estimated
decrease in optical density/min, measured at 550 nm) difficult to measure
and prone to error.
Activity of cytochrome oxidase in sucrose gradient fractions of bovine
corpus luteum homogenate
Cytochrome oxidase activity was maximal at a buoyant density of 1.16
g/cm3 (early luteal tissue gradient), 1.15 g/cm3 (mid-luteal tissue gradient)
and 1.12 g/cm3 (late luteal tissue gradient). In the presence of digitonin,







5. 0 5.4 5.8 6.2 6.6 7.0 7.4 7.8 8.2 8.6 9.0
Incubation pH
Figure 2.3.1 Determination of optimal pH for bovine luteal cytochrome
oxidase activity. Mean cytochrome oxidase (n=3) expressed in change in
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Figure 2.3.2 Effects of incubation with metal ions on cytochrome oxidase
activity. Activity in the absence of any added metal ions is indicated by
heavy broken line. Experiment was repeated on two different luteal
homogenates assayed in duplicate (graph is the mean of these experiments).
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g/cm3 in early, mid- and late luteal tissue sucrose gradients respectively
(Figure 2.3.3). Activity was distributed over a wider range of sucrose
concentrations in gradients of late luteal tissue.
2.3.2 Fluoride-sensitive acid phosphatase
Optimum pH determination
From Figure 2.3.4, it can be seen that activity of acid phosphatase was
maximal between pH 4.4 - 5.0. The optimal pH chosen for further assays
was pH 4.7.
Metal ion concentration
None of the ions tested significantly increased acid phophatase activity over
values obtained in the absence of added metal ions. Indeed, zinc,
manganese and calcium inhibited activity of this enzyme at concentrations
greater than 0.01 mM, 0.1 mM and 1 mM respectively (Figure 2.3.5).
Activity of acid phosphatase in sucrose gradient fractions of bovine corpus
luteum homogenates
Acid phosphatase activity displayed a buoyant density of 1.15 g/cm3 (early
luteal tissue gradient), 1.16 g/cm3 (mid-luteal tissue gradient) and 1.17
g/cm3 (late luteal tissue gradient). In the presence of digitonin, these
buoyant densities were increased to 1.17 g/cm3,1.18 g/cm3 and 1.18 g/cm3
respectively (Figure 2.3.6). Activities were similar at each stage of the luteal
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Figure 2.3.3 Distribution of cytochrome oxidase activity in bovine corpus
luteum sucrose gradient fractions, with (•) and without (o) digitonin
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Figure 2.3.4 Determination of optimum incubation pH for fluoride-sensitive
acid phosphatase activity. Three bovine CL homogenates were assayed in
duplicate, no differences in pH sensitivity were observed between
homogenates. Figure is representative of one such experiment.
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Figure 2.3.5 Effects of incubation with metal ions on bovine luteal fluoride-
sensitive acid phosphatase activity. Graphs show the mean of two
experiments using two different luteal homogenates assayed in duplicate.
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Figure 2.3.6 Distribution of fluoride-sensitive acid phosphatase activity in
bovine corpus luteum sucrose gradient fractions, with (•) and without (o)
digitonin treatment of homogenate prior to fractionation. Each sucrose
gradient fraction was assayed in duplicate, + fluoride. Two sets of early,
mid- and late luteal homogenates were assayed, no differences in the
distribution of activity throughout the gradients between different
homogenates from the same stage were recorded. Figure is representative of
one set of experiments.
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2.3.3 Alkaline phosphatase (plasma membrane marker)
Optimum pH determination
From Figure 2.3.7 it can be observed that alkaline phosphatase activity was
minimal below pH 9. Below pH 7, activity can be accounted for by the
presence of acid phosphatase. Alkaline phosphatase was observed to be
active at pH 9 and increased to a maximum at pH 10.8. Levels of activity
were reduced at a pfi greater than pH 11. The pH chosen for use in further
assays was pFl 10.8.
Metal ion concentration
Zinc was observed to be stimulatory to alkaline phosphatase at 0.03 mM.
This stimulation was highly concentration dependent and did not occur
outside a very narrow concentration range (Figure 2.3.8). Calcium displayed
a broader concentration over which stimulation was evident (maximal
stimulation at 5 mM); however, the broadest range of stimulatory
concentrations was displayed by magnesium, the stimulatory effect being
most pronounced at a concentration of 5 mM. Levels of stimulation by
magnesium were greater than the levels of stimulation observed to occur in
the presence of calcium ions. Thus in all assays magnesium acetate at a
concentration of 5 mM was routinely included, with zinc sulphate at a
concentration of 0.03 mM.
Activity of alkaline phosphatase in sucrose gradient fractions of bovine
corpus luteum homogenates
Alkaline phosphatase activity displayed a buoyant density of 1.18 g/cm3
(early luteal tissue gradient), 1.12 g/cm3 (mid-luteal tissue gradient) and 1.17
g/cm3 (late luteal tissue gradient). In the presence of digitonin, these
buoyant densities were increased to 1.19 g/cm3 and 1.14 g/cm3 in early and
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mid-luteal tissue sucrose gradients respectively, and decreased to 1.16 g/cm3
in late luteal tissue sucrose gradients (Figure 2.3.9). Also, in late luteal tissue
sucrose gradients it was consistently observed that the bulk of alkaline
phosphatase activity failed to enter the sucrose gradients to the same extent
that occurred in early and mid-luteal tissue gradients. In gradients from all
stages of the luteal phase, alkaline phosphatase activity was enriched in
fractions from the lower part of the gradient (45 - 55% sucrose).
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Figure 2.3.7 Optimum pH determination of bovine luteal alkaline
phosphatase activity. Activity was measured in duplicate, in the presence of
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Figure 2.3.8 Effects of incubation with metal ions on alkaline phosphatase
activity. Each metal ion concentration was assayed in duplicate. Graph
shows the means of two such experiments, using two different luteal
homogenates.
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Figure 2.3.9 Distribution of alkaline phosphatase activity in bovine corpus
luteum sucrose gradient fractions, with (•) and without (o) digitonin
treatment of homogenate prior to fractionation. Each fraction was assayed in
duplicate. This experiment was performed on two different sets of
homogenates, no differences in the distribution of activity in gradients were



































2.3.4 LH/hCG receptor binding (plasma membrane marker)
Distribution over sucrose gradient fractions of bovine corpus luteum
homogenate (Figure 2.3.10)
LH/hCG receptor binding equilibrated at a buoyant density of 1.18g/cm3
(early luteal tissue gradient) and 1.13 g/cm3 (mid-luteal tissue gradient). In
the presence of digitonin, these buoyant densities were increased to 1.19
g/cm3 and 1.15 g/cm3 respectively. Late luteal tissue gradients displayed
poor binding of iodinated hLH, distributed throughout the sucrose density
gradient fractions. Levels of binding were highest in mid-luteal gradients,
reaching approximately 2 x that observed in early luteal tissue gradients.
2.3.5 5'-nucleotidase (plasma membrane marker)
Optimum pH determination
Activity of 5'-nucleotidase was maximal at pH 6.4, though activity was
observed to be present at pH values 5.8 - 8.0. Thus it appeared that this
enzyme had a broad range of pH values at which it was active, and as such
does not appear to be acutely pH sensitive (Figure 2.3.11).
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Figure 2.3.10 Specific binding of 125I-hLH to sucrose gradient fractions of
bovine corpus luteum homogenates from the early, mid- and late luteal
phase, with (•) and without (o) digitonin treatment of homogenate prior to























Figure 2.3.11 Determination of optimum incubation pH for bovine luteal 5'-
nucleotidase activity. Activity was measured in duplicate in the presence of
3 mM cobaltous chloride. Figure is representative of two such experiments
using two different luteal homogenates (no differences in pH response were
recorded between homogenates.
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Distribution over sucrose gradient fractions of bovine corpus luteum
homogenate
In control gradients of mid-luteal tissue, activity of 5'-nucleotidase was
found to equilibrate in a broad peak, whose maximum activity equilibrated
at 1.13 g/cm3. In digitonin pretreated gradients, this peak of activity was
perturbed to 1.16 g/cm3, similar to the buoyant densities and digitonin
perturbation of the other plasma membrane marker activities assayed
(Figure 2.3.12).
2.3.6 N-acetyl glucosaminidase (lysosomal marker)
Optimum pH determination
Below pH 5.2 and above pH 6.0, activity of N-acetyl glucosaminidase was
minimal (Figure 2.3.13). Activity increased at pH 5.2, reaching a maximum
at pFI 5.8. In further assays of N-acetyl glucosaminidase an assay pH of 5.8
was used.
Metal ion concentration
All metal ions tested were inhibitory to N-acetyl glucosaminidase activity at
concentrations greater than 0.03 mM, apart from magnesium, whose
inhibitory effects were not observed until concentrations in excess of 10 mM.
Below this concentration, magnesium was stimulatory to activity, even at
concentrations below 0.03 mM (Figure 2.3.14). Greatest stimulation by
magnesium ions was observed at 1 mM. Thus this concentration of
magnesium acetate was used in future assays of N-acetyl glucosaminidase
activity.
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Activity of N-acetyl glucosaminidase in sucrose gradient fractions of bovine
corpus luteum homogenate
In sucrose gradient fractions from mid-luteal control homogenates, activity
of N-acetyl glucosaminidase peaked at a buoyant density of 1.17 g/cm^. In
sucrose gradients of digitonin-pretreated homogenates, activity was found
only in the top of the gradient, at a buoyant density of <1.05 g/cm^ (Figure
2.3.15). This activity was observed to be very strong (readable only when
diluted 1:10 in assay buffer) and concentrated into a small number of
fractions. Little activity was found in the fractions at the top of the gradients
when CL homogenates were not pretreated with digitonin.
2.3.7 NADPH cytochrome C reductase
Activity of NADPH cytochrome C reductase was found to be very low in
whole luteal homogenates and sucrose gradient fractions, and in fresh or
frozen and thawed fractions. To attempt to increase activity, assays were set
up with varying Triton-X-100 concentrations, over a range of NADPH
concentrations and EDTA concentrations (since this enzyme is thought to be
metal ion independent but may be inhibited by the presence of some metal
ions even at low concentrations - Bramley, unpublished data). No increase
in activity was recorded. Thus this enzyme was not active enough in bovine
luteal tissue to be utilised as an endoplasmic reticulum marker enzyme.
2.3.8 NADH cytochrome C reductase
Optimum pH determination
It was observed that NADH cytochrome C reductase activity was minimal
below pH 4 (Figure 2.3.16). Activity increased at pH values greater than 5,
reaching maximal levels at pH 7.0. At pH values above 7.0, up to pH 9,
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Figure 2.3.12 Distribution of 5'-nucIeotidase activity in bovine corpus
luteum (mid-luteal phase) sucrose gradient fractions, with (•) and without
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Figure 2.3.13 Determination of optimum pH of N-acetyl-fi-D-
glucosaminidase activity in bovine corpus luteum homogenate. Experiment
was performed twice in duplicate using two different mid-luteal bovine CL
homogenates. Figure is representative data from one such experiment.
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Figure 2.3.15 Distribution of N-acetyl-{3-D-glucosaminidase activity in
bovine corpus luteum (mid-luteal phase) sucrose gradient fractions, with (•)
and without (o) digitonin treatment of homogenate prior to fractionation.
Figure is representative of one such experiment, no differences were found
using different luteal homogenates (n=2). Assayed in duplicate.
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Activity of NADH cytochrome C reductase in sucrose gradient fractions of
bovine corpus luteum homogenate
NADH cytochrome C reductase activity displayed a buoyant density of 1.15
g/cm3 (mid-luteal tissue gradient). In the presence of digitonin, this buoyant
density was increased to 1.16 g/cm3 (Figure 2.3.17). Though these buoyant
densities were identical to those displayed by cytochrome oxidase, the
pattern over sucrose gradients is different. A much broader peak was
displayed by NADH cytochrome C reductase than was displayed by
cytochrome oxidase activity, thus NADH cytochrome C reductase does not
appear to be co-localized with cytochrome oxidase in the mitochondrion.
When the NADH cytochrome C reductase activity across sucrose density
gradients is compared to progesterone content on the same sucrose
gradients, both displayed similar patterns of distribution and digitonin
perturbation, however, the peak of progesterone content was found to be
consistently lighter than that of NADH cytochrome C reductase activity in
control gradients. Also, in some gradients a much greater digitonin induced
increase in the bouyant density of NADH cytochrome C reductase was
observed, however, neither progesterone content or cytochrome oxidase
followed this pattern.
2.3.9 DNA content of bovine luteal homogenate sucrose density gradient
fractions
In both control and digitonin pretreated sucrose gradients, DNA was
observed to equilibrate at the bottom of the gradient, in fractions with high
sucrose content (Figure 2.3.18) The large amount of DNA measured in the




Figure 2.3.16 Optimum pH determination for bovine luteal NADH
cytochrome c reductase activity. Figure derived from mean values from two
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Figure 2.3.17 Distribution of NADH cytochrome c reductase activity in
bovine corpus luteum (mid-luteal phase) sucrose gradient fractions, with (•)
and without (o) digitonin treatment of homogenate prior to fractionation.
Figure is representative of one such experiment, no differences were found




Figure 2.3.18 Distribution of DNA in sucrose gradient fractions of bovine
corpus luteum homogenate (mid-luteal phase), with (•) and without (o)
digitonin treatment of homogenate prior to fractionation. Figure is
representative of one such experiment, assayed in duplicate. No differences
in distribution of DNA in sucrose gradients of different mid-luteal
homogenates were observed (n=3 homogenates).
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2.3.10 Progesterone content of sucrose gradient fractions
Progesterone extraction recoveries
Recovery of progesterone following ether extraction of samples was
determined for each sucrose gradient fraction (Figure 2.3.19). Extraction
recovery percentages were then used to correct results of progesterone
content of extracted samples.
Progesterone content of extracted and non-extracted sucrose gradient
fractions
After correction for % recovery of tritiated progesterone, no differences were
observed between the progesterone content of extracted and unextracted
sucrose gradient fractions (Figure 2.3.20).
Progesterone content of sucrose gradient fractions of bovine corpus luteum
homogenate
Levels of endogenous progesterone were highest in a broad peak spanning
the buoyant densities 1.10 - 1.14 g/cm3. Pligh levels of progesterone were
observed in cytosolic (top of gradient) fractions and fractions from the
bottom of sucrose gradients. Flowever the main peak of endogenous
progesterone equilibrated in the aforementioned broad peak, indicating
likely association between progesterone and cellular membranes (Figure
2.3.21). Moreover, the buoyant density of the progesterone peak was
increased by digitonin, indicating the likely association of progesterone with
membranes rich in unesterified cholesterol. In addition, it was observed that
preincubation with digitonin reduced the amounts of progesterone
recovered in the cytosolic fractions. Levels of progesterone were noted to be
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Figure 2.3.19 Recovery efficiencies of solvent extraction of [3H]-progesterone
from sucrose gradient fractions of bovine (mid-luteal phase) corpus luteum
homogenate (sv=solvent blank, B=buffer blank, L, M & H =low, medium &



















10 20 30 40
Sucrose concentration (g/100g)
50
Figure 2.3.20 Comparison of direct progesterone radioimmunoassay of
sucrose gradient fractions (o) of (mid-luteal phase) bovine corpus luteum
homogenate with progesterone immunoassay of solvent extracted sucrose
gradient fractions (•) of (mid-luteal phase) bovine corpus luteum
homogenate (after correction of individual extraction recovery efficiencies).
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Figure 2.3.21 Progesterone content of sucrose gradient fractions of bovine
corpus luteum homogenates from the early, mid- and late luteal phase, with
(•) and without (o) digitonin treatment of homogenate prior to
fractionation. Data is from one set of luteal homogenates assayed in
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2.3.11 Protein concentrations of sucrose gradient fractions
Figure 2.3.22 shows the distribution of protein over sucrose gradient
fractions in control and digitonin pretreated gradients of bovine luteal
homogenate from early, mid- and late luteal phase corpora lutea. Levels of
total protein and distribution of protein over sucrose gradients were similar
at all stages. No digitonin perturbation of protein levels was evident.
2.3.12 Immunoblotting of steroidogenic enzymes
(i) P450 side chain cleavage (Plate 2.3.1)
Bands of protein were found to migrate with an apparent Mr of 49 kDa, the
molecular weight of P450 side chain cleavage. However, additional bands
were also detected at approximately 80 kDa, 65 kDa and 46 kDa. These
proteins were absent from the cytosolic fractions, though present in all other
fractions tested. Heaviest staining occurred in fractions known to contain
mitochondrial and microsomal material.
(ii) 3(3-hydroxysteroid dehydrogenase (Plate 2.3.2)
Multiple protein bands were detected using this anti-serum, however, the
most densely staining bands were found to be approximately 62 and 43 kDa
in size. The 62 kDa band was present in all fractions, though staining was
found to be present in greater quantity in fractions known to contain
microsomal material, which was the predominant location of the 43 kDa
band.
(iii) P450 17a hydroxylase/C 17,20 lyase
No detection of this enzyme was found in any of the fractions tested.
Positive detection did occur in control lanes (bovine theca cell homogenate)
however, indicating that its absence would not appear to be an artifact of the
methodology applied (not shown).
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Figure 2.3.22 Distribution of total protein in sucrose gradient fractions of
bovine corpus luteum homogenates from the early, mid- and late luteal
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Plate 2.3.1 Western blot of P450 side chain cleavage distribution in sucrose
gradient fractions of bovine corpus luteum homogenate. P450 side chain
cleavage indicated by arrowhead. Positions of intracellular organelles were
determined by organelle marker enzyme assay (P. mem = plasma
membrane, SER = smooth endoplasmic reticulum, GERL = Golgi
endoplasmic reticulum lysosomal network).
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Plate 2.3.2 Western blot of 30-hydroxysteroid dehydrogenase distribution in
sucrose gradient fractions of bovine corpus luteum homogenate. 30-
hydroxysteroid dehydrogenase indicated by arrowhead. Positions of
intracellular organelles were determined by organelle marker enzyme assay
(P. mem = plasma membrane, SER = smooth endoplasmic reticulum, GERL
= Golgi endoplasmic reticulum lysosomal network).
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Alkaline phosphatase displayed a pH maximum of 10.8 in bovine luteal
homogenates from all stages of the luteal phase. This is similar to the
optimal pH of this enzyme in rat ovarian tissue (pH 10.7, Bramley & Ryan,
1978a) and the sheep and porcine corpus luteum (G.S. Menzies, personal
communication). Also, the buoyant densities of alkaline phosphatase (when
fractionated on sucrose gradients) in sheep and pigs (Bramley & Menzies,
1986; 1988a) were similar to the results presented here for the bovine CL.
Alkaline phosphatase assays in rat ovarian tissues have included Mg2+
(Bramley & Ryan, 1978a). Studies with different cations demonstrated that
magnesium was also highly stimulatory to bovine luteal alkaline
phosphatase. Though zinc and calcium were also demonstrated to stimulate
activity of alkaline phosphatase in the bovine CL, the concentration ranges at
which stimulation occurred were much narrower than the stimulatory
concentration range of magnesium. Thus in practice magnesium ions and
zinc ions were the two metal salts routinely included in alkaline phosphatase
incubations.
From the results of the distribution of alkaline phosphatase, 5'-nucleotidase
and LH receptor binding, some disparity in the buoyant densities of the
three markers can be observed. In control gradients, alkaline phosphatase
peaked at a lower buoyant density (1.12 g/cm3) in mid-luteal tissue density
gradients than in early and late luteal tissue gradients (1.18 and 1.17 g/cm3
respectively). Digitonin perturbation was similar in early and mid-luteal
gradients. However, in late luteal tissue gradients, buoyant density was
decreased by digitonin. The reasons for the differences between the buoyant
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densities and effects of digitonin at different stages of the luteal phase are
unclear. However, a possible suggestion may be that as the luteal phase
proceeds, the demand for cholesterol to serve as precursor for
steroidogenesis may lead to cholesterol being removed from membranes, as
has been suggested for the mechanism of action of SCP2 (sterol carrier
protein 2) (Strauss & Miller, 1991). Thus, at times of maximal steroidogenic
activity, for example during the mid-luteal phase, membranes may be
cholesterol-depleted and would thus equilibrate at a lower buoyant density
than cholesterol rich membranes such as those found at the early luteal
phase. In late luteal tissue it would appear likely, from the distribution of
alkaline phosphatase and the other plasma membrane markers used, that
membrane integrity was lost, and degenerative processes associated with
luteolysis may have commenced. Indeed, alkaline phosphatase was detected
in significant amounts in the upper part of late luteal tissue sucrose density
gradients, and was unperturbed by digitonin, indicating that it was no
longer associated with a (cholesterol rich) membrane.
The distribution of LH receptor binding follows a very similar pattern to that
displayed by alkaline phosphatase in early and mid-luteal tissue gradients.
Levels of digitonin perturbation were also similar in both plasma membrane
markers. LH receptor numbers were highest during the mid-luteal phase in
sheep (Niswender et al, 1985a). The results presented here would appear to
agree with ovine data, with highest levels of LH binding found in density
gradients of mid-luteal tissue. LH binding was very low in density gradients
of late luteal tissue, most likely as a consequence of luteolytic changes. The
disparity observed between the buoyant densities of alkaline
phosphatase/LH receptor/5'-nucleotidase may be due to differences in the
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cell types of the corpus luteum in which they are located. It is unclear which
cell type (large or small luteal cells) possessed alkaline phosphatase and 5'-
nucleotidase activity (or both)/ and whether the plasma membranes of luteal
small and large steroidogenic cells are of similar density. Whether or not
large luteal cells contain plasma membrane LH receptors is also unclear,
though recent reports appear to indicate the likelihood that both luteal cell
types do indeed possess the LH receptor in the bovine corpus luteum
(Chegini et al, 1991). Thus it may be that the LH receptor is only a marker of
theca-lutein cells. Such differences in the buoyant densities of plasma
membrane markers have also been suggested to be due to (i) different
regions of the plasma membrane having different densities, and (ii) resealing
of membrane vesicles produced during homogenization,which may have
different buoyant densities (Bramley & Ryan, 1978 b).
The optimum pH determined for total and fluoride-sensitive acid
phosphatase was pH 4.7. This was similar to the pH maximum of fluoride-
sensitive acid phosphatase in rat ovarian tissue (pH 5.2). In the rat, fluoride-
insensitive acid phosphatase activity displayed an optimal activity at pH 6.5
(Bramley & Ryan, 1978a). However, no such difference in optimum pH
between the two forms was observed in bovine luteal tissue. Indeed, in the
case of the bovine enzyme, activity was maximum from pH 4.4 - 5.0, whilst
beyond pH 5.0 activity decreased. No stimulatory activity of metal ions was
recorded, though inhibition occurred in the presence of zinc, manganese and
calcium ions. Distribution of acid phosphatase was similar at all stages of
the luteal phase, as was the bouyant density shift induced by digitonin
perturbation. Activity was recorded between 1.15 - 1.17 g/cm3 in control
density gradients, similar to the buoyant densities of this enzyme found in
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the sheep and pig corpus luteum, and similar to the peak found in the
human corpus luteum (Bramley & Menzies, 1986).
Cytochrome oxidase activity was demonstrated to be minimal below pH 3.
Optimum activity was recorded in all bovine luteal homogenates tested at
pH 6.8. This was lower than the optimum pH of this enzyme in the rat
ovary, which peaked at pH 8.4, though the pH optimum was lowered to pH
6.2 in the presence of phosphate buffers (Bramley & Ryan, 1978a). None of
the metal ions tested caused any change in activity. The distributions of
cytochrome oxidase in early, mid- and late luteal tissue sucrose density
gradient fractions were similar, displaying buoyant densities of 1.16, 1.15
and 1.12 g/cm3 respectively. Digitonin perturbation was similar in early
and mid-luteal fractions, but slightly reduced in fractions of late bovine
corpora lutea. Nonetheless, cytochrome oxidase activity increased in
buoyant density in response to digitonin in all gradients assayed. In sucrose
density gradient fractions of the ovine and porcine corpus luteum, the
buoyant density of cytochrome oxidase activity was relatively unaffected by
digitonin pretreatment (Bramley & Menzies, 1986; 1988a; c). Thus, bovine
mitochondrial membranes may contain higher levels of unesterified
cholesterol than the mitochondria of other species.
Activity of N-acetyl-G-D-glucosaminidase was maximal at pH 5.8, and was
considerably enhanced in the presence of magnesium. Lysosomes,
represented by the activity of N-acetyl-fi-D-glucosaminidase, equilibrated at
a buoyant density of 1.17 g/cm^- As has been observed in the corpora lutea
of sheep and pigs (Bramley & Menzies, 1986; 1988), digitonin pretreatment
of bovine luteal homogenate caused the activity of N-acetyl-fi-D-
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glucosaminidase to equilibrate at the top of sucrose gradients, ie. in cytosolic
fractions, due to detergent (digitonin) permeabilisation of the lysosomal
membrane, and release of intralysosomal contents.
DNA sedimented at the bottom of sucrose density gradients, as has been
previously observed (Bramley & Menzies, 1986; 1988). Unlike the sheep and
pig corpus luteum, no NADPH cytochrome c reductase activity was
observed in the bovine corpus luteum. Whether this enzyme was indeed
absent from the bovine CL is unclear. However, under a range of conditions
suitable to demonstrate activity of this enzyme in other species, no activity
could be recorded. NADH cytochrome c reductase activity on the other
hand was readily measurable in the bovine CL, and demonstrated to be
optimal at pH 7.0. In the rat ovary, this enzyme was considered to be located
in the mitochondrion. However, in the human, ovine and porcine corpus
luteum, it was associated with the smooth endoplasmic reticulum, or a
subset of smooth endoplasmic reticulum vesicles. It has been demonstrated
in the ovine corpus luteum that two forms of this enzyme were present, a
lighter form whose buoyant density was slightly decreased by digitonin, and
a more dense form that was unaffected by digitonin treatment (Bramley &
Menzies, 1988). This dense form of activity was considered to be of
mitochondrial origin. In the density gradients assayed in this study,
digitonin increased the buoyant density of NADH cytochrome c reductase.
Activity peaked at 1.14 - 1.15 g/cm3 in control gradients, similar to the
buoyant density of ovine mitochondrial NADH cytochrome c reductase
(Bramley & Menzies, 1988). In digitonin pretreated gradients increases in
the buoyant density of NADH cytochrome C reductase were somewhat
inconsistent; in some gradients the shift was greater than others. However,
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in those gradients which displayed a large shift in the buoyant density of
NADH cytochrome C reductase no increased shift in the buoyant density of
progesterone was observed, suggesting that perhaps the two were not
associated directly. However, it was clear that on the basis of digitonin
induced increases in buoyant density, the locations of cytochrome oxidase
and NADH cytochrome c reductase were distinct. Also, cytochrome oxidase
activity displayed a much sharper peak of activity than did NADH
cytochrome c reductase. More work is required to elucidate whether or not
NADH cytochrome c reductase is of use as a marker of the endoplasmic
reticulum in the bovine corpus luteum, but since cytochrome oxidase has
been localised to the mitochondrion, it would appear unlikely that the
activity of NADH cytochrome c reductase is mitochondrially derived, from
the two enzymes' distinct behaviour in sucrose gradient fractions.
Of great interest was the location of endogenous progesterone in sucrose
density gradients of the bovine corpus luteum. Though a significant amount
of progesterone was found in the cytosolic fractions, the main peak of
progesterone equilibrated in a broad peak, spanning the buoyant density
range 1.10 -1.16 g/cm3- Its distribution showed a similar pattern to that of
the distributions of plasma membrane markers and NADH cytochrome c
reductase. However, in all cases, progesterone equilibrated at slightly lower
buoyant densities than NADH cytochrome c reductase. Moreover, digitonin
induced an increase in the buoyant density of progesterone, demonstrating
progesterone to be associated with particulate material containing
unesterified cholesterol. Associations.between cellular membranes and
progesterone secretion have been previously suggested. Rice et al (1986)
reported that associations between progesterone and the plasma membrane
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of sheep luteal cells represented non-specific intercalation of progesterone
into the membrane. Indeed, the accepted theory of progesterone secretion is
that due to its hydrophobic nature, it simply diffuses across the luteal cell
plasma membrane (Enders, 1973). Thus, the location of progesterone in
sucrose density gradients may be simply non-specific intercalation into the
luteal plasma membrane as it diffuses across. However, it would be
expected that under the conditions of this study that intercalation could
occur into all other cellular membranes also. Since this was clearly not the
case, and work in other species has demonstrated specific, membrane
association of progesterone (Bramley & Menzies, 1986; 1988 a; b; 1994), the
subcellular location of progesterone may be of importance. Others have
demonstrated the existence of specific binding proteins for progesterone in
the bovine corpus luteum (Willcox & Thorburn, 1981; Willcox & Alison,
1982; Willcox, 1983). However, since these proteins were located in the
cytosol of luteal cells, binding to these proteins cannot account for
association of endogenous progesterone with a particulate membrane
fraction. Since the theory of progesterone secretion has not gone
unchallenged, it was decided to investigate further the nature of the
interaction between progesterone and cellular membranes (see Chapter 3).
The intracellular locations of the different steroidogenic enzymes has been
well documented. The accepted subcellular locations of the main
steroidogenic enzymes have been determined by differential centrifugation,
followed by identification of enzymatic activity for each particular
steroidogenic enzyme, often in conjunction with electron microscopy
analysis of the fractions obtained (see Lieberman & Prasad, 1990, for review).
The accepted location of the cholesterol side chain cleavage system, which
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catalyses the formation of pregnenolone from cholesterol, is the inner
mitochondrial membrane (Strauss & Miller, 1991). However, early studies
demonstrated the absence of this enzyme in mitochondrial fractions (Lynn et
al, 1954; 1955). From the results presented here, it is clear that P450 see is
found in very small quantities in the cytosol, and in largest quantities in the
fractions thought to contain the endoplasmic reticulum and mitochondrial
material. It is unclear from these experiments whether or not this is simply a
case of contamination of microsomal fractions with mitochondria (since
microsomal preparations may also contain inner and outer mitochondrial
membranes), or whether in other organelles, besides mitochondria, side
chain cleavage enzyme may be located. Incubation of 20-methyl-5-pregnen-
3fi-ol with adrenal microsomes has been shown to result in the production of
corticosterone (Tait & Hodge, 1985). This conversion requires a number of
enzymatic activities, one essential process being the cleavage of the side
chain from the substrate. Thus, given current understanding of the
enzymatic production of steroids from sterol precursors, there is evidence to
suggest that P450 see may be located in either the endoplasmic reticulum
and/or the mitochondrion.
Bovine cholesterol side chain cleavage has been identified as a 49,000 Da
protein (Rodgers, 1986a, Young et al, 1995). In studies where antibodies have
been used to detect the presence of P450 see by immunoblotting, positive
results in the corpus luteum and follicles of cows have confirmed this size
(Rodgers et al, 1986a; b; c). In this study, a band of approximately 49,000 Da
was detected. However, other bands of different sizes were also evident.
Recently, it has been demonstrated in the bovine corpus luteum that cross-
linking between P450scc and its electron donor adrenodoxin occurs (Young
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et al, 1995). The formation of the 1:1 covalent, non-disulphide-linked cross-
linked protein is thought to be counteracted by the presence of anti-oxidants
such as fi-carotene present in the bovine corpus luteum (Young et al, 1995).
The molecular weight of the cross-linked product is 63 kDa (Young et al,
1995). In this study, bands of approximately 65 kDa were evident. It would
appear that this band is likely to be P450 see cross-linked to adrenodoxin.
The bands of 46 kDa and 80 kDa that were detected may be artifactual in
nature, due to either the use of an antibody raised against ovine P450 see, or
due to incomplete reduction/dissociation prior to electrophoresis. Thus, it is
not possible to say with certainty whether bands other than that at 49,000 Da
are the result of isoforms of P450 see modified by post-transcriptional
modifications, or due simply to non-specific antibody binding. From
experiments performed with antibodies raised against purified bovine P450
see, it appears that the cow corpus luteum contains only one form of P450 see
(Rodgers et al, 1986). It has been demonstrated that humans possess only
one gene coding for P450 see, but that the protein is made in an immature
form which is larger than the active enzyme, and then transported to the
mitochondria where it is activated by a specific endoprotease (Matocha &
Waterman, 1985). The higher molecular weight bands observed here may
therefore represent immature, inactive bovine P450 see.
No P450 17ahydroxylase/C17,20 lyase was observed in immunoblots of
sucrose density gradient fractions of bovine corpora lutea. The antibody
used was raised against the bovine form of this enzyme, and indeed was
shown to blot positively in control tissues (bovine theca cell homogenate).
This is in agreement with results obtained by others using different
antibodies. Rodgers et al, (1986c), observed that the P450
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17ahydroxylase/C17,20 lyase content of bovine follicles increased with
follicular development then was dramatically reduced to below detection
levels in corpora lutea. Levels of steroidogenic enzymes tend to reflect the
steroidogenic activity of the tissue examined (Rodgers et al, 1986c). Since it is
this enzyme that provides the substrate for the aromatase enzyme in the
preovulatory follicle, it would appear that the loss of P450
17ahydroxylase/C17,20 lyase from the bovine corpus luteum is the critical
factor in the inability of the cow corpus luteum to form oestradiol. Indeed,
mRNA levels for both P450 17a hydroxylase and P450 aromatase have been
observed to fall dramatically after the LH surge in cattle (Voss & Fortune,
1993).
The accepted intracellular location of 3fi-hydroxysteroid dehydrogenase/A4-
A5 isomerase (3S-HSD) is the endoplasmic reticulum. In the human corpus
luteum it has been localized to the perimitochondrial endoplasmic reticulum
(Strauss & Miller, 1991). The reported size of bovine 3C-HSD is 42 kDa
(Couet et al, 1990). In the results presented here, a band of approximately 43
kDA was evident in fractions enriched in mitochondrial and microsomal
enzyme activities. It would appear likely from the molecular size that this
band was 3C-HSD. Another band of approximately 65 kDa was evident in
all fractions. It is possible that SER vesicles could have formed during
homogenization of the luteal tissue, thus giving rise to the almost uniform
distribution of this protein in the fractions immunoblotted in this study,
however it is not known whether or not this protein is related to 32-HSD.
Hawatashi et al, (1985) have suggested the existence of a number of isoforms
of 36-HSD, and previous studies in the bovine ovary have indicated the
presence of up to 4 bands of different sizes in the bovine corpus luteum
(Couet et al, 1990). However, care must be exercised in the interpretation of
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the results of this latter study, since, as in the experiments reported here,
bovine tissue was blotted using antisera raised against the human form of
the protein and the homology between the two forms is only 79% (Couet et
al, 1990). In these studies, the heaviest protein bands equilibrated at
approximately 43 kDa and 65 kDa. Previous studies have also noted the
existence of a larger protein, of approximately 68 kDa (Couet et al, 1990) in
the bovine corpus luteum. It is likely that the 65 kDa band detected in these
experiments is the same protein that others have identified as the 68 kDa
band. It is not known whether or not this larger band could represent cross-
linking of the 3(3-HSD to another steroidogenic component such as an
electron transport protein. However, Young et al (1995) suggest that this
may possibly occur by oxygen radical damage with steroidogenic enzymes
other than P450 see. Though the existence of multiple forms of this enzyme
has been suggested (Gibb & Hagerman, 1976), it is not known whether these
are substrate or tissue specific (Strauss & Miller, 1991).
It was clear, however, that progesterone was not associated with the
steroidogenic enzymes immunoblotted in this study. Moreover, since these
enzymes represent mitochondrial and microsomal proteins, the exclusive
association of these organelles with endogenous progesterone does not
appear likely, in agreement with observations from experiments involving
organelle marker assays. The mechanism of progesterone release from the
luteal cell has not yet been demonstrated convincingly to be either active, or
passive diffusion across luteal membranes; together with the possibility of
intracrine effects of progesterone on luteal cells, the phenomenon of the
association of progesterone with material of membrane origin was
investigated further in following chapters.
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Chapter 3
Investigation of association between progesterone and
luteal membranes
3.1 Introduction
In the previous chapter it was demonstrated that progesterone
equilibrated in a broad peak spanning the buoyant density 1.10 - 1.14g/cm3
in a 10 - 50% (v/v) sucrose gradient. Whilst progesterone could not be
unequivocally localized to one of the major subcellular organelles, its
buoyant density was increased by the saponin, digitonin. Since digitonin
does not interact directly with progesterone, this suggested that the
progesterone was tightly associated with a membrane-bound component
that was affected by digitonin.
Previous studies on steroid binding in the porcine (Bramley & Menzies,
1988a; 1993; Menzies & Bramley, 1994), equine (Bramley et al, 1995) and
ovine (Bramley & Menzies, 1988c; 1994) corpus luteum have
demonstrated specific binding sites for [3H]-progesterone. After
incubation of luteal homogenates with labelled progesterone, and
fractionation on continuous sucrose gradients, fractions which
accumulated radiolabeled progesterone also contained the majority of
endogenous progesterone present. This fraction appeared to be associated
in those species with NADH-cytochrome C reductase activity, but not
with other endoplasmic reticulum markers (Bramley & Menzies, 1988a;
1993; 1994). Although other workers have described progesterone binding
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activity in the bovine corpus luteum, binding was found in the luteal
cytosol preparations (Willcox & Thorburn, 1981; Willcox & Alison, 1982;
Willcox, 1983). Binding of progesterone to a protein was thought to be a
mechanism whereby progesterone could be sequestered in a secretory
granule (Willcox & Thorburn, 1981; Willcox & Alison, 1982; Willcox,
1983). Others have attempted to demonstrate the existence of
progesterone in a secretory granular bound form (Gemmell et al, 1974;
Gemmell & Stacy, 1977; 1979; Quirk et al, 1979; Sawyer et al, 1979;
Gemmell et al, 1983). These studies were fuelled by the demonstration of
a luteal population of electron dense single-membrane-bounded granules
of about 250 nm in diameter which were morphologically and
cytochemically distinct from other cell organelles (Quirk et al, 1979; Parry
et al, 1980; Paavola & Christensen, 1981). However, subsequent studies
demonstrated these granules contained only oxytocin, not progesterone
(Rice & Thorburn, 1985; Rice et al, 1986).
The mechanism of secretion of progesterone remains enigmatic. A few
isolated studies based on ultrastructural observations have suggested (a)
that steroid may be transported in lipid droplets encased in smooth
endoplasmic reticulum (Rhodin, 1971) or, (b) transported within
canilicular endoplasmic reticulum (Yoshimura et al, 1968). However,
these have gained little acceptance and the mechanism of progesterone
secretion reported in most textbooks which address this topic ascribe
secretion to simple passive diffusion down a concentration gradient from
the cell in which it was synthesised, according to the general steroid
secretion mechanism proposed some years ago (Enders, 1973). Indeed, the
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ability of progesterone to intercalate into cholesterol-containing
phospholipid bilayers has been demonstrated (Carlson et al, 1983).
The scope of the work in this chapter was therefore to ascertain (i)
whether or not the subcellular fractions of the bovine corpus luteum
which sequestered endogenous progesterone could also bind exogenous
progesterone and, if so (ii) to examine the characteristics of progesterone
binding further to elucidate the physiological role of these binding sites.
142
3.2 Materials & Methods
3.2.1 General materials
All substrates, fine chemicals, inhibitors, reagents and unlabelled steroids
were purchased from Sigma Chemical Co., Poole, Dorset, U.K., from
BDH, Poole, Dorset, U.K. or from Amersham International pic,
Amersham, Bucks, U.K. Epostane (Stirling-Winthrop), the 3fi-
hydroxysteroid dehydrogenase inhibitor was a gift from Dr. R. Webb,
Institute of Animal Physiology & Genetic Research, Roslin, Midlothian,
and the progesterone receptor antagonist (RU 38486) was the gift of Dr. K.
J. Thong, Department of Obstetrics & Gynaecology, The University of
Edinburgh.
3.2.2 Tracers
Radiolabeled steroids used were: [l,2,6,7-3H]-labelled progesterone (100
Ci/mmol), [1,2,6,7-3H] testosterone (80 Ci/mmol) from Amersham
International pic, Bucks., U.K. and [7-3H] pregnenolone (10 Ci/mmol)
from New England Nuclear Research Products, Du Pont (U.K.) Ltd.,
Stevenage, Herts, U.K.
3.2.3 Ovarian Tissue
Ovaries were recovered from presumed non-pregnant cows slaughtered
at a local abattoir, and transported to the laboratory in ice-cold phosphate
buffered saline (PBS; sodium chloride (0.15 mol/1) in sodium phosphate
(10mmol/l; pH 7.4) within 1 hour of death. The stage of the luteal phase
was assessed by gross morphology (Figure 2.1), and corpora lutea were
dissected free from connective tissue and stroma, pooled according to
their assigned stage (early, mid-and late luteal phase), minced with
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scissors and homogenized in ice-cold sucrose (0.3mol/l)/ EDTA
(lmmol/l)/Tris-HCl (10 mmol/1), pH 7.4 (SET medium; 200 mg
tissue/ml) using a Polytron homogenizer (Kinematica, Lucerne,
Switzerland) with two 10-s bursts at full speed, interspersed with a 1-min
cooling period on ice. Homogenates were then filtered through two
layers of cheesecloth.
3.2.4 Sucrose density gradient fractionation
Continuous sucrose density gradients (30 ml; 10-50 % w/w) were prepared
by the method of Stone (1974) (see Chapter 2). Aliquots of homogenate
(2.5 ml) were mixed with either 0.5 ml SET medium (controls) or 0.5 ml
SET medium containing digitonin (10 mg/ml) and to both controls and
digitonin-treated gradients, 100,000 cpm of radiolabeled steroid, [3H]-
pregnenolone, [3H]-progesterone, or [3H]-testosterone was added. To
establish the in vitro progesterone binding assay to gradients of early,
mid- and late luteal tissue, no radiolabeled steroid was added. After a 30
min incubation on ice, 2.5 ml aliquots were gently layered over the
sucrose density gradients and centrifuged at 30,000 gav for 2h in a Sorvall
VTR 50 vertical tube rotor (4°C). Each gradient was then fractionated
using a Buchler-Searle Autodensiflo gradient fractionator equipped with
a meniscus-sensitive probe, and fractions (1ml) frozen at -20°C until
assay. In one representative experiment, fractions were assayed for
progesterone binding before and after freezing : no significant differences
were observed (data not shown). Where radiolabeled steroid was added,
250pl aliquots of 1 ml fractions collected from these gradients were
immediately mixed with 4 ml of scintillant fluid (Ecoscint A, National
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Diagnostics, Atlanta, Georgia) in scintillation vials, then counted for
tritium using an LKB Rackbeta II scintillation counter.
Aliquots of sucrose gradient fractions were assayed for progesterone
binding activity, endogenous progesterone content (by
radioimmunoassay), protein content and organelle marker enzyme
activities. Pools of fractions enriched in progesterone binding activity
were stored at -20°C for further analyses.
3.2.5 Assays
Measurement of the sucrose content of density gradient fractions was
performed using an Abbe refractometer (Atago, Japan). Protein was
measured by the method of Lowry et al (1951) using bovine serum
albumin (BSA) as a standard.
Marker enzyme activities specific for the major subcellular organelles and
luteal plasma membranes in the bovine corpus luteum were measured
using previously described optimised assays (Chapter 2).
Progesterone content of sucrose density gradient fractions was
determined as described in Chapter 2.
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3.2.6 Steroid binding to bovine luteal fractions in vitro
Aliquots (5-50|il) of bovine luteal fractions from sucrose gradients were
incubated at 4°C for two hours (except where indicated) in a system
containing 40 mmol/1 Tris-HCl (pH 7.4), 0.1% (w/w) BSA, [^H]-
progesterone (or other steroid where indicated) (50,000 cpm) and
digitonin (250 (ig/tube, except where indicated otherwise), with a final
incubation volume of 0.5 ml. Bound tracer was separated from free by
adding 1.0 ml of dextran-coated charcoal (DCC) (2.5g activated charcoal,
(250-350 mesh) (Sigma) and 0.25g Dextran-T (Sigma) in Tris-BSA assay
buffer). Tubes were centrifuged at 3000g for 10 min (4°C), then
supernatants decanted and mixed with 4ml scintillant, shaken and
counted for tritium by liquid scintillation spectrometry. Tubes with no
membranes but with digitonin, and tubes with membranes but no
digitonin were routinely included as controls. In binding specificity
experiments, steroids were dissolved in ethanol, added to the assay tubes,
then dried down at room temperature under a stream of nitrogen. Assay
buffer was then added and the tubes vortexed vigorously (30 sec) before
proceeding with the addition of the remainder of the assay cocktail and
the normal incubation. Where other substances (such as cofactors, other
saponins, etc.) were added to the assay, these were dissolved in assay
buffer (Tris-BSA), and the incubation volume maintained at 0.5 ml.
Where low solubility of particular test substances necessitated dissolving
in ethanol prior to addition to the assay, control tubes containing an
equal volume of ethanol alone were included.
146
3.2.7 HPLC analysis
Bound radiolabeled progesterone was extracted from the binding site by
mixing 1ml bound fraction (DCC supernatant, taken after binding
equilibrium was reached) with 2.5 ml petroleum ether and vortexing
vigorously for 10 minutes. The resulting emulsion was then centrifuged
at 2000 rpm, (4°C) for 10 minutes. The supernatant was decanted and
placed in a dry-ice/alcohol freezing solution. The solvent was decanted
from the frozen aqueous phase and dried down under a stream of
nitrogen before reconstitution in 100 jil of absolute ethanol. The column
used was a reverse-phase Bio-Rad Hi-pore column (250 x 4.6 mm).
Solvent (acetonitrile/H20) was run isocratically (1 ml/min) until all
substances has been cleared from the column (ca. 30 min). As standards,
[3H]-progesterone and unlabelled progesterone were also run.
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3.3 Results
3.3.1 Fractionation of bovine luteal homogenates preincubated with
steroid tracer (Figure 3.3.1)
Fractionation of bovine luteal homogenates on control gradients in the
absence of digitonin indicated little binding of [3H]-progesterone, [3H]-
pregnenolone and [3H]-testosterone (Fig. 3.3.1, A, B & C). However,
preincubation of tracer with homogenates in the presence of digitonin
increased the amount of progesterone (Figure 3.3.1 A) and pregnenolone
recovered in the gradient (Figure 3.3.1 B), with both steroids displaying a
broad peak of binding, equilibrating at a buoyant density of 1.10 - 1.14
g/cm3. In the absence of digitonin, binding of [3H]-testosterone was low,
and did not display the peak observed for progesterone and pregnenolone
(Figure 3.3.1 C), even in the presence of digitonin. The effect of digitonin
on steroid binding was more pronounced with progesterone than with
pregnenolone. In the absence of digitonin, little steroid tracer entered the
gradient; however, with digitonin present, increased amounts of all three
steroid tracers entered the gradients (though no specific binding was
apparent in the case of testosterone). A secondary effect of digitonin was
that it appeared to sharpen the peak of [3H]-progesterone binding (Figure
3.3.1 A). Binding of [3H]-progesterone was consistently greater than [3H]-
pregnenolone binding for a number of different homogenates treated in
this manner (n=4).
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Figure 3.3.1 Fractionation of bovine luteal homogenate incubated with
radiolabeled steroids in the presence (•) and absence (o) of digitonin. A
= luteal homogenate incubated with [3H]-progesterone, B = luteal
homogenate incubated with [3H]-pregnenolone, C = luteal homogenate
incubated with [3H]-testosterone.
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3.3.2 Steroid binding to bovine luteal fractions in vitro
3.3.2 (i) Protein concentration
In the absence of digitonin, [3H]-progesterone binding remained at non¬
specific levels, even when high concentrations of luteal membranes were
added to the assay. However, in the presence of digitonin binding of [3H]-
progesterone increased linearly, reaching a plateau at high membrane
concentrations (Figure 3.3.2).
3.3.2 (ii) Effects of digitonin
In the absence of digitonin, binding of both progesterone and
pregnenolone tracers remained low. Binding of progesterone increased
markedly with increasing digitonin content, but only in the presence of
luteal membranes (Figure. 3.3.3 A), reaching a plateau at a digitionin
concentration of 0.25 mg/tube. [3H]-pregnenolone binding also increased
with increasing digitonin concentrations in the absence of membranes
(Figure 3.3.3 B). However, binding was always much greater in the
presence of membranes, reaching a plateau at lower digitonin
concentrations (30 - 40 jig/tube) than was required in the case of
progesterone (0.25 mg/ tube). Thus the remainder of these studies were
conducted using [3H]-progesterone.
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Figure 3.3.2 [3H]-progesterone binding to increasing concentrations of
bovine luteal homogenate sucrose gradient fraction pooled from fractions
enriched in progesterone binding activity. Binding of progesterone was
detectable only in the presence of digitonin. In the absence of digitonin,
binding did not increase beyond non-specific levels (heavy dotted line).
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Figure 3.3.3 Effects of increasing digitonin concentration on [3H]-
progesterone and [3H]-pregnenolone binding to pooled sucrose gradient
fractions enriched in progesterone binding activity. A = progesterone
binding. Binding of [3H]-progesterone was low (ca. 4%) in the absence of
digitonin. B = pregnenolone binding, in the presence of sucrose gradient
fraction (o) and in the absence of sucrose gradient fraction (•). The above
figure displays data representative of two such sets of experiments.





3.3.2 (iii) pH of incubation
Progesterone binding to bovine luteal membranes was found to be
dependent on the pH of the incubation cocktail. Binding of progesterone
to membranes was absent below pH 4.5, but increased sharply with
increasing pH, reaching a plateau above pH 6.5 (Figure 3.3.4). Again, only
non-specific levels of binding (4-6%) were found in the absence of
digitonin over the pH range tested.
3.3.2 (iv) Duration and temperature of incubation
Radiolabeled progesterone binding to bovine luteal membranes
increased rapidly at all temperatures tested (4°C, 20°C, 37°C) reaching a
maximum at 4°C after 90 minutes (Figure 3.3.5). These levels were
reached in the first 10 minutes of incubation at 20°C and 37°C. However,
binding began to fall after this time point at 37°C, indicating a possible
loss of binding sites at this temperature. Once again, in the absence of
either digitonin or bovine luteal membranes, [3H]-progesterone binding
did not exceed non-specific levels (data not shown).
3.3.3 Specificity of bovine luteal progesterone binding sites
Unlabelled progesterone displaced the binding of tritiated progesterone at
low levels (IC50, 63 nM) (Figure 3.3.6). Testosterone was 100-fold less
active. Pregnenolone displaced [3H]-progesterone binding only at
micromolar concentrations, reaching half-maximal displacement only at
the maximum concentration tested (200 Jig/ml final assay concentration).
Other steroids such as oestradiol did not displace binding significantly.
Steroid precursors such as cholesterol, inhibitors of steroidogenic
enzymes (epostane and ketoconazole - inhibitors of the 3fi hydroxysteroid
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dehydrogenase and C17,20-lyase enzymes respectively) and the potent
progesterone receptor antagonist RU 486 did not compete for binding sites
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Figure 3.3.4 Determination of optimal pH for progesterone binding
activity, (o) = in the presence of sucrose gradient fraction (10|i.l), (• ) = no
sucrose gradient fraction added. Binding was measured in the presence of
digitonin (0.25 mg/tube). In the absence of digitonin, binding remained
at non-specific levels (5-6 %) at all pH intervals tested (data not shown).
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Figure 3.3.5 Effects of duration and temperature of incubation on
progesterone binding to pooled sucrose gradient fractions (10 pi) enriched
in progesterone binding activity. (•) = 4°C, (o) = 20°C, (A) = 37°C. Graph
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Figure 3.3.6 Displacement of [3H]-progesterone binding by progesterone
and other steroids, receptor antagonists and steroid metabolizing
enzymes. Bo = no added unlabelled steroid. Each unlabelled steroid was
assayed in triplicate, and each displacement experiment repeated using
three different homogenates. For clarity, only a selection of data is
displayed in the above figure, without error bars, since each membrane
preparation used in these experiments gave similar results with respect to
displacement of bound [3H]-progesterone. Differing Bo values are due to
different membrane preparations used for the above data sets. For full
description of displacement potencies see Table 3.1.
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Table 3.3.1 Potencies of steroids, precursors and inhibitory agents for [3H]-
progesterone binding sites in bovine corpus luteum sucrose gradient
fractions.
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A number of progesterone analogues were tested for their abilities to
displace the binding of radiolabeled progesterone. The only progesterone
analogues tested that showed displacement similar to that of
progesterone were 20a-hydroxyprogesterone and 20fi-
hydroxyprogesterone. Alterations on the C3 - Cll side of the molecule
resulted in a reduction in potency, suggesting that these positions may be
important in the specificity of the binding site for progesterone. Indeed,
there was no observable binding of iodinated progesterone (the iodinated
form of progesterone tested had the 125I attachment at Cll) (Figure 3.3.7).
3.3.4 Subcellular localization of bovine luteal progesterone binding sites
The marker enzyme assays (as described in Chapter 2) used were
cytochrome oxidase (mitochondrial marker), acid phosphatase (GERL
marker), alkaline phosphatase, LH receptor and 5' nucleotidase (plasma
membrane markers), N-acetyl glucosaminidase (lysosomal marker), DNA
(nuclear marker) and NADH-cytochrome C reductase (smooth
endoplasmic reticulum marker). From Figure 3.3.8 it can be seen that
progesterone binding equilibrated in fractions enriched in activities of
plasma membrane markers and to a lesser extent smooth endoplasmic
reticulum markers. However, it can be observed that in digitonin
pretreated subcellular fractions the perturbation of the buoyant density of
the progesterone binding site (30% sucrose to 32.7% sucrose) was more
similar to that of the plasma membrane markers (33% sucrose to 34.6%
sucrose) than the endoplasmic reticulum marker (30.2% sucrose to 35%
sucrose).
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Figure 3.3.7 Distribution of binding sites for tritiated progesterone (•) and
iodinated progesterone (o). No specific binding of either tracer was
observed in the absence of digitonin. However, in the presence of
digitonin, only tritiated progesterone was bound.
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Figure 3.3.8 Comparison of the distribution of major intracellular
organelles with the pattern of progesterone binding sites observed in
fractions of bovine luteal homogenates subjected to sucrose density
gradient fractionation, in the presence (•) or absence (o) of digitonin. (PM
= plasma membrane, ER = endoplasmic reticulum, MIT = mitochondia,
GERL = Golgi-endoplasmic reticulum-lysosomal complex, LYS =
lysosomes, N = nuclei).
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3.3.5 Subcellular localization of endogenous progesterone in sucrose
gradient fractions
Endogenous progesterone content was present in high levels in cytosolic
and nuclear fractions (Figure 3.3.9), which would appear to be free steroid
since it was readily removable by dextran-coated charcoal treatment (data
not shown). However, progesterone content equilibrated at the same
buoyant density (1.10 - 1.14 g/cm3) as fractions enriched in [3Hj-
progesterone binding activity. Moreover, the buoyant density of
progesterone content was perturbed by digitonin pretreatment to the
same extent as the buoyant density of [3H]-progesterone binding (Fig
3.3.9), suggesting that in the luteal cell endogenous progesterone is
associated with this particulate fraction.
3.3.6 Levels of progesterone binding throughout the bovine luteal phase
In density gradients of early luteal tissue, progesterone binding was
present at levels comparable to those observed in the mid-luteal phase,
(Figure 3.3.10). In the late luteal phase, [3H]-progesterone binding levels
were somewhat lowered.
164
Figure 3.3.9 Progesterone content (o) and progesterone binding (•)
activity of sucrose density gradient fractions of bovine luteal homogenate.
A = control gradient, B = digitonin pretreated gradient. Progesterone
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Figure 3.3.10 Levels of progesterone content (o) and progesterone binding
(•) during the early, mid and late luteal phase. Progesterone binding
activity was measured in the presence of digitonin (250 pg/tube). Figure
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3.3.7 HPLC analysis of steroid recovered from binding site
[3H]-progesterone tracer extracted from the progesterone binding site after
binding to equilibrium had the same retention time on reverse phase
HPLC as progesterone and [3H]-progesterone tracer, demonstrating that
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Figure 3.3.11 Reverse phase HPLC analysis of bound progesterone
extracted back from the luteal binding site (--•—) and fresh [3H]-




It has been demonstrated previously that both exogenous and
endogenous progesterone were sequestered by a unique particulate
fraction of the porcine, ovine and equine corpus luteum (Bramley &
Menzies, 1988a; 1993; 1994; Bramley et al, 1995). In the porcine and ovine
corpus luteum, the only intracellular organelle marker enzyme activity
consistently associated with progesterone binding activity was NADH-
cytochrome C reductase, a marker of the smooth endoplasmic reticulum
(Bramley & Menzies, 1988a; 1994). However, in the equine corpus
luteum, progesterone binding activity was more closely associated with
luteal cell surface membranes than any other organelle (Bramley et al,
1995)
In the present study of the bovine corpus luteum, NADH-cytochrome C
reductase equilibrated at a slightly higher buoyant density (1.14 g/cm3)
than [3H]-progesterone binding activity (1.10 - 1.14 g/cm3) (Figure 3.3.8).
However, bovine luteal plasma membrane markers followed an almost
identical pattern to that of progesterone binding, suggesting an
association between the plasma membrane and [3H]-progesterone
binding. Association of progesterone with luteal plasma membranes has
been suggested by other workers in the past, but was reported to be due to
non-specific intercalation of progesterone into luteal membranes (Rice et
ah, 1986). The results presented here demonstrated clearly that luteal
steroid binding sites were highly specific for progesterone. Furthermore,
if the binding observed in this study was simply due to the partitioning of
hydrophobic steroids into hydrophobic lipid bilayer membranes, then one
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would expect that binding would occur to other luteal membranes. This
was clearly not the case, as only plasma membranes, and to a lesser extent
the membranes of the smooth endoplasmic reticulum, were associated
with progesterone binding. Other membranes (eg. mitochondrial,
nuclear and lysosomal membranes) did not bind [3H]-progesterone
appreciably. Furthermore, inclusion of the detergent digitonin in the
binding assay was essential in order to demonstrate binding (Figure 3.3.3).
If steroid binding were simply due to steroid dissolution into luteal
membranes then it would be expected to occur in the absence of digitonin
also. It could be argued that digitonin treatment resulted in the
formation of lipid micelles into which progesterone could partition more
readily. However, the solubilization of the progesterone binding site
from bovine luteal membranes with the detergent octyl glucoside could
be demonstrated, with minimal losses in activity (see Chapter 5). In
digitonin-pretreated subcellular fractions, perturbation of the
■*
endoplasmic reticulum was slightly greater than that of the progesterone
binding site and that displayed by the plasma membrane markers (Figure
3.3.8). However, when compared to results obtained in Chapter 2, it can
be noted that the perturbation of NADH cytochrome c reductase was not
consistent - in some gradients very little increase in bouyant density with
digitonin treatment was observed, however in other gradients a much
greater shift was evidient. The reasons for this inconsistency are unclear.
Nontheless, in control gradients and digitonin pretreated gradients, both
progesterone content and binding were consistently found to equilibrate
in similar positions to the plasma membrane markers regardless of the
position of NADH cytochrome c reductase, and thus would appear to be
more closely associated with the plasma membrane than the endoplasmic
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reticulum, similar to experiments performed on the horse corpus luteum
(Bramley et al, 1995). However, due to the nature of enzymatic
identification of positions of organelles in density gradients and
contamination of eg. fractions enriched in plasma membranes with
membranes of the endoplasmic reticulum, it is difficult to ascertain the
exact location of the progesterone binding site, though from the data
presented here it would appear to be more likely to be associated with
luteal cell surface membranes rather than intracellular membranes. To
this end, differences in some samples between the buoyant densities of
the plasma membrane markers alkaline phosphatase and LH receptor
were observed, suggesting that these two activities may be located either
in different areas of the plasma membrane, or in areas differently
enriched in unesterified cholesterol. To resolve this question, more
detailed subcellular fractionation studies of bovine plasma membranes
would be required.
In the previous studies mentioned (Bramley & Menzies 1988a; 1993;
1994), preincubation of progesterone tracer with luteal homogenates prior
to fractionation led to recovery of most of the radiolabelled steroid in
cytosolic fractions which failed to enter the sucrose gradients. However,
preincubation with digitonin caused the majority of steroid to enter the
gradient, and to equilibrate at the same buoyant density as progesterone
binding activity (Bramley & Menzies, 1988a; 1983; 1994). The experiments
presented here showed the same behaviour in bovine luteal subcellular
fractions. Moreover, in agreement with previous studies, binding of
steroids other than progesterone and pregnenolone was poor or absent.
In all species studied, including these experiments in the cow corpus
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luteum, binding of radiolabeled progesterone was significantly greater
than binding of pregnenolone. Preincubation of luteal homogenates
with digitonin prior to fractionation increased the buoyant density of the
progesterone binding site, but decreased the recovery of progesterone
binding activity, as compared to levels found in control gradients. If
digitonin unmasked progesterone binding sites by inducing membrane
disruption (Bramley and Menzies, 1994), then the decrease in binding
activity following digitonin pretreatment may reflect inactivation of
binding sites during fractionation. Alternatively, preincubation of luteal
homogenate with digitonin may activate progesterone binding sites
which are not already active, allowing binding of endogenous
progesterone which is normally unbound (free cytosolic progesterone) to
be bound by the particulate binding site prior to fractionation, thus
effectively reducing the numbers of binding sites available to be
measured.
Digitonin forms non-covalent unimolecular complexes with steroids
possessing a 3fi-hydroxy-A5 configuration and a CI7 side chain (Miller,
1984; Severs & Robeneck, 1983; Murphy & Martin, 1985). This interaction
is responsible for the perturbation of the buoyant density of cell surface
membranes which contain high levels of unesterified cholesterol
(Bramley & Menzies, 1988). This interaction also occurs with
pregnenolone, resulting in higher levels of non-specifically bound
pregnenolone tracer in the absence of luteal membranes. In contrast,
progesterone, which does not interact with digitonin, was not bound in
the absence of membranes. Dextran-coated charcoal did not appear to
absorb [3H]-pregnenolone complexed to digitonin, as expected at the
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levels of digitonin used in the binding assay incubation cocktail (data not
shown). It is possible therefore that the binding potency of pregnenolone
relative to [3H]-progesterone binding may be grossly underestimated,
since there was no way of ascertaining how much of the pregnenolone
added to the assay cocktail was actually available to compete for binding
sites, and how much had been complexed by the digitonin present in the
assay incubation cocktail. The observation that only digitonin was able to
stimulate progesterone binding, and that all other membrane perturbants
tested failed to do so, demonstrated clearly that disruption of membrane
structure was not the sole mechanism by which digitonin acted to
stimulate steroid binding (see Chapter 6). Indeed, no other membrane
perturbants tested mimicked the effects of digitonin, indicating that this
effect was not mediated by membrane permeabilization alone (see
Chapter 6). However, digitonin may displace an endogenous steroid
from its binding site, allowing the progesterone tracer to bind. Perhaps
luteal binding sites are normally occupied by high levels of endogenous
steroid in the cell. Indeed, dextran-coated charcoal treatment of
membranes can increase the amount of radiolabeled progesterone bound
(see Chapter 5), suggesting occupation of a large proportion of binding
sites by endogenous steroid. Indeed, since the buoyant densities of
endogenous progesterone and progesterone binding were identical, then
it would appear that a significant proportion of the endogenous
progesterone found in the bovine corpus luteum was bound to this
membrane binding site.
Binding of progesterone in vitro was shown to be dependent on the
temperature, duration and pH of incubation, and binding increased
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linearly with increasing concentrations of bovine luteal membranes
added. Binding was specific for [3H]-progesterone. Radiolabeled
pregnenolone was bound to a lesser degree (though this may be at least
partly due to interactions between the radiolabeled pregnenolone and
digitonin in the absence of membranes). Binding of other steroid tracers
was poor or absent. Unlabelled progesterone competed for binding of
tritiated progesterone at very low concentrations (IC50 = 63 nM). From
Table 3.3.1 it is clear that androgenic steroids and progesterone analogues
have lower potency for [3H]-progesterone binding sites than does
progesterone itself. Furthermore, substances which inhibit steroidogenic
enzymes such as ketoconazole (inhibitor of 17 a hydroxylase/C17,20 lyase)
and epostane (inhibitor of 313-hydroxysteroid dehydrogenase) had no
effect on progesterone binding, demonstrating that binding of
progesterone was not due to binding of steroid to the active site of these
steroid metabolizing enzymes. Other steroids, steroid precursors, and
progesterone receptor antagonists showed little or no activity (Table 3.3.1),
confirming observations in other species (Bramley & Menzies, 1992; 1994)
and emphasising that luteal progesterone binding sites herein were
distinct from progesterone receptors.
It has been demonstrated that 3fi-hydroxysteroid dehydrogenase is
extremely sensitive to end-point inhibition, and has a six-fold greater
affinity for its product (progesterone) than it has for its substrate,
(pregnenolone) (Caffrey et al, 1979a). However, testosterone and
oestradiol are also potent inhibitors of this enzyme through the same
end-point inhibition that is exerted by progesterone (Caffrey et al, 1979a).
Hence, if binding of progesterone was due to binding to the active site of
175
this enzyme, then androgens and oestrogens would be expected to show
potent progesterone binding competition. From the results presented in
Table 3.3.1 this was clearly not the case. Moreover ANS, which blocks
steroid binding to Cortisol binding globulins, had no effect on luteal
progesterone binding. Finally, solvent extraction and reverse phase
HPLC of progesterone tracer bound to bovine luteal binding sites
demonstrated that >95% of radiolabel recovered had an identical
retention time to progesterone and [3H]-progesterone, indicating that
metabolism of progesterone had not occurred during binding.
The significance of the luteal progesterone binding site examined in these
experiments remains unclear. The data presented here agree with
previous data from the porcine corpus luteum in that binding sites were
of high affinity and were specific for progesterone, and that endogenous
progesterone was associated with these binding sites (Bramley & Menzies,
1994), and may indicate that these binding sites are involved in
sequestration of steroid, perhaps for secretion from the luteal cell. The
mechanism of secretion of progesterone has remained unresolved,
despite investigations by various workers over the past twenty-five years.
Progesterone binding to a specific binding protein enclosed by electron
dense granules has been proposed (Gemmell & Stacy, 1979; Quirk et al,
1979; Sawyer et al, 1979), and Quirk et al (1979) demonstrated fractions of
the bovine corpus luteum rich in secretory granules and progesterone,
though these granules were subsequently shown to contain oxytocin, and
further studies demonstrated that oxytocin and progesterone were
secreted independently of each other (Sernia et al, 1982; Rice et al, 1986;
Luck, 1988). Other workers described progesterone binding proteins
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isolated from the cytosol of the bovine corpus luteum, suggesting a
possible role in luteal steroidogenesis and/or secretion (Willcox &
Thorburn, 1981; Willcox, 1983). However, these proteins also bound
R5020 (a synthetic progestagen with high affinity for mammalian
progesterone receptors); unlabelled R5020 was unable to compete for
binding sites with [3H]-progesterone bound to particulate luteal binding
sites described here.
It has been suggested that progesterone may play an important role in the
regulation of the corpus luteum (Rothchild, 1981). It is possible,
therefore, that the binding described here may represent a binding to a
non-classical receptor for progesterone which is involved in the
autocrine regulation of luteal function. Studies which have addressed
the role of progesterone in the control of luteal function have thus far
concentrated on the genomic progesterone receptor, as have the majority
of studies of steroid function in general. However, non-genomic effects
of steroids have been known for a number of years, and thus the binding
site studied herein may play a role in the transduction of as yet
uncharacterised non-genomic effects of progesterone. The autocrine role
of luteal progesterone and possible involvement of the particulate
binding site studied herein is dealt with in more detail in following
chapters.
Due to the sensitivity of steroidogenic enzymes to end-point inhibition, it
has been suggested that there must be some modification of this feedback,
or progesterone synthesis would quickly halt. Suggestions have included
steroid-binding proteins which sequester progesterone and thereby
177
effectively remove its inhibitory effects on the 3f3-hydroxysteroid
dehydrogenase enzyme (Niswender & Nett, 1994). Since luteal
concentrations of pregnenolone are low as compared to luteal
concentrations of progesterone, it would appear likely that some
mechanism of removing progesterone to relieve its negative feedback on
the enzyme 3(3-hydroxysteroid dehydrogenase (which converts
pregnenolone to progesterone) is required (Caffrey et al, 1979a). Thus it is
possible that the progesterone binding sites studied here may function as
(i) a steroid binding protein whose function is to bind progesterone to
remove it from actively inhibiting its own formation, (ii) a binding
protein to shuttle progesterone in an aqueous soluble form to other parts
of the cell as part of an autocrine system, or (iii) to participate in the
secretion of progesterone from the luteal cell.
In conclusion, the bovine corpus luteum contains particulate binding
sites specific for progesterone. In later chapters of this thesis this binding
site is examined more fully, with attempts to purify it, studies of its
distribution in the preovulatory follicle and the specific cell types of the




Cellular distribution of progesterone binding sites in
the bovine corpus luteum and bovine preovulatory
follicle
4.1 Introduction
Early studies in the porcine and guinea pig CL indicated that the cell types of
the corpus luteum were derived from both the thecal and granulosa cells of
the preovulatory follicle (Loeb, 1906; Corner, 1919). This theory of the
origins of luteal cells is still accepted today, and has been described in a
number of species including the cow (Donaldson & Hansel, 1965; Priedkalns
et al, 1968), sheep (McClellan et al, 1975; O'Shea et al, 1980), pig (Corner, 1919)
and human (Guraya, 1971).
The experiments detailed in this chapter were designed to investigate the
cellular distribution of the progesterone binding site studied in previous
chapters in both the bovine corpus luteum and the bovine preovulatory
follicle, if indeed this binding site is present prior to luteinization. This
knowledge, coupled with that from experimental work detailed in earlier
chapters, should provide deeper understanding of the physiological role of
this progesterone binding site in the bovine ovary.
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4.2 Methods and Materials
4.2.1 Ovarian tissue
Ovaries were recovered from presumed non-pregnant cows slaughtered at a
local abattoir and transported to the laboratory in ice-cold phosphate
buffered saline (PBS; sodium chloride (0.15 mol/1) in sodium phosphate
(10mmol/l; pH 7.4) within 1 hour of death. The stage of the luteal phase was
assessed by gross morphology (Figure 2.2.1), and mid-luteal phase corpora
lutea were dissected free from connective tissue and stroma.
3.2.2 Recovery of granulosa and thecal cells
Granulosa cells were aspirated from non-atretic (clear, blood-free) small (<5
mm diameter), medium (5-10 mm diameter) and large (>10 mm diameter)
follicles of normal appearance using a fine-gauge needle and syringe. The
cells were recovered from the follicular fluid by centrifugation at 800 gav for
5 min, washed twice in 10 volumes of isotonic PBS and homogenized in ice
cold SET medium (2ml per ml packed cells) with 15 strokes of an all-glass
tight fit Dounce homogenizer. Theca cells were obtained by peeling the
thecal layer away from surrounding tissue (after careful scraping and rinsing
in ice-cold PBS to remove adherent clumps of granulosa cells) then
homogenized in SET (200 mg homogenate/ml) as described for granulosa
cells.
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4.2.3 Sucrose density gradient fractionation
Continuous sucrose density gradients (30 ml; 10-50% w/w) were prepared
by the method of Stone (1974) (see Chapter 2). Aliquots of granulosa and
thecal homogenate (2.5 ml) were mixed with either 0.5 ml SET medium
(controls) or 0.5 ml SET medium containing digitonin (10 mg/ml). After a 30
min incubation on ice, 2.5 ml aliquots were gently layered over the sucrose
density gradients and centrifuged at 30,000 gav for 2h in a Sorvall VTR 50
vertical tube rotor (4°C). Each gradient was then fractionated using a
Buchler-Searle Autodensiflo gradient fractionator equipped with a meniscus-
sensitive probe, and fractions (1ml) frozen at -20°C until assay.
4.2.4 Luteal cell dispersion
Corpora lutea were minced finely with scissors, then placed in dispersion
buffer (25 mis buffer/CL) (Dulbeccos phosphate-buffered saline, pH 7.3
(Sigma), 0.1 mM EDTA, 0.5% w/v BSA, DNAase I (8units/ml), heparin (25
units/ml), Pen-Strep (Sigma; 100 units penicillin/ml, 100 pg
streptomycin/ml) and agitated gently for 1 minute at room temperature.
The resulting suspension was then filtered through two layers of cheesecloth
to remove debris. This filtered suspension was then loaded on to an
elutriator for cell separation.
4.2.5 Large and small luteal cell elutriation
All parts of the elutriation system were cleaned and sterilised by flushing
with 2% H2O2 solution for 30 minutes. Elutriation buffer (Dulbeccos
phosphate-buffered saline, pH 7.3 (Sigma), 0.1% w/v BSA, DNAase I (1000
units/ml), heparin (25 units/ml), Pen-Strep (Sigma; 100 units penicillin/ml,
100 pg streptomycin/ml) was flushed through the system to remove any
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traces of peroxide. Cell suspensions (20 ml) were loaded into the elutriation
chamber (Beckman) by direct injection into the system, by-passing the
loading chamber. The initial pump (Masterflex) speed was 1, and the
elutriator rotor (Beckman) was adjusted to 750 gav. Cells were observed to
enter the elutriation chamber (by means of a strobe light, adjusted to the
speed of the centrifuge). Concomitant with injection of cell into the
elutriation system, 50 ml fractions were collected. After 2 fractions had been
collected (small luteal cells and erythrocytes), the pump speed was increased
to 2, and a further 2 fractions collected. Rotor speed was now reduced (500
gav), and the chamber inspected visually for disruption of the cell pellet
remaining. Rotor speed was reduced until the cell pellet in the elutriation
chamber was observed to disperse and cells to move towards the outlet. At
this point 4 x 50 ml fractions were collected, to flush the small cells trapped
in the cell pellet. Finally, the most dense cells (large luteal cells) were
elutriated from the chamber by increasing the pump speed to >3, and
decreasing the rotor speed to 250 gav.
50 ml fractions were then spun (250 g.av) for 10 minutes to pellet cells.
Supernatant was removed, and cells resuspended in 5 ml elutriation buffer.
Cell suspensions were then examined microscopically, and enriched
populations of small and large luteal cells were checked for viability by
trypan -blue exclusion (Sigma). Viability, as assesed by this method, was
found to be typically between 50 - 65 %.
4.2.6 Progesterone binding ability of isolated luteal cell sub-populations
Enriched cell populations of large and small luteal cells were pelleted by
centrifugation at 250 gav (10 minutes) then resuspended in sterile PBS, pH
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7.3. This wash step was repeated, to ensure removal of BSA present in the
elutriation buffer, which would otherwise interfere in measurements of
protein content. Cells were then homogenized (Dounce tight fit, 10 strokes)
and resuspended in PBS. Homogenates were then frozen at -20°C until
assay. Progesterone binding was assayed at suitable dilutions as described
in Chapter 2.
4.2.7 Protein determination
Protein levels of homogenates were determined by the method of Lowry et al
(1951) using bovine serum albumin (BSA) (Sigma) as a standard.
4.2.8 Progesterone binding to theca and granulosa cell homogenates
4 follicles from each group (small, medium and large) were processed as
detailed above. Progesterone binding was assayed in vitro as described in
Chapter 3, at a range of homogenate concentrations (10 |il - 50 |il). Protein
content of each homogenate was determined and results expressed as [3H]-
progesterone counts bound/ mg protein. Mean binding was calculated for
each follicular group and results presented + S.E.M. Statistical significance
of differences in progesterone binding activity between theca and granulosa
cells from each follicular group was assessed by students t-test, and
differences between cell populations from different groups by ANOVA.
4.2.9 LH binding to large and small luteal cell homogenates
LH binding to large and small bovine luteal homogenates was performed as
described in Chapter 1.
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4.2.10 SDS PAGE separations and Western blotting of bovine small and
large luteal cell homogenates
SDS PAGE gels were prepared as described in Chapter 2 (2.2.12). 30 fig (total
protein) of large and small cell homogenates were loaded onto each gel.
Western blotting was carried out as described in Chapter 2 (2.3.13). The
antibodies used were rabbit-anti-ovine P450 side chain cleavage, rabbit anti-
human 3fi - hydroxysteroid dehydrogenase/A4-A5 isomerase and rabbit-anti-
bovine P450 17 a hydroxylase/C17,20 lyase (kindly donated by Professor I.
Mason, Dept. of Clinical Chemistry, The University of Edinburgh). As
positive controls, gels to be blotted for P450 side chain cleavage and P450 17
a hydroxylase/C17,20 lyase were run with a lane containing 30 pg bovine
theca cell homogenate, and gels to be blotted for 3fi - hydroxysteroid




4.3.1 Progesterone binding to theca and granulosa cell homogenates from
small, medium and large sized follicles
Both granulosa and theca cell homogenates bound [3H]-progesterone,
though only in the presence of digitonin. Binding was found to be almost
ten-fold greater in theca cell homogenates than in granulosa cell
homogenates. Little difference was found between the binding capabilities
of the different follicle sizes (Figure 4.3.1), though a decrease in binding
activity of theca cells with increasing follicular size was apparent, though not
statistically significant.
4.3.2 Progesterone binding to theca and granulosa cell homogenate sucrose
gradient fractions
Both theca cell and granulosa cell homogenates subjected to sucrose density
gradient fractionation displayed progesterone binding activity when assayed
using the in vitro assay developed in the cow corpus luteum (Chapter 3).
Binding was observed to be greater in theca homogenate gradients than in
granulosa homogenate gradients. The buoyant density of the peak of
progesterone binding activity was higher in granulosa homogenate gradients
(1.12 - 1.15 g/cm3) (Figure 4.3.2) than in theca gradients (1.08 - 1.13 g/cm3)
(Figure 4.3.3) or luteal homogenate gradients (1.1 -1.14 g/cm3). In addition,
theca homogenate gradients displayed a peak of binding activity at a much
lighter buoyant density (1.05 - 1.07 g/cm3), as well as a peak in the same
position as was found in luteal homogenate gradients. In experiments where
theca and granulosa cell homogenates were incubated with digitonin prior to
fractionation, binding was markedly reduced. No binding was observable in
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digitonin pretreated granulosa cell homogenate gradients, however, in theca
cell homogenate sucrose gradients pretreated with digitonin a peak of
binding was observed at a lower buoyant density (1.14 - 1.16 g/cm3) than
that found in control homogenate gradients. No peak of binding at the top
of the gradient was observable in digitonin pretreated theca homogenate
gradients.
4.3.3 Progesterone binding characteristics of theca and granulosa sucrose
gradient fractions
Binding of [3H]-progesterone to granulosa and theca cell homogenate
sucrose gradient fractions was found to increase linearly with increasing
concentration of (sucrose density gradient) fraction added, reaching a
plateau at high membrane concentrations (Figures 4.3.4 and 4.3.5) Binding
was measurable only in the presence of digitonin. This plateau was reached
at lower membrane concentrations in theca cell homogenate (Figure 4.3.5)
sucrose gradient fractions (20 p.1/0.5 ml assay volume) than in granulosa cell
homogenate (Figure 4.3.4) fractions (30 pl/0.5 ml assay volume). In the
absence of digitonin, no binding was observable. Binding was found to be
higher in fractions of theca cell homogenate sucrose density gradients than





Figure 4.3.1 [3H]-progesterone binding to theca (shaded bars) and granulosa
cell (open bars) homogenates of small (< 5 mm diameter), medium (5-10
mm diameter) and large (>10 mm diameter) bovine preovulatory follicles.
Figure shows mean progesterone binding for each follicle group + S.E.M.
Differences in progesterone binding activity between theca and granulosa
cells from each group were highly significant (P<0.01) (t- test). No
significant difference was found between granulosa cells from each group,

























Figure 4.3.2 [3H]-progesterone binding to sucrose gradient fractions of
bovine granulosa cell homogenate, with (•) and without (o) digitonin
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Figure 4.3.3 [3H]-progesterone binding to sucrose gradient fractions of
bovine theca cell homogenate, with (•) and without (o) digitonin treatment
of homogenate prior to fractionation.
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Volume of fraction added (jllI)
Figure 4.3.4 [3H]-progesterone binding to increasing amounts of membrane
fraction pooled from sucrose gradient fractions of bovine granulosa cell
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Figure 4.3.5 [3H]-progesterone binding to increasing amounts of membrane
fraction pooled from sucrose gradient fractions of bovine theca cell
homogenate enriched in progesterone binding activity.
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4.3.4 Specificity of preovulatory binding sites for progesterone
Figure 4.3.6 shows the results of steroid displacement of progesterone
binding to granulosa cell homogenate sucrose density gradient fractions
enriched in progesterone binding. Progesterone displayed half-maximal
displacement of binding between 10 - 100 ng of cold progesterone added,
whereas other steroids (testosterone, pregnelolone) reach this level of
displacement only at concentrations 10 - 100 fold greater than that of
progesterone, or, in the case of oestradiol-17fi, showed little or no
displacement potency.
Displacement experiments were performed on theca cell homogenate
sucrose density gradient fractions from both peaks of progesterone binding
activity. Similar results were obtained with both the lower and higher
buoyant density progesterone binding peaks found over sucrose gradient
fractions (Figure 4.3.7). Unlabelled progesterone competed for binding sites
with [3H]-progesterone at low levels (10 - 100 ng added cold progesterone)
whereas testosterone displayed this level of displacement of progesterone
binding only at levels 100-fold greater than this. Pregnenolone displayed
less potent displacing ability over progesterone binding in fractions pooled
from the more dense peak of binding, than fractions pooled from the less
dense peak of progesterone binding activity in theca cell homogenate
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Figure 4.3.6 Displacement of [3H]-progesterone binding by unlabelled
steroids to pooled sucrose gradient fractions of bovine granulosa cell
homogenate enriched in progesterone binding.
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Figure 4.3.7 Displacement of [3H]-progesterone binding by unlabelled
steroids to pooled sucrose gradient fractions of bovine theca cell homogenate
enriched in progesterone binding. A = fractions pooled from low density
binding peak, B = fractions pooled from high density peak.
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4.3.5 Luteal cell separations and progesterone binding to separated small
and large luteal cells
Separation of luteal cells yielded enriched small cell populations with some
red blood cell contamination (typically 70% small luteal cells, 30% red blood
cells). Enriched large cell populations were approximately 80% large luteal
cells, the remainder being made up of clumps of small luteal cells and
clumps of cell debris.
Low levels of [3H]-progesterone binding were observed in enriched small
luteal cell populations. However, binding was observed to be almost 3-fold
greater in large luteal cell populations than in fractions enriched in small
luteal cells. In all cases binding was only observable in the presence of
digitonin (250 pg/tube) (Figure 4.3.8).
4.3.6 LH binding to isolated large and small luteal cells
Using the LH receptor binding assay detailed in Chapter 2, high levels of
binding were observed in both small and large luteal cells. However, no
quantification of the numbers of binding sites present could be determined
since binding could not be displaced by unlabelled hCG, and thus no
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Figure 4.3.8 [3H]-progesterone binding to separated small and large luteal
cells. Progesterone binding assay was performed in triplicate on each cell
type. Graph represents the mean of two such experiments, using dispersed
cells from two sets of mid-luteal phase CL.
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4.3.7 Western blots of steroidogenic enzyme content of isolated luteal cell
sub-populations (Plate 4.3.1)
(i) 3fi - hydroxysteroid dehydrogenase/A4-A5 isomerase: Both large and
small cells displayed strong detection of 3E-HSD. The molecular weight of
the bands detected in these experiments was 44 kDa. The reported
molecular weight of bovine 313-HSD is 42 kDa (Couet et al, 1990). It was also
observed that stronger detection was present in large luteal cells than in
small luteal cells fractionated on these gels.
(ii) The reported size of P450 side chain cleavage is 49 kDa (Rodgers et al,
1986a). In these experiments faint bands of 49 kDa are evident in both luteal
cell types. However, much denser bands are evident, equilibrating at a
molecular weight of approximately 68 kDa. Of these 68 kDa proteins,
stronger detection was found in fractionated large luteal cells than small
luteal cells.
(iii) P450 17 a hydroxylase/C 17,20 lyase: Positive detection, though very
slight, was evident in both large and small luteal cells when immunoblotted













Plate 4.3.1 Western blots of separated large and small luteal cell
homogenates for steroidogenic enzymes. 3f)HSD = 3fi - hydroxysteroid
dehydrogenase/A4-A^ isomerase, SCC = P450 side chain cleavage, and
C170H = P450 17 a hydroxylase/C 17,20 lyase. Arrowheads indicate
protein of interest (see text for details, sections 4.3.7 and 4.4)
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4.4 Discussion
The experiments presented in this study were designed to investigate
whether or not the novel progesterone binding site described in Chapter 3
was present in the preovulatory follicle and to attempt to elucidate a possible
function for this protein with respect to its cellular distribution in the follicle.
In addition, differences between small and large luteal cells with respect to
their LH receptor populations and steroidogenic enzyme content were also
investigated, as was the cellular distribution of the novel bovine
progesterone binding site in the corpus luteum.
Progesterone binding activity was found to be present in both cell types of
the bovine preovulatory follicle. Interestingly, much higher levels of
progesterone binding were found in the theca cells than in the granulosa, in
small, medium and large sized follicles. Prior to ovulation, the vast majority
of bovine follicular steroidogenesis is directed to the production of oestradiol
(Dieleman et al, 1983b). However, from 20 hours post LH surge, up until
ovulation, progesterone concentrations in follicular fluid rise (Dieleman et al,
1983b). In sheep, this rise is thought to be simply an accumulation of
progesterone in the follicular fluid, and not a reflection of the follicles
progesterone synthesizing ability (Murdoch & Dunn, 1982), however, it has
been demonstrated in cattle that this increase in follicular progesterone is
indeed a reflection of the steroidogenic output of the follicle, that is,
increased rate of synthesis of progesterone (Dieleman & Blankenstein, 1985).
This increase in progesterone synthesis occurs at the same time as
morphological luteinization of the granulosa cells occurs (Dieleman et al,
1983b). Thus it has been suggested that, in cows, the granulosa cells are the
main source of follicular progesterone at this stage of the oestrous cycle
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(Dieleman & Blankenstein, 1985). Since it was the theca cells which
contained the highest levels of progesterone binding activity, it would
appear unlikely that this progesterone binding site is involved in the
packaging of progesterone for secretion in the bovine preovulatory follicle.
However, it was unknown at what stage the follicles used in this study
were, and from which follicular wave they were taken. Hence it remains a
possibility that even the largest of the follicles assayed here were pre-LH
surge, and were thus not producing progesterone at increased rates. Indeed,
before the LH surge, and up to 20 hours post surge, thecal progesterone
production has been demonstrated to increase (Fortune & Hansel, 1979).
Fractionation of theca and granulosa cells recovered from bovine follicles
gave similar profiles of progesterone binding activity to that seen in the case
of fractionated bovine corpora lutea (Chapter 3). In theca cell fractionations
two peaks of binding were observed in control gradients, whereas only one
peak was evident in digitonin-pretreated gradients, equilibrating in a similar
position to that found in sucrose gradients of corpora lutea. This digitonin-
pretreated peak displayed similar levels of digitonin perturbation as
compared to perturbations seen in corpora lutea sucrose gradients, and was
also much reduced as compared to its control gradient equivalent, in the
same manner as was observed in sucrose gradient fractions of corpora lutea.
The secondary peak of progesterone binding activity found at the top of the
gradients of theca cell fractionations is likely to be due to membrane vesicles
created during homogenization procedures. Homogenization of theca cells
was performed using a hand-operated Dounce homogenizer; the tough
nature of this tissue meant repeated strokes to attain a smooth homogenate, -
conditions that are likely to produce membrane vesicles. Thus, in control
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gradients, these membrane vesicles may float to the top of the gradient along
with their associated progesterone-binding protein, but, as is reflected by the
results of these experiments, in homogenates pretreated with digitonin,
vesicles would be perturbed and would not float, but would instead become
sedimented at the correct buoyant density for such membranes.
In sucrose gradient fractions of granulosa cell homogenates, progesterone
binding was found to form only one peak, at approximately the same
position as the peak of binding found in gradients of bovine corpora lutea.
The lack of binding activity in digitonin-pretreated gradients may be due to
degradation of binding sites as appears to be the case in corpora lutea
sucrose gradients. Since binding was very low in granulosa cells, then any
degradation of binding sites would leave any progesterone binding activity
so low as to be undetectable. Alternatively, since only low levels of binding
were found in granulosa cells, activation of the progesterone binding site
prior to fractionation may have allowed the saturation of binding sites with
endogenous progesterone, making the measurement of progesterone
binding difficult.
The differences between the buoyant densities of the progesterone binding
peaks between theca and granulosa cells may be accounted for by differences
in the membrane composition of the two cell types. If indeed this is the case,
then if these differences are carried over after luteinization, then this may
possibly explain why such a broad peak of progesterone binding activity is
observed in luteal gradients, that is, it may be speculated that in luteal
gradients the single peak of progesterone binding activity may be two
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overlying peaks of binding activity, whose origins are cell specific and
whose associated membranes display slightly different buoyant densities.
Separation of luteal cells has, over the past fifteen years, become a common
practice in studies of the corpus luteum of many species. In all studies
performed in sheep and cows, enzymes such as collagenase have been used
to facilitate the dispersion of luteal tissue into single cells, which can then be
separated according to size and/or density. Recently however, a study of
the equine corpus luteum revealed that luteal cell types show different
sensitivities to the rigours of dispersion, most notably, to the use of
dispersion enzymes (Broadley et al, 1994). Indeed, it was demonstrated that
the LH receptor population of large luteal cells was more sensitive to
damage than that of small luteal cells (Broadley et al, 1994). Thus in this
study, mechanical dispersion of luteal cells was used to avoid any
differential damage to the two cell types' LH receptor populations. This
mechanical dispersion yielded large numbers of separated small and large
luteal cells, with reasonable cell viability, typically in excess of 50%. In
previous studies it has been demonstrated that numbers of LH receptors
found on small cells are much higher than numbers localized to large cells,
highlighting an important functional difference (Fitz et al, 1982). The control
of luteal steroidogenesis is exerted by both intra-ovarian paracrine factors
and endocrine factors produced elsewhere in the body. Pituitary-derived
LH is considered to be the single most important factor involved in the
support and function of the corpus luteum in cattle. Large cells cultured in
vitro however, show little or no response to LH concentrations that
maximally stimulate progesterone production in small luteal cells (5-10
ng/ml), and require concentrations of up to 100 ng/ml LH to elicit a
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response in increased progesterone production (Alila & Dowd, 1991). Thus
it appears likely that in vivo, large cells do not respond to LH stimulation,
since the levels of LH found in the circulation of ruminants is only of the
order of 5-10 ng/ml (Alila & Dowd, 1991). In sheep large luteal cells, which
possess LH receptors, little or no response to LH is observed (Harrison et al,
1987). Since other trophic substances such as PGE2 which mediate their
effects (increase in progesterone secretion) through the cAMP second
messenger system do have effects on these cells, as indeed do exogenous
cAMP analogues (Fitz et al, 1984; Silvia et al, 1984; Alila et al, 1988 a; b), it
appears that large luteal cells LH receptors are uncoupled from the cAMP
second messenger system (Hoyer et al, 1984; Hoyer & Niswender, 1986;
Harrison et al, 1987; Davis et al, 1989). The mechanism of this apparent
uncoupling is as yet unknown (Alila & Dowd, 1991). It is also possible that
this apparent uncoupling may be simply an artifact produced by the process
of tissue disruption. Unfortunately, no information on the stability or
existence of LH receptors of large and small luteal cells could be obtained
from the experiments detailed in this chapter. This was due to the inability
of the unlabelled hCG used to measure non-specific binding to displace
specifically bound LH tracer in LH binding assays of isolated luteal cell sub-
populations. This result was surprising since the same assay was used with
no such problem on sucrose gradient fractions of bovine corpora lutea. It is
not clear why difficulties in measuring specific binding of LH to isolated
luteal cell homogenates arose. The possibility that the LH receptors have
been damaged during mechanical disruption of the corpora lutea and the
subsequent elutriation of cells may be one explanation. However, no such
problems were encountered in measuring LH binding to homogenized
bovine corpora lutea (Chapter 1). Hence if receptor damage has occurred
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then it would appear likely that this damage occurred due to agents found in
the dispersal or elutriation buffers. However, this problem was not observed
in similar studies in the equine corpus luteum (Broadley et al, 1994). It
would be of interest to obtain anti-sera specifically raised against the bovine
forms of the LH receptor and PGF 2a receptor to use as indicators of purity
of luteal cell sub-populations (by Western blot of SDS-PAGE fractionated
large and small luteal cell homogenates), and to provide information on LH
receptor protein levels that did not rely on maintaining intact, functional LH
receptors. Also, it would be of value to characterise the LH receptor assay
for use on such samples. For example, it may be that unlabelled LH is more
suitable for displacement of bound LH tracer than is unlabelled hCG in such
experiments. Unfortunately these experiments were outwith the timescale of
this project.
In large luteal cells from the bovine corpus luteum, basal progesterone
secretion is 10-20 fold greater than the basal secretion of progesterone from
small luteal cells (Koos & Hansel, 1981; Alila et al, 1988). Indeed, in the sheep
corpus luteum 80% of progesterone output is large luteal cell derived.
Results presented in this study demonstrate that in the bovine corpus luteum
large luteal cells posses almost three times the amount of progesterone
binding activity as do small bovine luteal cells. Thus, if the progesterone
binding protein studied here is a component of the mechanism by which
progesterone is secreted, then the distribution of binding correlates with the
progesterone output of these cells in an unstimulated state. To further this
theory, it would be of interest to measure progesterone binding and
secretion from LH-stimulated and basally secreting small luteal cells, to
ascertain if indeed progesterone binding activity can be correlated with
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progesterone secretion. Pilot experiments have been performed to address
this question, but due to difficulties of tissue availability and time constraints
no firm conclusions have yet been drawn.
Also possible is that the progesterone binding protein studied here may be
involved in the relief of end-point inhibition of steroidogenic enzymes. End
product inhibition occurs with all of the enzymes involved in progesterone
biosynthesis (Niswender & Nett, 1994). For example, the affinity of 3B-HSD
for progesterone, its product, is approximately six times greater than that of
its substrate, pregnenolone (Caffrey et al, 1979a). It is suggested that
binding proteins sequester progesterone and thus remove its negative
feedback effects on its own production (Caffrey et al, 1979a). However, since
oestradiol and testosterone have similar high affinities for this enzyme (3(3-
HSD) (Caffrey et al, 1979a), then the protein studied here, since it does not
bind either of these steroids with a high affinity, may be specific for the relief
of end point-inhibition exerted by progesterone only, and thus would be an
integral part of a system of autocrine regulation of progesterone synthesis by
progesterone. There have been suggestions of this type of self-regulatory
system previously. Basal bovine luteal progesterone secretion has been
shown to be pulsatile (Rossmanith et al, 1991). Pulse frequency was
unaffected by hCG stimulation to tissue slices of bovine corpora lutea
perfused in vitro. However the amplitude and release rates of progesterone
were increased (Rossmanith et al, 1991) as a result of this treatment. This
pulsatile progesterone release was suggested to be due to large luteal cells
since it appeared to be independent of LH stimulation. Furthermore, the
antiprogesterone ZK 96.734 increased the amplitude and frequency of the
progesterone pulses, suggesting that progesterone exerted inhibitory effects
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on its own release by short, local inhibitory progesterone feedback in the
bovine corpus luteum (Rossmanith, 1991). As a secondary system the high
blood flow to the corpus luteum may also help to keep levels of steroid
down (Caffrey et al, 1979a) by efficient removal into the blood. Conversely,
progesterone has been suggested to up-regulate its own synthesis and
secretion (Rothchild, 1981). Hence, if the progesterone binding site was a
non-genomic receptor for progesterone involved in this type of autocrine
regulation, then it would be expected to be present in the cell type which
secreted the most progesterone. Since large luteal cells contained more
progesterone binding activity than small cells, and these are the cells
responsible for a large amount of the progesterone secreted by the corpus
luteum, it could be that this binding site operates through binding of
progesterone to exert stimulation of progesterone synthesis and/or
secretion. Increased progesterone production occurs in bovine follicles post
LH surge, and continues until ovulation (Dieleman & Blankenstein, 1985).
This increase is suggested to reflect morphological luteinization of granulosa
cells, however, prior to this time, follicular progesterone is thought to be
mainly theca derived (Dieleman et al, 1983b). If indeed the follicles
examined in these experiments were removed prior to the preovulatory LH
surge, then the cellular distribution of progesterone binding sites would also
fit in with this hypothesis. However, from the actual levels of binding
activity found theca and granulosa cells, and the observation that although
progesterone secretion from theca cells increases after the LH surge, it is the
granulosa cells which contribute the majority of follicular progesterone
(Fortune & Hansel, 1979), then it would appear that in the follicle the
progesterone binding site would be more likely to be involved in another
role. It would be of interest to repeat these experiments on follicular cells
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and measure the actual amount of progesterone in follicular fluid and the
theca and granulosa cells ability to synthesise progesterone in culture, to see
if any correlation between progesterone binding and progesterone
synthesising ability was evident. Thus it is unclear at present why there is
an apparent switch in the cell type which contains the most progesterone
binding from the theca in the follicle to the granulosa derived large luteal
cells in the corpus luteum.
Results of Western blots of steroidogenic enzymes in isolated bovine large
and small luteal cells showed that large luteal cells contain more 315 -
hydroxysteroid dehydrogenase/A4-A^ isomerase than do small luteal cells,
reflecting that in large luteal cells from the bovine corpus luteum, basal
progesterone secretion is 10-20 fold greater than the basal progesterone
secretion of small luteal cells (Koos & Hansel, 1981; Alila et al, 1988). Both
cell types appeared to contain surprisingly little P450 side chain cleavage (49
kDa). Interestingly, however, immunodetection of P450 side chain cleavage
revealed bands of approximately 68 kDa in both cell types. This band was
found in greater quantities in large luteal cells than in small luteal cells. It
has been reported that 1:1, covalent, non-disulphide linked cross-linkage of
bovine P450 side chain cleavage and its electron donor adrenodoxin occurs
(Young et al, 1995). The cross-linked product has a reported molecular
weight of 63 kDa (Young et al, 1995). It is likely that the approximately 68
kDa band evident in these experiments is due to this cross-linkng between
P45O side chain cleavage and adrenodoxin. Thus, though approximately
equal amounts of P450 side chain cleavage were observed in large and small
luteal cells, if no cross-linking of this type had occurred, there may have been
increased amounts of P450 side chain cleavage detected in large luteal cells
as compared to small luteal cells. Indeed, there is evidence to suggest that
greater quantities of P450 side chain cleavage are found in large luteal cells
than in small luteal cells (Rodgers et al, 1986b). This cross linkage may
occur in the tissue before experimental procedures commence. It is
suggested that low levels of anti-oxidants lead to this cross-linkage (Young et
al, 1995), and thus it would be of interest to determine the effects of inclusion
of anti-oxidants in the separation procedures employed here. In Chapter 2
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when bovine luteal sucrose gradient fractions were immunoblotted for the
detection of P450 17 a hydroxylase/C 17,20 lyase no detection was evident.
It was of interest to note that there was a small amount of this protein
detected in homogenates of large and small luteal cells. Detection sensitivity
in these experiments was increased because of the use of enriched
populations of luteal cells rather than luteal homogenate which contains a
number of non-steroidogenic cell types, thus per mg of total protein the large
and small cell homogenates would have contained higher levels of
steroidogenic enzymes. It does not appear that this enzyme is active in the
bovine corpus luteum (Savard, 1973), however, these experiments show that
it is present. Tranfection studies using P450 17 a hydroxylase/C 17,20 lyase
-specific DNA constructs have revealed that bovine luteal cells do not
express P450 17 a hydroxylase/CI7,20 lyase (Lauber et al, 1991). It is
possible that the P450 17 a hydroxylase/C 17,20 lyase detected may have
been synthesised before luteinization and is inactive in the corpus luteum,
however, the fact that it is present, even in small quantities may have some
importance since androgens are now implicated in the regulation of
granulosa cell function in developing follicles, and androgen receptor has
been detected in small amounts in the corpus luteum of rats (Tetsuka et al,
1995).
In summary, results presented in this chapter indicated that the progesterone
binding protein studied in Chapter 3 is found in different amounts in the cell
types of the bovine corpus luteum and the bovine preovulatory follicle.
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Chapter 5
Purification of the luteal progesterone binding protein
5.1 Introduction
Previous chapters have demonstrated the presence of a unique particulate
progesterone binding site in both the pre-ovulatory follicle and the corpus
luteum of cows. The significance of these binding sites to the regulation of
progesterone synthesis, or the secretion of this steroid, remains unclear. To
further examine the cellular distribution of this binding protein by, for
example, immunocytochemistry, necessitates the raising of a specific anti¬
serum against the binding site. An antibody raised against the progesterone
binding protein would also facilitate the study of the regulation of
progesterone binding protein at the molecular level, and could be used to
probe a bovine luteal cDNA library to facilitate isolation of the gene
encoding this progesterone binding protein.
To generate polyclonal antisera specific to the bovine progesterone binding
site, a purified sample of progesterone binding protein must first be
obtained. This chapter deals with the attempted purification of the bovine
luteal progesterone binding site.
Since it has been demonstrated that the binding protein in question is
membrane associated, the first stage of any purification requires the
solubilization of the protein. To this end, a number of detergents commonly
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used for protein extraction and purification were screened for suitability, the
criteria being optimal solubilization with minimal losses of activity.
Once solubilized, there are a number of protein purification techniques that
are commonly used sequentially to purify proteins of interest. A number of
these techniques have been exploited, each being subject to screening for its
purification potency and its effects on the activity of the progesterone
binding site being purified. The aim of this chapter was to devise a
purification strategy which would yield reasonable amounts of purified
progesterone binding protein without excessive losses in activity (since at
this stage progesterone binding activity is the only measure of the protein of
interest). The purified protein could then be micro-sequenced to provide
identification of the protein, and to indicate whether it is a novel protein
which has not yet been characterised.
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5.2 Materials and Methods
5.2.1 Inhibition of endogenous proteases
To minimise degradation of binding sites during solubilization procedures
and subsequent purification protocols, a cocktail of protease inhibitors was
added to solubilisation and extraction media. This cocktail contained ImM
EDTA (inhibitor of metalloproteinases), 2 (ig pepstatin A (inhibitor of
carboxy peptidases) and 1 mM PMSF (inhibitor of serine proteases).
Progesterone binding was assayed in the presence of this cocktail to ascertain
any adverse effects that these protease inhibitors may have on progesterone
binding. As a control, progesterone binding was assayed in the absence of
protease inhibitor cocktail (buffer control) and in the presence of ethanol at
similar levels to that found in the protease inhibitor cocktail (EtOH control)
due to PMSF being dissolved in ethanol (10 |il ethanol/PMSF per ml
incubation mix). Cocktail inhibitors/ethanol/buffer controls were incubated
for 30 min at 4°Cwith pooled sucrose density gradient fractions enriched in
progesterone binding, before removal of an aliquot of this mix to be assayed
in the in vitro progesterone binding assay.
5.2.2 Detergent solubilization of progesterone binding protein
Detergents (Boehringer Mannheim detergent kit, specially purified for
membrane research) were screened for their ability to solubilise the
progesterone binding site from its associated membranes, without causing
loss of binding activity. This screening was achieved by incubating pooled
sucrose density gradient fractions enriched in progesterone binding with
each detergent at a number of concentrations relative to the critical miscellar
concentration (CMC) of each detergent (lOxCMC, IxCMC, 0.5xCMC,
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0.3xCMC, O.lxCMC, 0.05xCMC). Each detergent was dissolved in 10 mM
Tris HC1, pH 7.4, 10% glycerol. Solubilization cocktails (detergent, buffer,
fractions enriched in progesterone binding and protease inhibitors) were
mixed on ice for 1 hour to ensure maximal solubilization, then centrifuged at
30,000 r.p.m for 1 hour at 4°C. Controls consisted of the solubilization mix
with no detergent added. Supernatants and pellets were then separated and
stored at -20°C until assayed for progesterone binding.
5.2.3 Removal of endogenous steroids
1 ml aliquots of dextran-coated charcoal were centrifuged in assay tubes
(1000 g.av 10 min, 4°C). Supernatants were aspirated and discarded, and 0.5
ml aliquots of detergent-solubilised sucrose gradient fraction enriched in
progesterone binding (solubilised progesterone b.p.) added to the charcoal
pellets. Tubes were then vortexed and incubated on ice for 10 min, before
centrifuging (1000 g.av, 10 min, 4°C). Supernatants were then removed and
assayed for their progesterone binding ability. To give an indication of the
effects of removal of endogenous steroid, samples of unstripped solubilised
progesterone b.p. were included in all assays.
5.2.4 Ion exchange chromatography
Anion and cation exchange resins were tested for their ability to bind the
progesterone binding protein in a batch test. 1ml aliquots of cation exchange
resin (CM-Sepharose, Pharmacia-Biotech) or anion exchange resin (DEAE-
Sepharose, Pharmacia-Biotech) were equilibrated with an equal volume of
10 mM Tris HC1 buffer, pH 7.4, containing 2 mM n-octyl glucoside. 200 pi of
each resin was then added to assay tubes and centrifuged (250 g.av, 4°C, 10
min) to compact the resin. Supernatants were aspirated, and 100 pi of
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solubilized progesterone b.p. added to resin pellets. 400 jil of each salt
elution buffer (Tris HC1, pH 7.4, 0 - 1M NaCl) was then added and each tube
vortexed to resuspend the resin. Each salt elution concentration was set up
in duplicate. After a 30 minute incubation (4°C, gentle agitation) tubes were
centrifuged (250 g.av, 4°C, 10 min), and supernatants assayed for
progesterone binding activity. Knowledge of the salt concentration which
caused elution of bound progesterone binding protein from the exchange
resin was then used to construct a narrow range of salt elution buffers to
ensure good selective elution of the binding protein. Columns (5 ml) of ion
exchange resins were prepared, by first equilibrating the resins as described
above, then incubating each resin with solubilised progesterone b.p. (30 min,
4°C, stirred), before pooling and collecting fractions (500 jil) from increasing
stepwise salt elutions. Fractions were then assayed for progesterone binding
activity. Fractions enriched in progesterone binding activity were then
pooled. Protein estimations were routinely carried out to provide an
indication of the degree of purification achieved.
5.2.5 HPLC separations
Two types of HPLC were attempted, anion exchange and hydroxylapatite
chromatography. Using a commercially available auto-injection system (Bio-
Rad), 1 ml of solubilised progesterone b.p. was loaded on to an HPHT
hydroxylapatite column (Bio-Rad). A micro-computer-controlled gradient
module was used to set up a linear gradient from 10 - 300 mM sodium
phosphate eluent solution buffer (10 - 300 mM NaH2P04/Na2HP04 buffer,
0.01 mM CaCl2, pH 6.8). Elution of protein was monitored by U.V. detection
(250 nm) and fluorimetry for 30 minutes, the time taken for the NaCl
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gradient to run from 0 - 100%, during which eighty 0.5 ml fractions were
collected.
Anion exchange chromatography was carried out on the above apparatus
using a Bio-Rad anion exchange column (50 X 7.8 mm MA7Q) . In a trial
experiment it was observed that the progesterone binding was eluted early
in the run, though other material remained bound to the column with much
longer retention times. Thus sufficient separation was achieved with a 15
minute run, running isocratically for 5 minutes (20 mM Tris HC1, pH 8.5),
then forming a linear gradient (20 mM Tris HC1, pH 8.5 to 20 mM Tris HC1,
500 mM NaCl, pH 8.5).
5.2.6 Affinity Chromatography
A number of progesterone analogues were tested for their ability to displace
bound [3H]-progesterone from solubilised progesterone binding protein (as
detailed in Chapter 3 for displacement experiments using sucrose gradient
fractions). 20 fi hydroxy progesterone (20B-OH-P4) was found to be the most
effective of these compounds. The affinity matrix chosen, Epoxy-activated
Sepharose CL-4B (Pharmacia), was deemed suitable because of its long
spacer arm, which theoretically should give the affinity ligand maximum
spatial freedom, allowing it to interact as fully as possible with the
progesterone binding protein.
A 1 mg/ml solution of 2OS-OH-P4 was prepared in coupling solution (1:1
dimethylformamide : distilled H2O) and the pH adjusted to pH 11 with IN
NaOH. This was mixed with 2 g of Epoxy-activated Sepharose CL-4B, which
was previously swollen in H2O, and washed under flowing distilled H2O on
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a sintered glass plate for 1 hour. Coupling was then allowed to proceed for
16 hours in a shaking water bath at 30°C.
After coupling, the gel was washed in fresh coupling solution, followed by
distilled H2O, on a sintered glass plate. Next, the gel was washed alternately
in 0.1M sodium acetate buffer, 0.5 M NaCl, pH 4 and 0.1 M Tris HC1, 0.5M
NaCl, pH 8 (3 cycles of each buffer). Finally, any uncoupled reactive oxirane
groups were blocked by incubation of the gel in 1M ethanolamine for 16
hours at 45°C. Gels were then washed thoroughly in sample application
buffer (10 mM Tris HC1, pH 7.4). As a control to determine the specificity of
interactions between the affinity construct and the progesterone b.p., a
sample of gel was processed in the above manner with no ligand linking, in
which all reactive groups were blocked with ethanolamine.
200 pi aliquots of DCC-stripped solubilized progesterone b.p. were applied
to 0.5 ml pellets of each gel (control gel and 20S-OH-P4—affinity construct),
in the presence and absence of 160 pi 10 mg/ml digitonin (amount of
digitonin required for maximum stimulation of 200 pi of solubilised
progesterone b.p.), and incubated for 2 hours at 4°C. Tubes were then
centrifuged (1000 g.av, 10 min, 4°C). Supernatants were removed and
transferred to fresh tubes. Pellets were then eluted by two methods, (i)
increasing ionic strength (addition of 0.5 ml 1 M NaCl) or (ii) by lowering pH
(addition of 0.1 M sodium acetate buffer, pH 4). From ion-exchange
experiments it was noted that 1M NaCl had little effect on the activity of the
progesterone binding site. Thus no further processing of these elutions was
required. However, elutions of pH 4 buffer were spun to equilibrium in
30,000 Da nominal molecular weight limit (nmwl) cut-off filters (Millipore),
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and resuspended in 10 mM Tris HC1, pH 7.4. Supernatants and eluted
fractions from affinity and control gels were assayed for progesterone
binding ability.
5.2.7 Chromatofocusing
20 mis PBE 94 (Pharmacia) were equilibrated by rinsing with 100 mis of
0.025 M ethanolamine acetate buffer, pH 9.4. Gel was then poured into a 15
x 0.5 cm column. To ensure correct column packing, all columns were tested
with 100 pi of 10 mg/ml horse heart cytochrome c (Sigma). After
connecting the column outflow to a U.V monitor and plotter (Bio-Rad) set to
detect at 280 nm, 5 ml of eluent buffer (PBE 96, pH 6) (Pharmacia) were
applied, followed by application of 1 ml of solubilised progesterone b.p.,
which had been pre-equilibrated in eluent buffer. Eluent was then applied at
a flow rate of 1 ml/min, and 0.5 ml fractions collected until the pH of the
collected fractions stabilized at pH 6, as measured by pH paper (Whatman,
pH 4 - 10). Fractions were then assayed for the ability to bind [3H]-
progesterone, as described previously.
5.2.8 Gel filtration
5 cm x 0.5 cm columns of Sephadex G-100 (Pharmacia) were prepared by
swelling the dried gel in 0.1 M ammonium bicarbonate overnight. Columns
were then poured and equilibrated with eluent buffer (10 mM Tris HC1, pH
7.4, containing 2 mM n-octylglucoside). Aliquots (100 - 300 pi) of DCC-
stripped solubilised progesterone b.p. were then applied, and elution buffer
applied at a flow rate of 1 ml/min. 0.5 ml fractions were collected until the
column had been eluted with five times the column bed volume of eluent
buffer. Fractions were then assayed for [3H]-progesterone binding ability.
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5.2.9 Centrifugal separators
DCC-stripped solubilised progesterone b.p. (100 pi) was applied to 5000 Da,
10,000 Da, 30,000 Da (Millipore) and 100,000 Da (Centricon) nominal
molecular weight limit (nmwl) cut-off filters. These were then centrifuged
(500 g.av., 4°C) until all of the applied sample had been filtered. Retentates
were resuspended in 10 mM Tris HC1, pH 7.4, containing 2 mM n-
octylglucoside, and the centrifugation/filtration step repeated. Retentates
were then resuspended in the same buffer and retentates and filtrates were
assayed for the ability to bind [3H]-progesterone. Also, the effects of
repeated re-suspension and filtration in 100 kDa nmwl cut-off filters with
respect to progesterone binding activity were investigated.
5.2.10 Freeze drying
Samples to be freeze dried were centrfuged to equilibrium in 30,000 Da
nmwl cut-off filters (Millipore). Retentates were then resuspended in 0.1 M
ammonium bicarbonate, transferred to fresh tubes, and frozen on solid CO2
for 1 hour. Samples were transferred to freeze-drying apparatus and freeze
dried overnight.
5.2.11 Gel electrophoresis
Denaturing SDS-PAGE (7.5%) gels were prepared as described in Chapter 2.
Non-denaturing PAGE gels were prepared in the same manner, omitting
SDS and 2-mercaptoethanol from gels, and both running and sample buffers.
Samples were applied to non-denaturing gels without boiling.
After each gel run was complete, gels were removed from the running
apparatus (Bio-Rad Protean xi) and fixed overnight in 4:1:5 methanol: glacial
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acetic acid : distilled H2O. After removal from fixative solution, gels were
stained using a commercially available silver nitrate kit (Sigma). Once
background bleaching was complete, gels were examined and re-stained if
necessary. Once satisfactory staining was achieved, gels were then
photographed, labelled, then re-photographed.
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5.3 Results
5.3.1 Effects of protease inhibitor cocktail
As displayed in Figure 5.3.1, the cocktail of protease inhibitors had no
deleterious effect on progesterone binding.
5.3.2 Detergent solubilization of progesterone binding protein
One of the detergents tested, (decanoyl-N-methylglucamide), caused a loss
of activity at high concentrations and was thus unsuitable for solubilization
of the progesterone b.p. Of the other detergents tried, n-dodecylglucoside
failed to solubilize the binding site. However, both n-dodecyl-fi-D-maltoside
and n-octylglucoside effectively solubilized the binding site from its
associated membrane material. n-Octylglucoside was chosen as the
detergent for solubilization procedures because it was most effective at its













buffer control EtOH control protease inhibitor cocktail
Figure 5.3.1 Lack of effect of protease inhibitor cocktail on progesterone
binding activity of sucrose gradient fraction enriched in progesterone
binding activity.
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Figure 5.3.2 Trial of detergents to solubilize the progesterone binding protein
away from associated membranes. Open bars represent [3H]-progesterone
binding to 30,000 rpm pellet, shaded bars represent [3H]-progesterone
binding to 30,000 rpm supernatant. Results for each detergent were
calculated from the mean of two separate such experiments. All assays were
performed in triplicate, and results expressed as pg of [3H]-progesterone
bound/per mg of protein. See Results (5.3) and Discussion (5.4) for further
details.
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5.3.3 Stripping of endogenous steroid
Dextran stripping of solubilised progesterone b.p. increased the amount of
binding present by up to 60% (Figure 5.3.3)
5.3.4 Ion exchange chromatography
A typical elution profile of progesterone b.p from a CM-sepharose column is
shown by Figure 5.3.4. From batch tests, no binding of progesterone b.p. to
the cation exchange resin was evident. Flowever, it was clear that though
the progesterone b.p. does not bind to CM-Sepharose, a significant amount
of inactive material does bind and was thus removed by this resin.
Figure 5.3.4 (lower graph) shows a typical elution profile of progesterone
b.p. from a column of DEAE-Sepharose. Results from batch tests
demonstrated that the progesterone b.p. was bound by anion exchange resin,
indicating that the binding protein has a net negative charge at neutral pH.
The salt concentration at which the progesterone b.p became dissociated
from the anion exchange resin was found to be 400 mM NaCl. During both
types of ion exchange chromatography, losses in activity were low (5-10 %).
HPLC anion exchange chromatography resulted in minimal losses of
progesterone binding activity. The progesterone b.p. was eluted early in
each HPLC run, before commencement of the elution gradient, indicating a
difference in the binding properties of anion exchange gels and anion
exchange HPLC matrices used (Figure 5.3.5). No progesterone binding
activity could be recovered from the hydroxylapatite HPLC column; thus












Figure 5.3.3 Effect of removal of endogenous steroid by dextran coated
charcoal stripping on progesterone binding activity of solubilised
progesterone b.p. Open bar represents untreated solubilised progesterone
b.p., shaded bar represents dextran coated charcoal stripped solubilised
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Figure 5.3.4 Elution profiles of progesterone b.p from CM-Sepharose and
DEAE-sepharose ion exchange gels. Elution was achieved with stepwise




Figure 5.3.5 Elution profile of progesterone b.p from an HPLC anion
exchange matrix, (o) = progesterone binding activity; heavy black line
NaCl gradient (0% = 0 M, 100 % = 0.5 M)
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5.3.5 Gel filtration
In experiments where solubilised progesterone b.p was applied to a G-100
column and eluted with buffer containing no detergent, binding activity
passed quickly through the column, with a short retention time, and
appeared to run as an aggregate. Also, large losses in activity were
observed. Where elution buffer contained detergent (2 mM n-
octylglucoside) the binding activity was observed to pass through the
column more slowly than in the absence of detergent, being eluted much
later (Figure 5.3.6). However, 150 - 200 (il of fraction was necessary to show
maximal binding, as compared to 30 jil of solubilized progesterone b.p
before G-100 fractionation, with the result that activity losses of between 40 -
70% commonly occurred. These losses were investigated by mixing fractions
obtained from gel filtration experiments together to see if binding activity
could be reconstituted. However, these were unsuccessful, and binding
activity could not be restored. Also, the possibility of the binding site
adsorbing to G-100 was examined by testing the effects of inclusion of gel on
progesterone binding activity in a batchwise test as detailed for the ion
exchange matrices. However, no direct interaction between G-100 and the
progesterone binding site was evident. In practice, shorter G-100 columns
were used (5 cm) in an effort to keep losses to a minimum. However,
activity losses were still substantial. Thus, gel filtration was suitable only for




























Figure 5.3.6 Elution of progesterone b.p from Sephadex-GlOO gel filtration
column, with (•) and without (o) 2 mM n-octylglucoside in eluent buffer.
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5.3.6 Affinity chromatography
It could not be ascertained whether or not the progesterone b.p. bound to the
immobilised 20(3 OH-progesterone because no activity could be recovered in
these experiments. However, this was also the case for unlinked, fully
blocked affinity matrix. In batchwise tests it was ascertained that the affinity
matrix, whether bound to 20(3 OH-progesterone or not, had the ability to
completely inactivate progesterone binding activity present.
5.3.7 Chromatofocusing
As was the case with the affinity matrix, no activity could be detected after
passing solubilised progesterone b.p. through a chromatofocusing column.
In batchwise tests, it was demonstrated that contact with the
chromatofocusing matrix destroyed all binding activity present. This effect
was exerted by the gel, since the buffers used in this process were
demonstrated to have no effect on progesterone binding activity.
5.3.8 Freeze drying
It was demonstrated that freeze drying of semi-purified extracts rich in
progesterone binding activity followed by reconstitution of the freeze dried
residue in 10 mM Tris HC1, pH 7.4 caused some loss of activity, but the
progesterone binding activity could be reconstituted (ca. 15% losses).
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5.3.9 Molecular weight cut-off filters
Binding was recovered in the retained fractions of all filters (Figure 5.3.7 A).
This indicated that the progesterone binding site was larger than 100 kDa
(highest nmwl filter) in its active form. Repeated resuspension and
recentrifugation caused an approximately 10% loss of activity with each
resuspension and refiltration cycle with 100 kDa cut-off filters (Figure 5.3.7
B).
5.3.10 Electrophoresis of progesterone binding site
Plate 5.3.1 shows the proteins present in bovine corpus luteum whole
homogenate (lane 1), proteins present in a sample of solubilised
progesterone b.p. (lane 2) and those proteins present after cation and anion
exchange chromatography of this sample (lane 3). From this gel it can be
observed that these initial purification stages greatly reduced the total
number of proteins present in samples of progesterone b.p. as compared to
the initial protein content of a luteal homogenate.
Plate 5.3.2 shows the total proteins present in a sample of solubilised
progesterone b.p. after gel filtration following ion-exchange
chromatography. This gel was a non-denaturing gel, and it can be seen that
much of the protein appears to have aggregated, since very few protein
bands are apparent and those which are present detect very strongly.
Plate 5.3.3 shows the results of electrophoresis of a sample of semi-pure
solubilised progesterone b.p. after ion-exchange and gel-filtration
chromatography and ion-exchange HPLC. Lane 1 contains protein from
filtrates of 100 kDa nmwl cut-off filtration, which contained no progesterone
binding activity. Lane 2 contains the semi-pure solubilised progesterone b.p.
Lane 3 contains the retentate from 100 kDa nmwl cut-off filters, which
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contains progesterone binding activity. It can be observed that there are two
bands of protein (indicated by arrowheads) present in both the 100 kDa
nmwl retentate and unfiltered semi-pure progesterone b.p. samples (both
contain progesterone binding activity) (lanes 2 and 3) which are both absent
in the sample of filtrate from 100 kDa nmwl filtration of semi-pure
progesterone b.p. (which contained no progesterone binding activity).
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Figure 5.3.7 A = Test of molecular weight cut-off filters. In all cases
progesterone binding activity was found exclusively in retentates recovered
from filter cups. B = Repeat resuspension and filtration of progesterone
binding site in 100 kDa cut-off filters caused losses of 5 -10% of [3H]-
progesterone binding activity with each filtration. No activity was found in
filtrates from these experiments.
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Plate 5.3.1 SDS-PAGE electophoresis gel (sliver nitrate stained) of whole
bovine luteal homogenate (lane 1), n-octylglucoside solubilised progesterone
b.p. (lane 2) and n-octylglucoside solubilised progesterone b.p. after anion
and cation exchange chromatography (lane 3).
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Plate 5.3.2 Non-denaturing PAGE gel of n-octylglucoside solubilised
progesterone b.p. which had been purified by anion and cation ion exchange
chromatography and G-100 gel filtration (lane 1).
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Plate 5.3.3 SDS-PAGE gel of purified progesterone b.p. Lane 1 contained a
sample of the filtrate obtained by centrifuging n-octylglucoside solubilised
progesterone b.p. (which had undergone ion-exchange chromatography
(anion, cation and HPLC anion) and gel filtration) in a 100 kDa nmwl cut-off
filter. Lane 2 contained a sample of the same semi-pure preparation without
100 kDa nmwl filtration, and lane 3 contained the retentate from such
filtration experiments. Arrowheads indicate the presence of protein bands
found in lanes 2 and three, but absent from lane 1 (see text for details).
236
5.4 Discussion
Protein purification systems employ a number of techniques to achieve the
goal of obtaining a pure sample of the protein of interest which can then be
used for further characterization and identification. The experiments
detailed in this chapter were designed to allow purification of the
progesterone binding protein studied in previous chapters.
From results of sucrose gradient fractionation of luteal homogenates it was
observed that the progesterone binding protein under study was membrane
associated. However, it was not known whether or not this membrane
association was intrinsic or extrinsic. Since detergent solubilization can be
used to separate either type of protein from the membrane, this was the
method chosen to remove the progesterone binding protein from its
membrane location.
From the results of detergent solubilization experiments, it can be seen that
control tubes (no added detergent) appeared to exhibit a degree of
solubilization (Figure 5.3.2). It should be noted, however, that although the
fraction containing some of the progesterone binding activity of controls
does not sediment at centrifugal forces powerful enough to sediment
membranes, this did not indicate that solubilization has occurred. Under a
number of conditions, formation of microvesicles can occur. These require
centrifugal speeds in excess of 100,000 g to sediment, and even then the
supernatant may still contain a wide range of molecular species (Findlay,
1990), some of which may not be fully solubilized. Also, the more effective a
detergent is at solubilizing protein from membranes, the greater the
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likelihood of activity losses occurring as phospholipid is stripped away from
the protein (Findlay, 1990). It is common therefore to include 10 - 50%
glycerol in the solubilization buffer to avoid complete removal of membrane
material and ensure lipid replacement with only detergent. A low
concentration of glycerol (10%) was used to avoid the necessity of using
centrifugal speeds of 200,000 g to pellet microvesicles through the denser
medium; inclusion of glycerol may be partially responsible for the seemingly
spontaneous "solubilization" that appears to occur. Indeed, when greater
centrifugal speeds were used the amount of binding activity found in the
supernatants of controls was reduced (data not shown). However, for
practical reasons detergents were tested using lower speeds so that a
microcentrifuge could be used to facilitate a higher throughput of samples.
Inclusion of protease inhibitors was designed to complement the inclusion of
glycerol by giving some degree of protection against unwanted proteolytic
degradation of the progesterone binding protein.
From the results of detergent screening, it can be seen that both n-
dodecylglucoside and decanoyl-N-methylglucamide had adverse effects on
progesterone binding activity. However, both n-octylglucoside and n-
dodecyl-G-D-maltoside caused solubilization of the progesterone binding site
from the membrane without unacceptably high activity losses. The
detergent chosen for further use was n-octylglucoside. This decision was
based on two factors; firstly n-octylglucoside displayed a wider
solubilization concentration range, and secondly had a higher critical
micellar concentrations (CMC). Detergents with low CMC values, such as
dodecyl-fi-D-maltoside (CMC=0.18 mM), are more difficult to remove than
detergents with high CMC values, such as n-octylglucoside (CMC=23.2
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mM), which can be removed by simple dialysis (Findlay, 1990). Also, n-
octylglucoside has the advantage over a wide range of ionic detergents
available that it is uncharged. The use of an uncharged detergent avoids
complications of alteration of the charge of the protein to be purified which
may arise if, as in this case, the charge properties of the protein are to be
exploited in its subsequent purification.
Dextran coated-charcoal stripping of solubilized progesterone b.p. was
observed to increase binding activity by up to 60%. This was most probably
due to the removal of endogenous progesterone that competes with the [3H]-
progesterone added to measure binding in the in vitro assay (Chapter 3).
Thus, to obtain maximum binding from the smallest possible sample, all
solubilized extracts were treated in this way before subsequent purification
steps were employed.
From the results of ion-exchange chromatography, it can be seen that the
progesterone b.p. adsorbs only to anion exchange gel, displaying a net
negative charge. Inclusion of cation exchange chromatography in the
purification strategy was deemed worthwhile however, since this method
removed other contaminants with a net positive charge. Non-ionic detergent
(n-octylglucoside) was included in all elution buffers to prevent protein
aggregation and to maintain the progesterone b.p.'s native charge.
Interestingly, the progesterone b.p. did not appear to adsorb to the HPLC
anion exchange column. This may be explained by the higher elution
pressures utilised in HPLC, or the differences in adsorption properties
between HPLC matrices and ion-exchange gels. Hydroxylapatite HPLC
caused complete loss of activity, possibly due to separation of one or more
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sub-units of the progesterone b.p., because of differing elution profiles of
these subunits.
Gel filtration experiments were limited in their successful applicability in
this study. Large losses of activity (40 - 70%) accompanied all procedures
giving size separations. From experiments designed to examine the nature
of this activity loss, it did not appear that the actual matrix (Sephadex G-100,
Pharmacia) had any direct interaction with the progesterone b.p. which
could account for the losses of activity. It appears from these experiments
that the progesterone b.p may dissociate into two or more components
required to confer progesterone binding activity. The separated components
may be protein subunits, cofactors or other prosthetic groups. Re-mixing of
fractions obtained from gel filtration experiments did not restore activity.
Thus once separated, the components of the progesterone binding site could
not be reconstituted. This was also apparent with non-denaturing PAGE
gels; no activity could be measured in fractions eluted from these gels.
Results obtained from centrifugation with molecular weight cut-off filters
appeared to indicate that the progesterone b.p. was larger than 100 kDa,
since all activity was retained by filters with a nmwl > 100 kDa.
Interestingly, when the retained fraction was resuspended and refiltered,
similar losses in activity were noted each time. This may also be indicative
of subunit separation. At the centrifugal speeds employed, a sub-unit <
lOOkDa may become separated and filtered through the cut-off membrane.
Indeed, electrophoresis of retentates of these filters, demonstrated that bands
of protein less than 100 kDa were routinely observed, even after repeated
washing and refiltering, suggesting that the active progesterone b.p. can be
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resolved into two or more sub-units by SDS/2-mercaptoethanol reduction.
Unfortunately, because of the lack of a pure sample of progesterone b.p. to
raise antibodies, it was not possible to identify which protein bands were
involved in progesterone binding activity, and were part of the progesterone
binding complex.
The complete loss of all activity in experiments using chromatofocusing and
affinity media was somewhat surprising. Given that each of these matrices
has a reasonably high porosity the likelihood of the protein-detergent
complex, (which may be large) being completely sterically hindered is
unlikely. Hydrophobic interaction chromatography resin was also tested
(results not shown) in a batch test without any sucessful recovery of activity,
however, this was not considered to be an ideal tool for the purification of
this particular protein, since the presence of any detergent will effectively
attenuate hydrophobic interactions between protein and gel. In the case of
the affinity gel, it was demonstrated that the gel itself was responsible for the
loss of activity. The reason for this was unclear, since losses occurred in the
absence of digitonin, and thus could not be accounted for by instability of
the activated binding protein compared to its inactive, un-(digitonin)-
stimulated state. Inactivation occurring with hydrophobic interaction
chromatography may possibly be accounted for by separation of subunits,
with the differential elution of each subunit of the progesterone b.p. No
logical explanation can be given for the inactivation that occurred when the
progesterone b.p was in contact with the chromatofocusing gel. This
technique is a relatively recent innovation compared to the other purification
strategies employed. Its advantages include its compatability with
detergents. The buffers used in all of these procedures were tested
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separately, but had little or no deleterious effect on progesterone binding
activity. Also, these losses cannot be accounted for by some spurious size
separation caused by the matrix, since batch tests revealed that activity was
lost to the same degree as was observed in column studies. Had this been
the case, then it would have been expected that losses of the same order
would also be encountered when using ion-exchange gels. Clearly this was
not the case. Proteolysis is also unlikely to be the cause, since increasing
protease inhibitor concentrations had no effect on conservation of
progesterone binding activity after contact with these gels. It is thus difficult
to speculate on the causes of these losses of activity. A number of other gels
are commercially available for these methods of protein purification, but due
to constraints of time, the testing of other available products was not
possible in this study. A number of new protein purification strategies have
recently been developed which may provide future progress with this work,
such as the 'Rotofor' system developed by Bio-Rad. This system allows the
electrophoresis (from preparative stages up to final purification stages) of
proteins in free solution, similar to PAGE/isoelectric focusing using
polyacrylamide gels. Powerful techniques such as this were outwith the
timescale imposed by completion of this thesis, however.
Given the relative instability of the progesterone b.p. as indicated by the
large losses of activity encountered during attempts to purify it, it was
somewhat surprising that activity could be reconstituted from freeze-dried
extracts. The fact that this was possible, will enable long term storage of
semi-pure progesterone b.p. without any inherent problems of proteolytic
degradation upon thawing of frozen aqueous extracts.
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From the results of the SDS/PAGE purity checks, it is clear that the goal of
purifying the progesterone b.p. was not achieved. Nonetheless, it can be
seen from Plate 5.3.3 that a reasonably pure sample of progesterone b.p. was
obtained. This gel showed that the filtrate from 100 kDa nmwl cut-off filters
(where there is no progesterone binding activity) lacked 2 protein bands
which were present in the retentate and semi-pure progesterone b.p.
preparations. It would appear likely from the heavy amounts of protein
present in both filtrate and retentate that the 69 kDa band may be a serum
protein. This protein cannot be the progesterone b.p. however, because of its
presence in the filtrate. Thus it is possible that the progesterone b.p. is either
one of the bands larger than 69 kDa, or indeed, a complex of these bands. A
progesterone binding complex would appear to be the most likely, since
binding activity was retained by 100 kDa filters, yet (when run out under
reducing conditions) the retentate appeared to contain 2 bands (in addition
to the heavy 69 kDa band), both of which had molecular weights less than
100 kDa. A combination of these bands yields a molecular weight greater
than 100 kDa, and would thus be retained by these filters. This possibility of
a multimeric progesterone binding complex of two or more suburiits may
also explain the activity losses encountered in gel filtration experiments.
Further experiments would be required to test whether the progesterone
binding site consists of smaller protein subunits which can be separated by
size, and which do not appear to re-associate when re-mixed together.
In summary, attempts were made to purify the progesterone binding protein
from the bovine corpus luteum. Though some degree of success was
achieved, results from techniques commonly employed in protein
purification were disappointing. Losses of activity were high, and more
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importantly, could not be fully explained even after experimental
investigation. It would appear likely, however, that the progesterone b.p. is
not a single moiety, but more probably is composed of two or more subunits.
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Chapter 6
Investigation of the mechanism of action of digitonin in
activation of bovine luteal progesterone binding sites
6.1 Introduction
In previous chapters it was demonstrated that both the bovine corpus
luteum and follicle possessed progesterone binding sites which were distinct
from the genomic progesterone receptor. These binding sites appeared to be
localised to the plasma membrane.
To demonstrate progesterone binding to these binding sites, the presence of
the saponin digitonin was required in all binding incubations. The work
detailed in this chapter was designed to attempt to determine the action of
digitonin on these novel progesterone binding sites, and through this to gain
a deeper understanding of the possible physiological action of these binding
sites. Given the difficulties encountered during the purification of the
progesterone binding protein, further elucidation of the way in which
digitonin interacts with the binding protein may provide another avenue
through which new purification rationales based on digitonin : binding site
interactions may be utilised.
Digitonin and other digitalis analogues such as digoxin, digitoxin etc. are
derived from the foxglove Digitalis purporea. The main medicinal use of
digitalis-derived saponins has been in the treatment of congestive heart
failure and some cardiac arrhythmias, usually in the form of digoxin. It is
for this reason that the parent digitalis compounds and their analogues are
often classified as cardiotonic steroids
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Interactions between digitonin and cholesterol have been exploited in a
number of biochemical techniques, most notably freeze-fracture membrane
studies. Studies demonstrated that by complexing digitonin to membrane-
localised cholesterol, losses of cholesterol during further experimental
procedures leading to electron microscopy could be minimised (Darrah et al,
1971). The experiments which lead to this discovery utilised digitonin as a
marker of 3-13-hydroxysterols, to which it binds in a unimolecular manner
(Severs & Robeneck, 1983).
More recently, it has been suggested that an endogenous digitalis-like factor
may be present in certain tissues, notably the human ovary (Jakobi et al,
1991). It has been suggested that there may be some correlation between
increased levels of this endogenous digitalis-like factor and hypertension
during pregnancy (Gusden et al, 1984; Graves & Williams, 1984; Poston et al,
1989), though evidence for this link, and indeed evidence for the existence of
the endogenous digitalis-like factor remains incomplete (see Chapter 7,
General Discussion for further details).
Digitonin forms unimolecular non-covalent complexes not only with
cholesterol, but also with other steroids which possess a 3-fi-hydroxy-A5
configuration and a C17 side chain (Miller, 1984; Severs & Robeneck, 1983;
Murphy & Martin, 1985). Thus, whereas digitonin will complex with
cholesterol and pregnenolone, no interaction would be expected with
progesterone. From the results presented in Chapter 3, this would appear to
be the case, since progesterone binding does not occur in tubes containing
only digitonin and [3H]-progesterone without the inclusion of luteal
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membranes. Moreover, HPLC analysis of progesterone recovered from the
binding site (thus, after exposure to digitonin) indicated that the only steroid
recovered was free progesterone. It is the interaction between digitonin and
cholesterol which causes the increase in buoyant densities of cellular
membranes containing unesterified cholesterol when homogenates of
corpora lutea are incubated in the presence of digitonin prior to
fractionation.
The experiments in this study were designed to examine the role of digitonin
in stimulating progesterone binding in the bovine corpus luteum, by first
identifying whether or not the interaction between the progesterone binding
site and digitonin is direct, and focussing on the mechanism of this
interaction. Secondly, the specificity of this interaction with regard to
whether or not other saponins and compounds with similar actions could
mimic the effects of digitonin on progesterone binding was investigated.
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6.2 Methods and materials
6.2.1 Trials of various commercial preparations of digitonin.
Preparations of digitonin were purchased from a number of suppliers in
various grades, and tested for their ability to stimulate progesterone binding.
The preparations used were
a/ BDH standard grade (prepared pre-1990)




f/ Calbiochem 'super-pure' (>99% pure digitonin)
Each preparation was dissolved in Tris HC1, pH 7.4, 0.1% BSA (progesterone
binding assay buffer) with gentle warming, to a concentration of 10 mg/ml.
Where the solubility of a preparation was too low to reach this concentration
in aqueous media, a lower concentration was prepared and the amount
added to the assay tubes was adjusted accordingly to enable direct
comparisons of the different preparations abilities to stimulate progesterone
binding at all concentrations tested. Progesterone binding assays were then
performed on pooled sucrose gradient fractions enriched in progesterone
binding as described in Chapter 3, using each of the digitonin preparations.
6.2.2 TLC separation of digitonin preparations
Solutions of Sigma digitonin and BDH digitonin were prepared in absolute
ethanol (1 mg/ml). 200 [il of each solution was spotted on to silica gel TLC
plates (Sigma) which had been equilibrated in running solvent, and
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separated using a solvent system of 9:1 chloroform: methanol (running
solvent). This solvent system was tested with pure digitonin (Calbiochem)
and was found to cause little or no movement of digitonin from the origin.
However, all other steroids tested with this system showed good migration.
Hence, any steroidal impurity in Sigma digitonin should be clearly resolved
from digitonin. As control/steroid identification lanes, 200 pg (1 mg/ml
solutions in absolute ethanol) of progesterone, testosterone, pregnenolone,
oestradiol, 17-a-hydroxyprogesterone and DHA were spotted on to the TLC
plate also. When the solvent front reached 4 cm from the top of the plate,
TLC plates were removed, air dried, then evenly sprayed with an aerosol of
20% (v/v) H2SO4 (in absolute ethanol). After air drying, plates were then
incubated at 100°C until charring of separated compounds was evident.
Once cooled, plates were photographed.
6.2.3 Use of digitonin analogues and other membrane perturbants to
mimic effects of digitonin
In the same way that different digitonin preparations were tested for their
ability to stimulate progesterone binding in Section 6.2.1, the following
substances were tested for their ability to stimulate progesterone binding.
Due to the relatively low solubilities of these substances in aqueous buffers,
all (apart from those marked by *) were dissolved in ethanol (10 mg/ml),
added to assay tubes and dried down under a stream of nitrogen. As
controls, tubes containing ethanol alone were also dried down. As a positive
control, an identical set of tubes was prepared and digitonin dissolved in
ethanol (10 mg/ml) added, then treated in the same way as tubes containing
the other compound tested. In the case of the two aqueous soluble saponins,
controls consisted of buffer alone, with no dissolved saponin, and a set of
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positive controls consisting of digitonin dissolved in assay buffer (Tris HC1,
pH 7.4), spanning the same concentration range as the compounds being
tested. In each case the progesterone binding assay was carried out as
described in Chapter 3. In experiments where the test compound had been
dissolved in ethanol and dried down, careful vortexing ensured maximum
resuspension of the dried residue in the incubation cocktail. The compounds
























In addition, each of these substances was also tested for their ability to
inhibit binding of [3H]-progesterone, as described for steroid displacement
assays in Chapter 3. With the exception of 18/ and 19/, each of the above
substances was assayed at least twice for both their ability to stimulate or to
displace [3H]-progesterone binding to two different pooled membrane
fractions enriched in progesterone binding. These two substances, the
streptolysins A and O, were each assayed only once due to the extremely
hazardous nature of these substances and subsequent disposal procedures.
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6.2.4 Determination of the importance of the sterol complexing activity of
digitonin during progesterone binding
Cholesterol digitonides and pregnenolone digitonides were prepared by
dissolving 1 mg of digitonin in ethanol (770 pmoles digitonin) and adding
either cholesterol or pregnenolone dissolved in ethanol at an excess of 100
(imoles. Thus, at these concentrations, all digitonin should be saturated, ie.
no free digitonin should be present. These mixtures were allowed to
complex overnight, at 4°C, then dried down under a Stream of nitrogen. The
resultant crystals were re-dissolved in absolute ethanol, and spotted on to a
silica gel TLC plate. As a control, 1 mg/ml digitonin was also dried down,
re-dissolved in absolute ethanol, then spotted on to a TLC plate. A solvent
mix of 9:1 chloroform : methanol was used to separate digitonides from free
steroid. The area in which the digitonides and digitonin equilibrated was
ascertained by running identical plates and charring as described above.
Since the digitonides showed little or no migration, whereas free steroid did,
ascertaining the area of silica to be removed was straightforward.
Digitonides (and control digitonin) were scraped off the TLC plate, and
eluted into absolute ethanol by incubating the silica scrapings in 500 pi
ethanol overnight at 4°C. To ensure elution of digitonides and control
digitonin from the silica, a sample of the eluted samples was run on a TLC
plate. From the molar ratios of digitonin and steroid present, the weight of
digitonide (and control digitonin) which corresponded to the amount of
digitonin required to demonstrate stimulation of progesterone binding was
calculated, and added to assay tubes at concentrations below and above the
threshold of digitonin stimulation of progesterone binding. Tubes were then
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dried down as described above, then assay cocktail added (with no
additional digitonin present) and progesterone binding determined.
6.2.5 Interaction of progesterone binding sites with digitonin
This experiment was designed to ascertain whether having activated
progesterone binding, digitonin remains bound, or, if this is not the case,
whether a steroid complexed to the digitonin can be demonstrated after
stimulation of binding. This required the purchase of [3H]-labelled
digitonin. Since radiolabeled digitonin was not commercially available, a
contract was taken out with DuPont (New England Nuclear Research
products) to prepare tritiated digitonin. The purest grade of digitonin
available (Calbiochem) was exposed to a stream of tritium gas for two
weeks. However, TLC of the radiolabeled digitonin supplied revealed that
massive degradation of digitonin had occurred; so that at best, only 0.5% -
1 % of the total product was represented by intact digitonin. Even if purified
to homogeneity, this would not have been sufficient to use experimentally.
At the time of writing this problem has not been resolved.
6.2.6 Investigation of the interaction between digitonin, progesterone
binding sites, and progesterone
To ensure that digitonin was not affecting binding by prior formation of a
steroid:digitonin complex, the progesterone binding assay was set up as
described previously but with delayed addition of membranes at various
times thereafter. The assay cocktail, including 25 |il 10 mg/ml digitonin was
added to tubes. Membranes were added to control tubes immediately,
whilst other tubes had membranes added at 15 minute intervals, up to 4
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hours. The experiment was performed in triplicate. Incubation was for two
hours (4°C) before separation of bound and free [3H]-progesterone.
6.2.7 Is digitonin required throughout progesterone binding ?
The aim of this study was to determine whether, once membranes had been
exposed to digitonin, removal of digitonin returned the progesterone
binding site to its inactive state, or if, once stimulated by digitonin, the
progesterone binding site remained in an active, stimulated state in the
absence of digitonin. 500 pi of pooled sucrose gradient fraction enriched in
progesterone binding was incubated with 1.5 ml assay buffer (Tris HC1, pH
7.4) containing 12.5 mg digitonin (equivalent amount of digitonin to normal
progesterone binding assay i.e. 10 pi of membranes incubated with 250 pg
digitonin) for 1 hour, at 4°C. As a control, 500 pi of the same pooled
fractions were incubated with buffer alone. The mixtures were loaded into
separate 30,000 nmwl centrifugal separators (Millipore) and centrifuged at
750 gav until all liquid had been removed. Membranes were then
resuspended in Tris HC1, 0.1 % BSA, pH 7.4 (containing no digitonin) (assay
buffer) and re-centrifuged. This wash step was repeated twice. Membranes
were finally resuspended in assay buffer to the original volume (500 pi).
Progesterone binding was assayed on 15 pi aliquots of each membrane
preparation (digitonin-stimulated and control membranes) in triplicate, with
or without digitonin added to the assay (250 pg). Progesterone binding was
then assayed as described previously.
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6.3 Results
6.3.1 The potency of different digitonin preparations stimulation of
progesterone binding
All of the digitonin preparations tested were capable of stimulating [3H]-
progesterone binding to pooled bovine luteal sucrose gradient fractions
enriched in progesterone binding activity (Figure 6.3.1). However, the
different preparations displayed different potencies. Calbiochem (pure
digitonin) was the most potent of the preparations tested. However, at
concentrations above 500 pg/tube, decreased binding was observed. The
other preparations of digitonin did not decrease binding until concentrations
in excess of lmg/tube were reached. Digitonin supplied by Sigma was the
least potent stimulator of progesterone binding activity. TLC of Sigma and
BDH digitonin preparations revealed no differences in migration or the
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Figure 6.3.1 Trial of abilities of different commercial preparations of
digitonin to stimulate [3H]-progesterone binding to bovine luteal
membranes enriched in progesterone binding activity.
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Plate 6.3.1 Thin layer chromatography of BDH digitonin and Sigma
digitonin, using a 9 :1 chloroform : methanol running solvent. l=200jxg BDH
digitonin, 2=200|i.g Sigma digitonin, 3=200pg progesterone, 4=200|i.g
testosterone, 5=200pg pregnenolone, 6=200pg oestradiol-17b, 7=200|ig 17-
hydroxyprogesterone, 8=200pg DHA.
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6.3.2 Ability of digitonin analogues, cardiotonic steroids and other
membrane perturbants and detergents to stimulate or displace
progesterone binding.
Apart from digitonin, none of the substances tested displayed any
stimulation of progesterone binding activity, nor did any of these substances
inhibit/compete for progesterone binding sites. Digitonin stimulated [3H]-
progesterone binding to the same extent after being dissolved in ethanol,
dried down and reconstituted in assay buffer as was observed using
digitonin dissolved in the usual manner.
6.3.3 TLC of pregnenolone and cholesterol digitonides to remove free
steroid
Plate 6.3.2 shows the mobility of the digitonides and free steroids present in
digitonide preparations. As can be seen from this plate, digitonides do not
migrate using a solvent system of 9 :1 chloroform : methanol, however, both
pregnenolone and cholesterol showed considerable migration, allowing
separation of digitonides from free steroids.
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Cholesterol Pregnenolone Digitonin Cholesterol Pregnenolone
Digitonin Digitonin
Plate 6.3.2 TLC of pregnenolone and cholesterol digitonides using a 9 : 1
chloroform : methanol solvent system.
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6.3.4 Effects of pregnenolone and cholesterol digitonides on progesterone
binding
Pregnenolone : digitonide was unable to stimulate progesterone binding
above non-specific levels. Though apparent slight stimulation of
progesterone binding occurred at low concentrations of cholesterol
digitonide, increasing the cholesterol : digitonide concentration lowered
progesterone binding. Digitonin which had been processed in the same
manner but not complexed to steroid retained its ability to stimulate
progesterone binding (figure 6.3.2).
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Amount of digitonin/digitonin present
in digitonide added (mg)
Figure 6.3.2 Ability of cholesterol and pregnenolone digitonides to stimulate
progesterone binding. The digitonin tested in these experiments had been
processed (see Section 6.2.4 Methods and Materials) in the same manner as
the digitonides. The amount of digitonin present in each digitonide
preparation was calculated and the amount of digitonide added to the assay
adjusted accordingly so that each point contained the same amount of
digitonin (as digitonide) as the assay containing uncomplexed digitonin.
Heavy black line indicates levels of stimulation achieved using fresh
digitonin that was dissolved in assay buffer. Heavy black broken line
indicates levels of non-specific binding. Preg dig = pregnenolone digitonide,
chol dig = cholesterol digitonide, Rec dig = digitonin recovered from TLC
plate (uncomplexed - see methods and materials).
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6.3.5 Stimulation of membranes with digitonin followed by subsequent
removal of digitonin
Membranes which had been stimulated with digitonin remained in an active
stimulated state after removal of digitonin. No further digitonin stimulation
was required for these membranes to bind [3H]-progesterone. When
digitonin-prestimulated membranes were assayed in the presence of
digitonin, no additional stimulation was observed. Control membranes
which had not been previously stimulated by digitonin showed binding only
in the presence of digitonin added during the assay; no binding was
observed in the absence of digitonin in the assay cocktail (Figure 6.3.3).
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Figure 6.3.3 Effects of stimulation of luteal membranes with digitonin and
subsequent removal of digitonin prior to assay for [3H]-progesterone
binding + digitonin added to the assay.
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6.3.6 Preincubation of membranes and [3H]-progesterone with digitonin
prior to assay (Figure 6.3.4)
Preincubation of [3H]-progesterone with digitonin prior to addition of luteal
membranes had no effect on binding of that [3H]-progesterone to pooled
luteal membranes (enriched in progesterone binding activity), relative to
levels of binding measured when [3H]-progesterone was preincubated with
buffer alone, then added to the rest of the assay. Preincubation of luteal
membranes with digitonin prior to assay had little effect on binding, as
compared to levels observed when [3H]-progesterone was incubated with
digitonin or buffer. However, preincubation of membranes with buffer prior
to assay caused a reduction in [3H]-progesterone binding (15% bound as
compared to 25% bound in samples where membranes had been incubated
with digitonin prior to assay) which was time dependent. Decreased
binding was not observed until membranes and buffer had been incubated









membranes preincubated with digitonin
[3H]-P4 preincubated with digitonin
membranes preincubated with buffer
[3H]-P4 preincubated with buffer
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Figure 6.3.4 Effects of preincubation of membranes and of [3H]-
progesterone with digitonin prior to addition of rest of assay cocktail. Figure
is representative of two such experiments.
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6.4 Discussion
Digitoniri was found to be the major saponin component present in
preparations of digitalis derived from the foxglove Digitalis purpurea. Since
then, the presence of another saponin, gitonin, in preparations of digitonin
has been recognised (Fieser & Fieser, 1959). Whereas the glycosidic
sidechain of digitonin is composed of two glucose, two galactose and one
xylose units, that of gitonin consists of only 3 galactose and one xylose. In
commercial preparations of digitonin there may be up to 10 - 20%
contamination by gitonin (Fieser & Fieser, 1959), unless the preparation
states otherwise (eg. Calbiochem "pure" digitonin).
The major use of digitonin has been in freeze fracture membrane studies.
These techniques have exploited the 1:1 non-covalent interaction between
digitonin and unesterified cholesterol and other 312-hydroxysterols (Severs &
Robeneck, 1983). When digitonin interacts with cholesterol in membranes,
characteristic lesions are produced which are indicative of the presence of
sterols when the membrane is viewed by freeze fracture (Severs & Robeneck,
1983). Two other chemicals are commonly used for such techniques, the
saponin tomatin and the polyene antibiotic fillipin, both of which appear to
have similar actions to digitonin (Severs & Robeneck, 1983). Another major
use of digitonin has been in the processing of tissue for electron microscopy,
since incubation of tissue with digitonin alleviates the problem of loss of
cholesterol during tissue preparation (Napolitano & Scallen, 1969; Sterzing &
Napolitano, 1972; Napolitano et al, 1972). Since then, the uses of digitonin
have multiplied, but in essence all of its uses pertain to its interaction with
cholesterol. Originally, in this study, digitonin was used to perturb the
265
buoyant densities of membranes containing unesterified cholesterol as a tool
to examine associations between luteal progesterone and luteal intracellular
organelles (Chapter 2). However, the experiments described in this chapter
were designed to elucidate the mechanism by which digitonin stimulated
progesterone binding to isolated bovine luteal membranes.
It was of interest to note the different potencies of different preparations of
digitonin with respect to the stimulation of [3H]-progesterone binding to
bovine luteal sucrose gradient fractions. Since the pure digitonin
preparation from Calbiochem stimulated binding, it would appear that it is
indeed digitonin that causes stimulation of progesterone binding, not an
impurity present in digitonin from other commercial suppliers. This
preparation decreased binding at concentrations above 500 jig/tube. The
reasons for this decrease are unclear, though digitonin at such high
concentrations may interfere with the binding site. The solubility of BDH
preparations of digitonin in aqueous buffers appeared to have lessened.
Before 1990, digitonin was supplied to BDH by a Swiss company, but after
1990 it was supplied by a German company. How this resulted in a change
in the solubilities of the two preparations is unclear. However, BDH
themselves were unaware of this change, so no further information was
forthcoming. It was of interest to note that the digitonin preparation
supplied by Sigma was the least potent stimulator of [3H]-progesterone
binding of all the preparations tested. Though the supplier was consulted on
the purity of their product and the purity checks which were employed, no
information was forthcoming on why this digitonin preparation appeared to
be different to other digitonin preparations tested. Certainly
chromatography on TLC plates revealed no differences between Sigma and
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BDH preparations. However, these experiments used only one solvent
system, and it is possible that chromatography under different conditions
may have revealed an impurity. The presence of an impurity in Sigma
digitonin preparations may inhibit binding, or, if the level of impurity is
high enough less Sigma digitonin would be added to binding assays relative
to other preparations tested. The impurity present runs similarly to
digitonin on TLC, and it may be gitonin (Fieser & Fieser, 1959). Since gitonin
is not commercially available it was not possible to test it for any stimulatory
or inhibitory effects on steroid binding.
None of the digitonin analogues tested stimulated [3H]-progesterone
binding to membranes, nor competed for binding when [3H]-progesterone
binding was measured in the presence of digitonin. Also, none of the other
detergents or cholesterol perturbants tested either stimulated or inhibited
binding in the presence of digitonin. Of particular interest was the lack of
effect of tomatin and filipin. Both of these compounds have been used
extensively for electron microscopy and freeze fracture techniques (Severs &
Robeneck, 1983; Elias et al, 1979; Steer et al, 1984). Both tomatin and filipin
have been observed to cause similar lesions in membranes to those caused
by digitonin (Elias et al, 1979). However, filipin cannot interact with
membrane cholesterol in regions of membrane coated with clathrin. When
clathrin is removed, filipin : cholesterol interactions occur as normal (Steer et
al, 1984). Thus the progesterone binding site may have a similar domain
which is not activated by these cholesterol binding agents, but is activated by
digitonin. This would imply that digitonin alone can penetrate to interact
with membrane steroids. The action of digitonin on the progesterone
binding site is not due simply to a detergent effect, or to a cholesterol
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perturbation effect. From the results of preincubation experiments, it is clear
that digitonin did not directly interact with [3H]-progesterone. This is
backed by a wealth of literature on this subject which rules out digitonin -
progesterone interaction at physiological pH. However, the action of
digitonin on membranes must be extremely rapid, since no differences in
binding were observable between any of the time points in this study. A
rapid reduction of binding occurred when membranes were incubated with
buffer prior to assay (ca. 1 min), but binding did not decrease any further.
However, when membranes were incubated with buffer and digitonin prior
to assay, a decrease in binding occurred only after 15 minutes of incubation
time. It is likely that these decreases were due to endogenous proteolysis,
since no protease inhibitors were included in the preincubation cocktails.
The delay in the decrease of binding in the presence of digitonin may
indicate an inhibitory effect of digitonin on proteolytic enzymes.
From the results of the experiments in which digitonin was complexed to
cholesterol or pregnenolone, it is clear that the sterol binding domain of
digitonin is critical to the stimulation of progesterone binding activity.
However, since the mode of binding between digitonin and sterols is
unknown, it is not certain whether or not the digitonin-sterol binding site is
directly involved with stimulation of progesterone binding to luteal
membranes, or whether the lack of stimulation by digitonide is due to
formation of a larger, differently shaped complex which is unable to interact
with the progesterone binding site. If the sterol binding domain is indeed
directly involved in the stimulation of progesterone binding, then it may be
speculated that digitonin may complex with a (endogenous) sterol which
occupies this binding site, resulting in the release of a sterol: digitonide from
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the binding site, thus allowing progesterone tracer to bind. However, since
(as demonstrated in Chapter 2) a large proportion of endogenous luteal
progesterone is associated with this progesterone binding site, these
progesterone binding sites are probably normally occupied by progesterone.
Attempts have been made to resolve this point by extracting digitonin from
progesterone binding cocktails after digitonin treatment of luteal
membranes, and chromatographing (TLC) the extracted digitonin to see if
any other steroid is associated with it. However these experiments have met
with little success because of the extremely high detection sensitivities
required and the high levels of steroid co-extracted along with the digitonin
from assay incubations. It would appear likely that the mechanism of action
of digitonin may be complex, since other agents which will mimick at least
some of the known actions of digitonin (detergents, cardiotonic steroids,
sterol complexing and cholesterol perturbing agents) had no stimulatory
effect on [3H]-progesterone binding.
I have demonstrated that membranes remain in an activated state after
digitonin removal; that is, once the progesterone binding site has been
activated by digitonin, it no longer requires digitonin to be present in the
assay cocktail to bind progesterone. This provides further evidence that
digitonin interacts with the binding site directly rather than with
progesterone. Digitonin may bring about a conformational change in the
progesterone binding protein/complex which enables access of [3H]-
progesterone to the binding site. However, since digitonin is still required
for binding site activation even when the binding site has been solubilised
from its membrane by octylglucoside (Chapter 5), digitonin stimulation of
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progesterone binding is not dependent on enabling access of progesterone
across the luteal membrane on which the binding site is located.
The problems encountered when attempting to incorporate tritium (3H) on
to molecules of digitonin were unexpected. Degradation of digitonin to the
extent which occurred is difficult to explain, since digitonin is a relatively-
stable compound, requiring no special conditions (ie. temperature, humidity-
control) for long term storage. During consultation with the laboratory
which attempted this radiolabelling proceedure, it became evident that this
problem had occurred in the past with attempts to radiolabel digitonin,
though no explanation for this failure had been proposed. At the time of
writing the matter remains unresolved. Preparation of radiolabeled
digitonin will enable completion of this study.
Recently, a number of studies have been published in which progesterone
binding to sperm surface membranes has been reported. A recent article has
indicated the involvement of digitonin in this progesterone binding
(Ambhaikar & Puri, 1995). Interestingly, the studies reported in this article
indicated that progesterone binding was not observed in the absence of
detergents. However, in the presence of detergents, binding of progesterone
was evident. The most potent of the detergents tested was digitonin
(Ambhaikar & Puri, 1995). Similar concentrations of digitonin stimulated
[3H]-progesterone binding to the rat sperm cell surface membranes as were
required to promote [3H]-progesterone binding to bovine luteal cell surface
membranes. In sperm, RU 486 was unable to compete with [3H]-
progesterone for binding to spermatozoa, and 17 a-hydroxyprogesterone
and R5020 showed only partial displacement of [3H]-progesterone bound
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(Ambhaikar & Puri, 1995). Unlabelled progesterone displaced bound [3H]-
progesterone at nanomolar concentrations (Ambhaikar & Puri, 1995). Thus a
similar progesterone binding site to that studied here is present in
spermatozoa. Progesterone exposure to sperm surface causes an influx of
calcium. This may initiate the acrosome reaction (Blackmore et al, 1990). It
has been suggested that digitonin may unmask progesterone binding sites
on the spermatozoa cell surface (Ambhaikar & Puri, 1995). However, this
work is at present in its early stages. It will be of interest to follow the
progress of investigators studying the role and characteristics of this binding
site in sperm cells.
In summary, the action of digitonin which brings about stimulation of
progesterone binding is unlikely to be one of the 'classical' actions of
digitonin, since other membrane perturbants, cholesterol complexing agents,
saponins and detergents all fail to mimick the action of digitonin. Further
work is required to solve this enigma. The use of radiolabeled digitonin
should answer the question of how digitonin stimulates progesterone
binding, whilst purification of the protein complex which forms the
progesterone binding site may provide useful insights. It will be of
particular interest to follow the progress of workers who study progesterone
binding to sperm surface membranes, since the question of how digitonin





In this section the results presented in the preceding chapters will be
discussed further, evidence will be presented to clarify some of the
experimental results obtained, and literature on the possible relevance of the
progesterone binding site will be discussed.
7.1 The progesterone binding site is not a steroidogenic enzyme
In Chapter 3, it was observed that inhibitors of 313 - hydroxysteroid
dehydrogenase/A^-A^ isomerase, P450 17 a hydroxylase/C 17,20 lyase did
not compete with [3H]-progesterone for luteal progesterone binding sites.
Moreover, steroids which have equal or greater affinities than progesterone
for the steroidogenic enzymes did not displace [3H]-progesterone binding to
the extent that would be expected if steroid binding were due to binding to
one of these enzymes. It has been demonstrated that 313-hydroxysteroid
dehydrogenase is extremely sensitive to end-point inhibition, and has a
greater affinity for its product (progesterone) than it has for its substrate,
(pregnenolone) (Caffrey et al, 1979a). However, testosterone and oestradiol
are also potent inhibitors of this enzyme through the same end-point
inhibition that is exerted by progesterone (Caffrey et al, 1979a). Hence, if
binding of progesterone was due to binding to the active site of this enzyme,
then androgens and oestrogens would be expected to show potent
progesterone binding competition. Results of Western blots of fractions of
cow corpus luteum did not appear to correlate with the distribution of
progesterone binding sites in sucrose gradient fractions, although some
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overlap between the locations of the steroidogenic enzymes and
progesterone binding site was evident. To ascertain that progesterone
binding was completely distinct from steroidogenic enzymes the following
experiment was performed. Bovine luteal microsomes were prepared from
freshly prepared bovine luteal homogenate, resuspended in SET buffer, 10
mM n-octylglucoside, and mixed for 2 hours at 4°C. This mix was then
recentrifuged (100,000 gav 2 hours, 4°C), and the supernatant (solubilised
bovine luteal microsomes) removed. The solubilised microsomes were then
extracted batchwise by DEAE-Sepharose (Pharmacia). Extracted samples
were stored, and the binding site eluted from the gel with salt (see Chapter 5,
5.3.4). To SDS PAGE gels, 30 |ig of solubilised luteal microsomes, 30 pg
(total protein, measured by Lowry method) of DEAE extracted solubilised
microsomes, and 30 pg of (400 mM) NaCl elution from DEAE elution was
added. Finally, each gel was run including molecular weight markers and
suitable positive control tissues (human placental microsomes in blots for
immunodetection of 313 - hydroxysteroid dehydrogenase/A^-A^ isomerase,
P45O SCC and adrenodoxin, and bovine theca homogenate for P450 17 a
hydroxylase/C 17,20 lyase). Western blotting was carried out as described
in Chapter 2 (2.3.13), using the antibodies described therein. Fractions were
also assayed for progesterone binding activity. It was found that solubilised
luteal microsomes and the fraction eluted from DEAE-Sepharose with (400
mM) NaCl contained comparable amounts of progesterone binding activity.
The fraction that had been DEAE extracted was found to be depleted of
progesterone binding activity, as was expected from experiments detailed in
Chapter 5. Results of the Western blots (Figure 7.1) showed that (i) when
immunoblotted for P450 side chain cleavage, no detection of this enzyme is
evident in either the DEAE extracted fraction (progesterone binding
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depleted) or the DEAE eluted fraction (progesterone binding enriched)
indicating that P450 SCC is extracted by DEAE but not eluted by 400 mM
NaCl and thus cannot be the progesterone binding site, (ii) when
immunoblotted for P450 17 a hydroxylase/C 17,20 lyase, both the DEAE
eluted and extracted fractions showed no detection of this enzyme, and,
since the DEAE eluted fraction contained progesterone binding activity,
progesterone binding cannot be due to this enzyme, and finally (iii) when
immunoblotted using an antibody directed against 3fi - hydroxysteroid
dehydrogenase/A^-A^ isomerase, no detection was evident in DEAE
extracted fractions (progesterone binding depleted). Detection of this
enzyme was observable in DEAE eluted fractions (progesterone binding
enriched), however, much lower detection of 313 - hydroxysteroid
dehydrogenase /A^-A^ isomerase as compared to levels of detection in
solubilised bovine luteal microsomes was evident. Given that solubilised
bovine luteal microsomes and the fraction eluted from DEAE-Sepharose
with 400 mM NaCl contained comparable amounts of progesterone binding
activity, progesterone binding cannot be due to binding to this enzyme.
Thus, the possibility of the progesterone binding studied here being due to
steroid binding to one of the steroidogenic enzymes can be ruled out.
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Figure 7.1 Western blotting of bovine luteal microsomal extracts for P450
side chain cleavage, 3f3-hydroxysteroid dehydrogenase/A^-A^ isomerase and
P450 17 a hydroxylase/C 17,20 lyase; sol. |i = n-octylglucoside solubilised
luteal microsomes, ex. = DEAE extracted solubilised luteal microsomes, el. =
400 mM NaCl elution from DEAE, and +ve = positive control tissue for
protein of interest. See text (7.1) for further details.
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7.2 Is there an endogenous digitonin-like activator in luteal tissue ?
The existence of an endogenous digitalis-like factor / naturetic hormone
(DLIF) which has the ability to inhibit Na+, K+ ATPase has been suggested
by a number of studies. The existence of this substance(s) is often associated
with conditions involving fluid volume expansion (Gruber et al, 1980; Graves
& Williams, 1984; Jakobi et al, 1987; 1989). The presence of DLIF in follicular
fluid of gonadotrophin treated women has been demonstrated (Jakobi et al,
1989). The ovarian follicles of such patients have undergone a marked
volume expansion. The source of DLIF has been suggested to be the ovary
(Jakobi et al, 1991). However, other investigations have indicated the source
of DLIF to be the adrenal glands, (Tamura et al, 1986), cardiac tissue, (Fagoo
et al, 1986) and hypothalamic tissue (Anner et al, 1990). Much attention has
focused on the adrenal as a source of DLIF. Using stimulators and inhibitors
of Cortisol secretion from the adrenal cortex, it has been demonstrated that
increased DLIFlevels in plasma occur in conjunction with stimulation of
Cortisol secretion (Vinge et al, 1993).
False-positive results have been reported when serum from third-trimester
pregnant women was subjected to radioimmunoassay for digoxin (Kerkez et
al, 1990). A link between elevated DLIF levels and pregnancy-induced
hypertension has been suggested (Gusden et al, 1984; Graves & Williams,
1984; Poston et al, 1989). However, other workers have refuted this
suggestion (Gonzalez et al, 1987) and studies designed to investigate DLIF
levels as a clinical indicator of hypertension have concluded that the
correlation between DLIF levels and hypertension was too low to be of use
clinically (Kerkez et al, 1990).
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Digoxin is derived from the foxglove Digitalis purpoea, and shares a similar
structure to digitonin, which is also derived from this source. This raises the
possibility of a substance of ovarian origin (DLIF) which may be structurally
similar to digitonin. Such a substance may act as an (endogenous) activator
of progesterone binding protein in the luteal cell. Experiments to determine
DLIF levels in homogenates of bovine corpora lute and bovine luteal sucrose
gradient fractions were undertaken. However, the commercial assay kit to
detect digoxin that most workers have used to determine DLIF levels
(RIANEN, New England Nuclear) was no longer available. An anti-digoxin
antibody purchased (Sigma) had only very low cross-reactivity with digoxin.
Though a number of batches of this antibody were tested, the antibody titre
that gave reasonable detection of digoxin was so low that assay sensitivity
was lost. Information from the supplier revealed that the antibody was
raised against a digoxin-conjugate, which because of its large size and shape
produced an antibody which recognised free digoxin poorly. At the time of
writing no other anti-digoxin antibodies are available to resolve this
problem.
Other experiments involved TLC of solvent extracts of bovine corpora lutea
to ascertain if compounds which migrated similarly to digoxin, digitonin
and a number of other digitonin analogues were present. No such
endogenous substances were detected in these experiments (data not
shown). However, this does not discount the possibility that such a
substance may exist, since the efficiency of extraction of such compounds
from luteal tissue was not determined, and the sensitivity of detection
(H2SO4 charring) is known to be low.
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If indeed the bovine corpus luteum did contain an endogenous activator of
progesterone binding that operated in a similar way to digitonin in in vitro
studies, (whether or not this substance is related to digitonin) it may be
present in extremely small quantities. Given the high steroid concentration
in this tissue, detection would be difficult. Conversely, the source of
progesterone binding activator may not be the ovary, and activation of luteal
progesterone binding effects may be regulated in an endocrine fashion by
another organ. Progesterone binding protein /non-classical progesterone
receptors in the corpus luteum would remain inactive until secretion of
endogenous activator stimulated them. Clearly, this is an area that requires
further investigation. However, activation of the progesterone binding site
occurs in vivo, since fractionation of bovine corpora lutea without exposure
to digitonin indicates association of endogenous progesterone with this
binding site.
7.3 Are progesterone binding sites present only in steroidogenic tissues ?
To ascertain whether or not the progesterone binding site examined here
was present in any other organ apart from the ovary, homogenates of other
bovine tissues were preparedand assayed for progesterone binding activity.
The tissues treated in this way were bovine lung, kidney, heart, liver, skeletal
muscle and adrenal gland. Binding of [3H]-progesterone to these tissues
could only be detected in the presence of digitonin. Levels of binding were
varied in these tissues, though the specificity of binding sites for
progesterone was similar to that determined in the corpus luteum (Table
7.1).
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(numbers of + denotes levels of binding activity found)
Table 7.1 Levels of progesterone binding activity found in various tissues.
Thus, it is clear that the progesterone binding site is not exclusive to the
bovine ovary. Thus, it appears unlikely that the progesterone binding sites
are involved in the secretion of progesterone, as originally postulated.
Progesterone and progesterone metabolites are known to have anaesthetic
effects in a number of tissues (Backstrom et al, 1990). Thus, the binding site
studied herein may represent the membrane protein through which these
anaesthetic effects are mediated. Furthermore, a large body of evidence
exists which shows that steroids, in addition to their classical, genomic
actions, also have non-genomic receptor mediated effects on a number of cell
types. It is not possible that the progesterone binding studied here is a
general, 'fluke' effect that occurs with tissues in the presence of digitonin.
Evidence to refute this possibility came from experiments in which bovine
corpora lutea were fractionated without any exposure to digitonin.
Endogenous progesterone was found to be localised in the same fractions
(by radioimmunoassay) as the progesterone binding site, thus the
progesterone binding site was occupied by progesterone before any
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artifactual effects of digitonin could have occurred. Levels of binding
differed between tissues, and, between cell types of the same tissue. Thus,
different levels of progesterone binding activity were observed in theca and
granulosa cell membranes from the same bovine pre-ovulatory follicles, and
between small and large luteal cells isolated from the same corpus luteum.
7.4 The progesterone binding site may be a non-genomic steroid receptor
The significance of progesterone binding to membranes from other tissues
remains unclear. However, these progesterone binding sites do not appear
to be involved in the mechanism of progesterone secretion (though, in the
absence of studies of progesterone synthesis in other tissues, this possibility
cannot be completely discounted). Indeed, progesterone may have a range
of effects which at present are unknown. The nature of progesterone
binding to these other tissues and effects of progesterone on these tissues
clearly requires more work, however, this was outwith the scope of this
thesis which is concerned only with the ovarian progesterone binding site.
Indeed, a recently published report has demonstrated the presence of
genomic progesterone receptor mRNA in male peripheral veins and blood
vessel walls (Bergqvist et al, 1993), though as yet there is no physiological
role of progesterone on such tissues. The presence of progesterone receptor
mRNA has also been demonstrated prostate stromal cells (Mobbs et al, 1990).
Furthermore, the presence of 3f3-HSD and the synthesis of progesterone in
Schwaan cells has also been reported, where it may play a role in promotion
of myelin repair (Koenig et al, 1995). Hence, the actions of progesterone may
be much wider and more diffuse than its functions as a sex steroid. Indeed,
the progesterone binding site may actually be a form of non-genomic, non-
classical, plasma membrane located progesterone receptor. Putative plasma
280
membrane receptors for steroids have been previously suggested. Specific
progesterone binding to synaptosomal membrane preparations of the
mediobasal-hypothalamic-anterior hypothalamic-preoptic area of rat brains
has been demonstrated (Tischkau & Ramirez, 1993). In common with the
binding site investigated herein, alterations to the Cll position of
progesterone decreased binding potency, however Cll iodinated
progesterone was bound to some degree. Alterations to the C3 position did
not appear to affect binding. Although digitonin was not required to
stimulate binding in these preparations, digitonin was the detergent used to
solubilise membrane fractions. Thus, progesterone binding to these fractions
may have been stimulated by digitonin. These experiments concluded that
the hypothalamic membrane progesterone binding site were sex-specific.
Moreover, the levels of progesterone binding were oestrogen-dependent
(Tischkau & Ramirez, 1993). Recently, progesterone has been shown to
increase oxytocin receptor mRNA in the hypothalamus of lactating rats
(Thomas et al, 1995). Moreover, this effect was observed in cells in which
few, if any, genomic progesterone receptors can be demonstrated, and was
suggested to perhaps be mediated through a non-genomic steroid receptor
(Thomas et al, 1995).
Progesterone has been observed to affect brain cell excitability. These effects
were observed to be extremely rapid, and, furthermore, were demonstrated
in the cerebellum and where few intracellular steroid receptors could be
observed (Smith et al, 1987). Indeed, conclusions reached from such studies
point to a mechanism of progesterone action other than that mediated via
classical intracellular receptors, with suggestions including progesterone
interactions with membrane binding sites (Smith et al, 1987). Furthermore,
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progesterone acts to expand the area occupied by oxytocin receptors in the
ventromedial hypothalamus of oestradiol-primed female rats (Schumacher et
al, 1990). This effect was observable within 30 minutes of progesterone
exposure and lasted up to 8 hours (Schumacher et al, 1990). It was concluded
that the effects of progesterone on these tissues were due to either a direct
effect of progesterone binding to the cell membrane or to an effect on the
oxytocin receptor, perhaps by the induction of a conformational change in
the oxytocin receptors from a low affinity state to an active high affinity state
(Schumacher et al, 1990), or the modification of the oxytocin receptors lipid
environment by intercalation of progesterone into the lipid bilayer. This
intercalation has been demonstrated in the corpus luteum (Carlson et al,
1983a). Nonetheless, these effects all appeared to be specific for
progesterone. Other steroids (5a-dihydroprogesterone, 3a-hydroxy-5a-
pregnane-20-one, cholesterol and oestradiol) all failed to affect the oxytocin
receptors (Schumacher et al, 1990). Thus, a recent review of steroid hormone
action concluded that steroids may act in two ways, (i) through the classical
genomic steroid receptors and (ii) by binding to membrane receptors to
produce very rapid effects (Wehling, 1994).
It was of great interest to note that other investigators have found a digitonin
activatable progesterone binding site with similar characteristics to the luteal
NCP4-BP studied herein. Studies have demonstrated that progesterone
initiates the acrosome reaction (AR) in sperm, via a rapid influx of calcium
(Blackmore et al, 1990). Follicular fluid triggers this effect (Thomas & Mizel,
1988), but once stripped with dextran-coated charcoal to remove steroids,
this effect was lost. Interestingly, it was noted that progesterone was less
potent than follicular fluid at triggering AR; in studies, it was observed that
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25 % fewer sperm underwent AR with progesterone than with follicular
fluid (Osman et al, 1989). It has been suggested that some other factor
present in follicular fluid may potentiate the progesterone response
(Ambhaikar & Puri, 1995). This raises the possibility of a novel class of
progesterone cell surface receptors in a variety of tissues and cell types,
whose presence has been previously unacknowledged due to their
requirement of digitonin for in vitro activation.
7.5 Progesterone binding is not due to either non-specific intercalation of
steroid into luteal membranes, or binding to steroid binding globulin
Progesterone binding did not occur to other luteal membranes, only to the
plasma membrane. Intercalation of progesterone into luteal plasma
membranes has been reported as non-specific interactions (Rice et al, 1986).
Clearly, the binding studied here was distinct from these interactions, since
binding was highly specific for progesterone. Moreover, if steroid
intercalation into membranes were responsible for progesterone binding,
other steroids, by their hydrophobic nature, would also be bound by the
binding site, and progestins such as RU 486 would be expected to show
some competition for binding. Moreover ANS, which blocks steroid binding
to Cortisol binding globulins, had no effect on luteal progesterone binding.
7.6 Possible physiological functions on non-classical progesterone
binding protein
In sheep, the onset of luteolysis is triggered by the action of PGF2C1 on large
luteal cells, via a specific PGF2CC receptor which consists of 362 amino acids
(Graves et al, 1995). Interestingly, levels of PGF2CC receptor appear to be
directly correlated with circulating progesterone levels (Graves et al, 1995).
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Large luteal cells respond to PGF2CC stimulation with activation of protein
kinase C (Wiltbank et al, 1989) and calcium release from intracellular pools
(Wegner et al, 1990; 1994) . In sheep, progesterone production is regulated
by both protein kinase A (PKA) and PKC. Small luteal cells do not possess
PGF20C receptors and thus cannot respond to PGF 2a. However, PKC is
inhibitory to progesterone production by both cell types (Wiltbank et al,
1993). Associated with PGF2a binding to large luteal cells, there is a rapid
and precipitious drop in 3(3 HSD mRNA levels in large luteal cells (ca. 80 %
decrease after 1 hour) (Hawkins et al, 1993). Since the synthesis of this
enzyme is constitutive, only a 28% fall in progesterone output from large
luteal cells (which account for ca. 80 % of total luteal progesterone) at this
time (Hawkins et al, 1993). It has been suggested that some form of
intercellular communication exists between large and small luteal cells and
that this communication transmits the luteolytic message from large cells to
small cells (Niswender & Nett, 1994). Thus, from the chronological sequence
of events in luteolysis, falling concentrations of progesterone may facilitate
the transmission of luteolytic signals from large luteal cells to small luteal
cells. These speculations are based on observations made in sheep; however,
a similar system would appear likely to function in the bovine corpus
luteum, though the acute role of PKC is less well defined. Nonetheless, if
progesterone does indeed have autocrine/paracrine actions on its own
synthesis, the non-classical progesterone receptors studied here may mediate
actions of progesterone in the corpus luteum. The suggestion that
progesterone may exert some control over its own synthesis is not new. In
1981, Rothchild postulated that progesterone had the ability to increase its
own synthesis and secretion. Hence, higher levels of non-classical
progesterone binding protein (NCP4-BP) found in large luteal cells as
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compared to small luteal cells would appear to fit with this hypothesis. If
progesterone secretion is increased by progesterone actions mediated via
NCP4-BP, then cells with a greater NCP4-BP level would secrete greater
amounts of progesterone. Indeed, the large luteal cells of the bovine corpus
luteum were demonstrated to contain the highest levels of NCP4-BP. Also, it
is not known why basal secretion of progesterone from small luteal cells is so
low as compared to basal progesterone secretion by large luteal cells,
though it does not appear to be due to cholesterol availability (Wiltbank et al,
1993). Thus it may be speculated that the low basal secretion of progesterone
from small luteal cells may be due to a lack of sufficient numbers of NCP4-
BP to mediate stimulatory effects opf progesterone. Experiments to test this
hypothesis would involve culturing separated luteal cells with inhibitors of
3{3 HSD (eg. epostane, trilostane) to lower endogenous progesterone levels,
and then adding exogenous progesterone to the cultures. Initially, we would
measure effects on the levels of steroidogenic enzymes and LDL receptor
expression, and on IP3 turnover, calcium influx and pregnenolone formation.
The use of inhibitors of classical progesterone receptors (RU 486) would
determine whether effects of progesterone observed were due to genomic
progesterone receptor binding, or to NCP4-BP. Since the NCP4-BP does not
bind RU 486, any effects of progesterone that were not abolished by RU 486
treatment could possibly be mediated by the NCP4-BP.
Studies which have addressed the suggestion that progesterone may have
actions on the corpus luteum have thus far concentrated on actions of
progesterone mediated via classic, genomic progesterone receptors. From
immunohistochemical studies, genomic progesterone receptors have been
observed in the theca and stromal cells of monkey (Hild-Petito et al, 1988)
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and human ovaries (Press & Green, 1988). Post-luteinization, human
granulosa-lutein cells stain positively for nuclear progesterone receptor
(Horie et al, 1992). A relationship between progesterone levels and
progesterone receptors in primate corpora lutea from the early and mid-
luteal phase has been demonstrated. However, there appeared to be a lack
of correlation between serum progesterone, progesterone receptor mRNA
and progesterone receptor during the late luteal phase (Duffy & Stouffer,
1995a). However, other recent studies failed to detect any change in levels of
progesterone receptor in human corpora lutea over the course of the luteal
phase (Duncan et al, 1995). LH has also been implicated in the control of
expression of progesterone receptor in granulosa cells from monkeys
(Stouffer & Duffy, 1995b).
Progesterone may act as a locally produced luteotrophin in the corpus
luteum (Rothchild, 1981) which stimulates its own synthesis and secretion.
Alternatively, it may play a role in the development and regulation of the
corpus luteum, or in the inhibition of antral follicle growth during the luteal
phase (Rothchild, 1981). Recent radioligand binding studies have
demonstrated progesterone receptor binding in the primate corpus luteum
when endogenous progesterone levels are decreased by inhibition of
steroidogenesis (Slayden et al, 1994), and progestins upregulate the activity
of the steroidogenic enzymes responsible for luteal progesterone synthesis in
rat granulosa cells (Ruiz de Galarreta et al, 1985) and pig theca cells (Tonetta,
1987). Moreover, progestins stimulate LH receptor expression in cultured
bovine luteal cells (Jones et al, 1992). Studies in chicken granulosa cells have
indicated that progesterone may play a role in the stimulation of fibronectin
production (Conkwright & Asem, 1995). However, no studies have yet
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addressed the question of whether progesterone may also have actions that
are not mediated via classical genomic progesterone receptors. From the
data presented here, there appears to be a correlation between progesterone
content and NCP4-BP levels in the bovine corpus luteum. NCP4-BP levels
are highest during the luteal phase when progesterone secretory activity is
maximal, however, due to the nature of tissue collection in these experiments
no information on circulating progesterone levels was available. Thus it will
be of value to examine both NCP4-BP levels in bovine luteal tissue and
circulating progesterone levels, as well as classical progesterone receptors
and progesterone receptor mRNA in the same animals.
7.7 Non-classical progesterone binding sites may be involved in the relief
of end-point inhibition of steroidogenic enzymes
As mentioned previously, progesterone, through end-point inhibition of 3(3
HSD, has the ability to inhibit its own synthesis. Ovine luteal 313-
hydroxysteroid dehydrogenase is extremely sensitive to end-point
inhibition, and has a six-fold greater affinity for its product (progesterone)
than it has for its substrate (pregnenolone) (Caffrey et al, 1979a). Thus, there
must be a mechanism which removes the inhibitory effects of progesterone
on its own synthesis. The most common suggestion is binding proteins
which sequester progesterone and thus prevent it competing with
pregnenolone for binding to 3(3 HSD (Caffrey et al, 1979a). Hence, higher
levels of binding protein would be required to facilitate higher levels of
progesterone synthesis. Thus, from the distribution of progesterone binding
protein in the cells of the ovary, it may be that in this tissue, non-classical
progesterone binding sites may function to alleviate end-point inhibition of
steroidogenesis. However, since the binding site is found in non-
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progesterone synthesising tissues, a function other than relief of end-point
inhibition would appear more likely.
7.8 Conclusion
In conclusion, the experiments presented in this thesis have demonstrated
for the first time the presence of non-classical progesterone binding sites
associated with the plasma membranes of bovine luteal cells. These non-
genomic progesterone binding sites do not appear to be a part of the
progesterone secretory mechanism. Present in both the bovine corpus
luteum and the bovine preovulatory follicle, these binding sites may be
involved either directly (as in the case of a non-genomic steroid receptor) or
indirectly (in the case of relief of end-point inhibition of steroid synthesising
enzymes by a progesterone binding protein) in the regulation of
progesterone synthesis in the bovine corpus luteum.
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